| pathwayRes |
pathway |
pathwayTitle |
HGNC |
| https://identifiers.org/wikipathways/WP1401_r123622 |
WP1401 |
Neurotransmitter release in cholinergic motor neurons |
/Y40H4A.1 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EEF2K |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF4G3 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF4EBP3 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/PABPC1 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF2AK2 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF4G1 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF4EBP1 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF4EBP2 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF4H |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF2AK1 |
| https://identifiers.org/wikipathways/WP32_r117350 |
WP32 |
Translation factors |
/EIF2AK3 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP7B1 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP4X1 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/HS2ST1 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP2W1 |
| https://identifiers.org/wikipathways/WP1029_r122565 |
WP1029 |
Notch signaling pathway |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP1018_r95783 |
WP1018 |
Apoptosis |
/GZMB |
| https://identifiers.org/wikipathways/WP1019_r120928 |
WP1019 |
FAS pathway and stress induction of HSP regulation |
/MIR34C |
| https://identifiers.org/wikipathways/WP1011_r117623 |
WP1011 |
TCR signaling pathway |
/PDPK1 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP27C1 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/SULT1C2 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP26C1 |
| https://identifiers.org/wikipathways/WP1006_r80841 |
WP1006 |
Metapathway biotransformation |
/CYP2F1 |
| https://identifiers.org/wikipathways/WP1050_r117036 |
WP1050 |
Oxidative stress response |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP1069_r117549 |
WP1069 |
Integrin-mediated cell adhesion |
/MIR34C |
| https://identifiers.org/wikipathways/WP1069_r117549 |
WP1069 |
Integrin-mediated cell adhesion |
/PDPK1 |
| https://identifiers.org/wikipathways/WP3176_r117959 |
WP3176 |
IL-17 signaling pathway |
/IL17RB |
| https://identifiers.org/wikipathways/WP3247_r105915 |
WP3247 |
Aflatoxin B1 metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3240_r117507 |
WP3240 |
Endoderm differentiation |
/MIR375 |
| https://identifiers.org/wikipathways/WP3280_r117534 |
WP3280 |
Heart development |
/MIR1-1 |
| https://identifiers.org/wikipathways/WP994_r106018 |
WP994 |
Oxidative phosphorylation |
/GZMB |
| https://identifiers.org/wikipathways/WP1005_r117527 |
WP1005 |
GPCRs, class B secretin-like |
/ADGRE1 |
| https://identifiers.org/wikipathways/WP1023_r95764 |
WP1023 |
mRNA Processing |
/CELF2 |
| https://identifiers.org/wikipathways/WP1013_r120484 |
WP1013 |
Triacylglyceride synthesis |
/MOGAT3 |
| https://identifiers.org/wikipathways/WP1053_r106011 |
WP1053 |
Estrogen metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP1053_r106011 |
WP1053 |
Estrogen metabolism |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP1025_r117479 |
WP1025 |
B cell receptor signaling pathway |
/PDPK1 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP7B1 |
| https://identifiers.org/wikipathways/WP1064_r117573 |
WP1064 |
Notch signaling pathway |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP4X1 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP2W1 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP27C1 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP26C1 |
| https://identifiers.org/wikipathways/WP1077_r125262 |
WP1077 |
Oxidation by cytochrome P450 |
/CYP2F1 |
| https://identifiers.org/wikipathways/WP2901_r123067 |
WP2901 |
Gonadotropin-releasing hormone (GnRH) signaling |
/MMP2 |
| https://identifiers.org/wikipathways/WP2901_r123067 |
WP2901 |
Gonadotropin-releasing hormone (GnRH) signaling |
/MMP14 |
| https://identifiers.org/wikipathways/WP2901_r123067 |
WP2901 |
Gonadotropin-releasing hormone (GnRH) signaling |
/PRKX |
| https://identifiers.org/wikipathways/WP3141_r105936 |
WP3141 |
BDNF signaling pathway |
/PDPK1 |
| https://identifiers.org/wikipathways/WP3132_r80689 |
WP3132 |
Regulation of toll-like receptor signaling pathway |
/MIRLET7E |
| https://identifiers.org/wikipathways/WP3139_r87525 |
WP3139 |
Gastric cancer network 2 |
/MIRLET7E |
| https://identifiers.org/wikipathways/WP3132_r80689 |
WP3132 |
Regulation of toll-like receptor signaling pathway |
/MIRLET7I |
| https://identifiers.org/wikipathways/WP3150_r117617 |
WP3150 |
Sulindac metabolic pathway |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3190_r87958 |
WP3190 |
NRF2 pathway |
/SLC6A18 |
| https://identifiers.org/wikipathways/WP3190_r87958 |
WP3190 |
NRF2 pathway |
/ADH7 |
| https://identifiers.org/wikipathways/WP3191_r117636 |
WP3191 |
TSLP signaling pathway |
/MTOR |
| https://identifiers.org/wikipathways/WP3209_r80804 |
WP3209 |
Arylhydrocarbon receptor (AhR) signaling pathway |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3209_r80804 |
WP3209 |
Arylhydrocarbon receptor (AhR) signaling pathway |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP3202_r123272 |
WP3202 |
Cell differentiation - index |
/MIR1-1 |
| https://identifiers.org/wikipathways/WP3197_r117515 |
WP3197 |
Focal adhesion |
/PDPK1 |
| https://identifiers.org/wikipathways/WP3198_r125339 |
WP3198 |
Glycerophospholipid biosynthetic pathway |
/MOGAT3 |
| https://identifiers.org/wikipathways/WP3226_r117477 |
WP3226 |
Aryl hydrocarbon receptor |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3226_r117477 |
WP3226 |
Aryl hydrocarbon receptor |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP3214_r105960 |
WP3214 |
Influenza A virus infection |
/MIR34C |
| https://identifiers.org/wikipathways/WP3227_r117637 |
WP3227 |
Thyroid stimulating hormone (TSH) signaling pathway |
/PDPK1 |
| https://identifiers.org/wikipathways/WP3234_r117613 |
WP3234 |
Sulfation biotransformation reaction |
/SULT1C2 |
| https://identifiers.org/wikipathways/WP3232_r117616 |
WP3232 |
Sphingolipid metabolism |
/ASAH2 |
| https://identifiers.org/wikipathways/WP3254_r106002 |
WP3254 |
Lidocaine metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3248_r105983 |
WP3248 |
Tryptophan metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3264_r108155 |
WP3264 |
Tamoxifen metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3264_r108155 |
WP3264 |
Tamoxifen metabolism |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP3248_r105983 |
WP3248 |
Tryptophan metabolism |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP3263_r97778 |
WP3263 |
Benzo(a)pyrene metabolism |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP3248_r105983 |
WP3248 |
Tryptophan metabolism |
/CYP7B1 |
| https://identifiers.org/wikipathways/WP3273_r117561 |
WP3273 |
Neural crest differentiation |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP3259_r89837 |
WP3259 |
Metastatic brain tumor |
/MIR34C |
| https://identifiers.org/wikipathways/WP3250_r117483 |
WP3250 |
Cardiac hypertrophic response |
/PDPK1 |
| https://identifiers.org/wikipathways/WP3248_r105983 |
WP3248 |
Tryptophan metabolism |
/CYP2F1 |
| https://identifiers.org/wikipathways/WP3259_r89837 |
WP3259 |
Metastatic brain tumor |
/MIRLET7E |
| https://identifiers.org/wikipathways/WP970_r117512 |
WP970 |
Fatty acid omega-oxidation |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP970_r117512 |
WP970 |
Fatty acid omega-oxidation |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP966_r116790 |
WP966 |
Insulin signaling |
/PDPK1 |
| https://identifiers.org/wikipathways/WP3273_r117561 |
WP3273 |
Neural crest differentiation |
/PAX7 |
| https://identifiers.org/wikipathways/WP970_r117512 |
WP970 |
Fatty acid omega-oxidation |
/ADH7 |
| https://identifiers.org/wikipathways/WP3282_r117615 |
WP3282 |
T cell receptor and co-stimulatory signaling |
/NRON |
| https://identifiers.org/wikipathways/WP981_r117571 |
WP981 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP993_r105949 |
WP993 |
Arylamine metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP978_r119000 |
WP978 |
EGF/EGFR signaling pathway |
/PDPK1 |
| https://identifiers.org/wikipathways/WP990_r117531 |
WP990 |
GPCRs, other |
/LGR6 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/TOB1 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/TOB2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/TXNRD2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOM |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/CTH |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/CTH |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/ABCA1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/ABCA1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SEPHS2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/ALOX5AP |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/GPX6 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/CBLIF |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOH |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/GPX4 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/APOE |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOV |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/LDLR |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/LDLR |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/LRP2 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/MAT1A |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOT |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/MSRB1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOS |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENON |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/PTGS1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOK |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOW |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/TCN1 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/CUBN |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOO |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOI |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/CBS |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/CBS |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOF |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/GGT1 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/RUNX2 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/BMP2 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/SMAD4 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/SMAD1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/DIO2 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/F2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/F2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/ALOX5 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/IFNG |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/IFNG |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/IL1B |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/IL1B |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/IL6 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/IL6 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/INS |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/INSR |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/NFKB1 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/CCL2 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/CCL5 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/SHMT2 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/BMPR2 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/TNF |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/ICAM1 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/MTHFR |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/MTR |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/MTRR |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/SOD2 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/SOD3 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/TCN2 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/SCARB1 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/BMPR1A |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/SMAD6 |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/BMPR1B |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/NOG |
| https://identifiers.org/wikipathways/WP1425_r126273 |
WP1425 |
Bone morphogenic protein signaling and regulation |
/SMURF1 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/CRP |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/ALB |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/F7 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/APOA1 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/APOB |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/MPO |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/NFKB2 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/SERPINE1 |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/PLAT |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/PLG |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/RELA |
| https://identifiers.org/wikipathways/WP1533_r121695 |
WP1533 |
Vitamin B12 metabolism |
/SOD1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CX3CL1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1G |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA2D2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK8IP2 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/MDH1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/WAS |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNB1 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/TCF3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG5 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG4 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/RUNX1T1 |
| https://identifiers.org/wikipathways/WP2942_r119083 |
WP2942 |
DDX1 as a regulatory component of the Drosha microprocessor |
/DDX1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1S |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MKNK2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1I |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/SALL4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1F |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL17 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CSK |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/NFKBIB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG7 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL24 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/WASL |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL7 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RAPGEF2 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/ZBTB16 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP16 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ITK |
| https://identifiers.org/wikipathways/WP2942_r119083 |
WP2942 |
DDX1 as a regulatory component of the Drosha microprocessor |
/DROSHA |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PTK2B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK8IP1 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/ACO1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PREX1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HSPA2 |
| https://identifiers.org/wikipathways/WP2942_r119083 |
WP2942 |
DDX1 as a regulatory component of the Drosha microprocessor |
/DGCR8 |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/AJUBA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP9 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/RARA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TAOK3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/HCRTR2 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/IDH1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK8IP3 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/PML |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG8 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA2D4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1C |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA2D1 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/WIF1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1D |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA2D3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNB3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HSPA6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNB4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP8 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NTF3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1H |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1E |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HSPA1B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HSPA1L |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NTF4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPP5D1P |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/NRON |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNG3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/ATP8A1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTHFS |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CXCR6 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTHFD2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR9 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/ALDH1L1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/FTCD |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP10 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/CHRNA3 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/CHRNA4 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/CHRNA5 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/CHRNB2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTFMT |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR4 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR7 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR8 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/CTLA4 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CX3CR1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/DHFR |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/DRD2 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/DRD3 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/DRD4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP7 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/DYRK1A |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/EDNRA |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/AHCY |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/EDNRB |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/AHCYL2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/FPR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/FPR2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/FPR3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NTSR2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/ACKR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/TAC4 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/GALR1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTHFD1L |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/GHSR |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/GLRX |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/AMT |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/GNRHR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR10 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CXCR3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/GRPR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/HCRTR1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HSPB1 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/KCNK3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPT |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MAT1A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAX |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NMBR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NPY1R |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NPY2R |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NPY6R |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NPY5R |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NTSR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/OPRD1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/OPRK1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/OXTR |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/PC |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/KCNK9 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/PDCD1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NLK |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K20 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPM1A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPM1B |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/AVPR1A |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/AVPR1B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPP3CB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPP3CC |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPP3R1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPP3R2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/NPY4R |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/ERBIN |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TAOK1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PTPN7 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PTPRR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/BDKRB2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CXCR5 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/SSTR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/SSTR2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/SSTR3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/SSTR4 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/SSTR5 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/BRS3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/TACR2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/TACR3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/TRHR |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/TYMS |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/PPP1R1B |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/DYRK2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/GALR3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PTPN5 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPKAPK5 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MKNK1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/GALR2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCKAR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCKBR |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/CHRNA6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TAOK2 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/CHDH |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K14 |
| https://identifiers.org/wikipathways/WP2942_r119083 |
WP2942 |
DDX1 as a regulatory component of the Drosha microprocessor |
/MRE11 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TNFRSF1A |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/GSK3B |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/DLD |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/FH |
| https://identifiers.org/wikipathways/WP2942_r119083 |
WP2942 |
DDX1 as a regulatory component of the Drosha microprocessor |
/NBN |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF8 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/DKK1 |
| https://identifiers.org/wikipathways/WP2942_r119083 |
WP2942 |
DDX1 as a regulatory component of the Drosha microprocessor |
/RAD50 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/BCL9 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/DLST |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/PCK1 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/WNT1 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/ACLY |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/PDHA1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NGF |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/MYC |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/AKT1 |
| https://identifiers.org/wikipathways/WP2942_r119083 |
WP2942 |
DDX1 as a regulatory component of the Drosha microprocessor |
/ATM |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PRKCA |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/SQSTM1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RPS6KA4 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/LRP5 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/IDH3A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP4K2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RAC3 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/PYGO1 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/SUCLG2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/GNG12 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HRAS |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/TRAF6 |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/UBE2N |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/IRAK1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK11 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/LRRK2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CHUK |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/UBE2V1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/AKT3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TAB1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP4K1 |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/CHUK |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K8 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ATF2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CRK |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK14 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DAXX |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/DDC |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/EGFR |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ELK1 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/AKT1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/AKT2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TAB2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FOS |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/FSHR |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/GART |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/GNA12 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/GNB1 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/GSK3A |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/GSK3B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HSPA1A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FAS |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/IKBKB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/IKBKB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/IL1B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/IL1R1 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/IL2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FASLG |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/INS |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/INSR |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/JUND |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/LCK |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ARRB1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ARRB2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/MC3R |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MEF2C |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K5 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K11 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MYC |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NFATC1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/NFKB1 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/NFKB1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NFKB1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NRAS |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PAK1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PAK2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ECSIT |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/GNG2 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/PPP3CA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPP3CA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PPP5C |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/PRKCA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK7 |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/MAPK8 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK8 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK9 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK10 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK13 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP2K5 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP2K7 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/PTPN6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RAC2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RAF1 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/RASA1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASA1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RPS6KA3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/BDNF |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPK12 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/CCL2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/SHMT2 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/SLC18A2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/SOS2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/SRF |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/STK3 |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TGFB1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TGFB2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TGFB3 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/TH |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/TNF |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TNF |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TP53 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TRAF6 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/ZAP70 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K12 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/IL1R2 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/CALM1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CASP3 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/CAT |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP4K3 |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/IKBKG |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/IKBKG |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/KMO |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/KYNU |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP3K13 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RPS6KA5 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CD14 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/CD28 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAP4K4 |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/CD40 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK13 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/COL1A1 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/RAF1 |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/NFKB1 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/NFKBIA |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK1 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK8 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK9 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK12 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK10 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK11 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/MAPK14 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/AKT3 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/CS |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NFATC3 |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/SDHA |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/OGDH |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/PPARD |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/CSNK1A1 |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/IL1A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FLNC |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FLNB |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/LEF1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNA1B |
| https://identifiers.org/wikipathways/WP2453_r123103 |
WP2453 |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
/DLAT |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ELK4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CACNB2 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/CDK5 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/TXNRD3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR5 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CRKL |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/CSNK1A1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/GADD45A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DDIT3 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/DNMT1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/DNMT3A |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/DNMT3B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/FOLH1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/GPX1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/GPX2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/GPX3 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/GSR |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NR4A1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/HSPA8 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/ICAM1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/IL1A |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CXCR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CXCR2 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTHFD1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/MTHFR |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTHFR |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/MTR |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTR |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MTRR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/OPRL1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/OPRM1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PRKCD |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/BHMT |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/SHMT1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SOD2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SOD3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/TACR1 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/TCN2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/PRDX2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/TXNRD1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/LAMTOR3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPKAPK2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SCARB1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CDC25B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASGRF1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGFR2 |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/PRKCZ |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGFR3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASGRP2 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/LRP6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF10 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF22 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NFKB2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ARAF |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF20 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/STK4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF14 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF9 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RELB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PLA2G4C |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF21 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF6 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PDGFRB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF12 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MAPKAPK3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PLA2G4A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF23 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/FLT3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RRAS |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF13 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RRAS2 |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/APC |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF5 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF7 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PRKACB |
| https://identifiers.org/wikipathways/WP3656_r117955 |
WP3656 |
Interleukin-1 induced activation of NF-kB |
/TIFA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NTRK2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASGRP3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF18 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/DUSP2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF17 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PLA2G4D |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGFR4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF11 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF19 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PRKACG |
| https://identifiers.org/wikipathways/WP3658_r116670 |
WP3658 |
Wnt/beta-catenin signaling pathway in leukemia |
/AXIN2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PLA2G4F |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/FGG |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/FGA |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/FGB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASGRP4 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RELA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF3 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PLA2G4E |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGF16 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NF1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PDGFA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PLA2G4B |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/RASGRP1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASGRP1 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/ADCY2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR3 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/CRP |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/DIO1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/DIO3 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/AGTR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/AGTR2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/EGF |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/EPHB2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/ALB |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/F7 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FGFR1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/MRAS |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/FLNA |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/FYN |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/MAT2B |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/GNAI1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/GRB2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/APOA1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/APOB |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/KRAS |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/STMN1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/LHCGR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/MC1R |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/MC2R |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/MC4R |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/MC5R |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/MPO |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/ATF4 |
| https://identifiers.org/wikipathways/WP241_r126998 |
WP241 |
One-carbon metabolism |
/ATIC |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/NFATC2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/NFKB2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/NTRK1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SERPINE1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PDGFB |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/PDK1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/PLAT |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/PLCG1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/PLG |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/PPP1CA |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/AVPR2 |
| https://identifiers.org/wikipathways/WP1602_r126381 |
WP1602 |
Nicotine effect on dopaminergic neurons |
/PRKACA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PRKACA |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/PRKCG |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/PTEN |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/PTGS2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RAP1A |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RAP1B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASA2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/RASGRF2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/RELA |
| https://identifiers.org/wikipathways/WP288_r125016 |
WP288 |
Nod-like receptor (NLR) signaling pathway |
/RELA |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/BDKRB1 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SELENOP |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/SOD1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/BRAF |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TGFBR2 |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/TRAF2 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/C3AR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/TSHR |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/C5AR1 |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CCR2 |
| https://identifiers.org/wikipathways/WP15_r125000 |
WP15 |
Selenium micronutrient network |
/XDH |
| https://identifiers.org/wikipathways/WP24_r126263 |
WP24 |
Peptide GPCRs |
/CXCR4 |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/CD8A |
| https://identifiers.org/wikipathways/WP2583_r117181 |
WP2583 |
T cell receptor and co-stimulatory signaling |
/CD8B |
| https://identifiers.org/wikipathways/WP382_r126333 |
WP382 |
MAPK signaling pathway |
/CDC42 |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/KRAS |
| https://identifiers.org/wikipathways/WP2643_r123429 |
WP2643 |
Nanoparticle-mediated activation of receptor signaling |
/PTK2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/CYP51A1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/LIG3 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/MYLIP |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/REV3L |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/IDS |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/DPF1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ELOVL5 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/PNKP |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ERCC8 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/ARID1B |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/MSMO1 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/FOXC1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/SOAT1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/NTHL1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCD1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/IDI1 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HYAL2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ACSL4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/XRCC1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCE1 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/PAX2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/UNG |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/GPC4 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/FDFT1 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/HSPB11 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCD3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NLK |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MSH2 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCB1 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/IFT27 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CHD8 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NFATC4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLI |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/PCYT1B |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PORCN |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MPG |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/SALL1 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/EYA1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SFRP1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DKK4 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/SQLE |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/LIG1 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HYAL4 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SFRP4 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PPP3CB |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/CYP2C18 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCD2 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/NAGLU |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/NEIL3 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/SC5D |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/CHKA |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/MVK |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/HMGCS1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/HMGCR |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MSH3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/OGG1 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HYAL1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MSH6 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/DHCR24 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/ARID1A |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ELOVL4 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/INVS |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ACOT2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ELOVL3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SFRP5 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ACAT2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PPP3CC |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLM |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/SMUG1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GRK4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR7 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/IDUA |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCA4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MBD4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL25 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/NR1H2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/HSD17B7 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/TERF2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MUTYH |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/DPF2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/HMGCS2 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/CEPT1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/DOCK2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ERCC5 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/GNS |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/REV1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/XPA |
| https://identifiers.org/wikipathways/WP4316_r120818 |
WP4316 |
miRNA degrading enzymes |
/PNPT1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PRICKLE1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/TDG |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCC2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CUL4A |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NKD1 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/GALNS |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/XCL1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/LBR |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/ETNK2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SFRP2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NKD2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL14 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DAAM2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/TIAM2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/EBP |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/NSDHL |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CETN2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CER1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/TM7SF2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/DCLRE1C |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/GGPS1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/NEIL2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DKK2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WIF1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CUL4B |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ABCG1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/LSS |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCR5 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/FDPS |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/CYP4A22 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/VANGL2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/PMVK |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PRICKLE2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SENP2 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/SPRY1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SOX17 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/SOX17 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ABCA1 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HGSNAT |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLL |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/MVD |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/SOAT2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/DDB1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CX3CR1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FEN1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CXXC4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/APEX2 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/GUSB |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MGMT |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCR6 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL19 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/DHCR7 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HPSE2 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HPSE |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/VANGL1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMARCC1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/XCR1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR9 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/FOXC2 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/SOX11 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CTNNBIP1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR8 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FRAT2 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/SGSH |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PRKX |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR10 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/ROBO2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NOTUM |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GRK1 |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/CYP4F2 |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/CYP4F12 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCR3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/NHEJ1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PPP3R2 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/FAT4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/XRCC6 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAD54B |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ELOVL2 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/DPF3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PPP3R1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ERCC6 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/GLI4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/PRKDC |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CSNK2A3 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/LHX1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FRAT1 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/NUBP2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CSNK1E |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/CTLA4 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/HSCB |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/ABCB7 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/FDX1 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/FDXR |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/ISCU |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/FXN |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/NARF |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/NFU1 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/HSPA9 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/NUBP1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/ROR1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/ROR2 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/GLRX5 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/LYRM4 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/RYK |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FOSL1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/KREMEN1 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/NFS1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAD52 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/BRCA1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ERCC1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MRE11 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/NR1H3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RFC1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RFC2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/MAPK9 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/BCAR1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAD51 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3CB |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CAMK2B |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLD1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNB5 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CSNK2A2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CAMK2A |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/SREBF1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/GLI2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLD3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNB1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GSK3B |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/PALB2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PXN |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/JAK2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/SCD |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLE2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/SOS2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/NFKBIA |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CSNK2A1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/HCK |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/NBN |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/IKBKB |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/AKT2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3CG |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RPA3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLD2 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/GATA3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL12 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/MAPK8 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DKK1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAD51C |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/GLI1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RFC5 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNB3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCE |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAD50 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNB4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/WDR48 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL20 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLE4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCL |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/STAT1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/AKT3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RPA2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/FOXO3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLK |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/BMP4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG13 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG11 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNGT1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/RAC2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/SHC2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NFATC1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FAAP24 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/RAF1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RPA1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SERPINF1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/H3-3B |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/PCNA |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RFC3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/VAV3 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/FADS2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/CDK4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/BRIP1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ARRB1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PPP3CA |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/BRCA2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCI |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ARRB2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/VAV1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCD2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CAMK2D |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/CDKN2A |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/SHC3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLE3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PAK1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ATM |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/FADS1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CHEK1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ACSL1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL28 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ELMO1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCC |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/NCF1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/VAV2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/SHC1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG3 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/USP1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/H3-3A |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL5 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RFC4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/WRN |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/RET |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PRKCB |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PRKCB |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNGT2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CRK |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG8 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/SOST |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/STAT3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CENPX |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/FASN |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/STAT2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLH |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3CD |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNB2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG12 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG5 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/EXO1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/HRAS |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ATR |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CENPS |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLD4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ERCC4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG7 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLE |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCB |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCF |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FAAP100 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCA |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCM |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/H2AX |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/HMGB1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GRK6 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FAN1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/SREBF2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CSNK2B |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/NRAS |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CHUK |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/FANCG |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNG10 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/LYN |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/IKBKG |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL5 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/GSK3B |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/IFNG |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/FAS |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/IL2 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/IL4 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/IL5 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/IL10 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/IL12A |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/JUN |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/RHOA |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/LRP5 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/MYC |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT16 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PRKCA |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/RAC1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CCND1 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/TGFB1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT5A |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT10B |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/AXIN1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CCND2 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/CD28 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/CD80 |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/CD86 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/FGR |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL26 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HEXB |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ROCK1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NFATC3 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/EED |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MLH1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/XRCC5 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/TCF7 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CRKL |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/CHKB |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RBX1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/APEX1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PLCB4 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PLCB4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL22 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/CDK6 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/EZH2 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/GLI3 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/GLI3 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/CHPT1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR6 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/ARSB |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CSNK1A1 |
| https://identifiers.org/wikipathways/WP4316_r120818 |
WP4316 |
miRNA degrading enzymes |
/XRN1 |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/EPHX2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/PMS2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/ACSL3 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SMO |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/PARP2 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/PEMT |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ROCK2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/ROCK2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL21 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PLCB2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PLCB2 |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/CYP2C8 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL9 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/LEF1 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/ETNK1 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/SLIT2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CAMK2G |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PLCB3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PLCB3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/XRCC4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/XPC |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL13 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/PTDSS1 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/PCYT1A |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL16 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/RBBP4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PRKCD |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/SGPL1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL11 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/GLB1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/LIG4 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/PTDSS2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCR2 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/PCYT2 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/PTCH1 |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/CYP4A11 |
| https://identifiers.org/wikipathways/WP4815_r110276 |
WP4815 |
Glycosaminoglycan degradation |
/HEXA |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL27 |
| https://identifiers.org/wikipathways/WP3933_r127616 |
WP3933 |
Kennedy pathway from sphingolipids |
/PISD |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/GTF2H5 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL15 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD10 |
| https://identifiers.org/wikipathways/WP5152_r125997 |
WP5152 |
Iron-sulfur cluster biogenesis |
/CIAO2B |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CCND3 |
| https://identifiers.org/wikipathways/WP4316_r120818 |
WP4316 |
miRNA degrading enzymes |
/EXOSC4 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/MNAT1 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/CYP46A1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNAI3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PRKCZ |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/RASGRP2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/POLB |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CDC42 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/ACTL6B |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DAAM1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/NFATC2 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ERCC2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/JAK3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/GTF2H1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/GTF2H3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNAI2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/RAP1A |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAP1A |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAD23B |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY7 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCR4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/RAP1B |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GNAI1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/KRAS |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CDK7 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/CCNH |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/DDB2 |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/CYP27A1 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/ACTL6A |
| https://identifiers.org/wikipathways/WP4718_r125822 |
WP4718 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
/CH25H |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/RB1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PIK3R5 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PRKACB |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/PARP1 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/GTF2H2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PARD3 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/GFRA1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY8 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/TIAM1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/BRAF |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CTBP1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY9 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/ERCC3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PPBP |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PF4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PRKACG |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/GREM1 |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/GDNF |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CXCL10 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PTK2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL11 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GRK2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/RELA |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY5 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/STAT5B |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/ADCY6 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/CTBP2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GRB2 |
| https://identifiers.org/wikipathways/WP4204_r123410 |
WP4204 |
Tumor suppressor activity of SMARCB1 |
/SUZ12 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/RAD23A |
| https://identifiers.org/wikipathways/WP4830_r125308 |
WP4830 |
GDNF/RET signaling axis |
/AGTR2 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/PLCB1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PLCB1 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCR3 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/SHC4 |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/PPARA |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/GRK5 |
| https://identifiers.org/wikipathways/WP4946_r117703 |
WP4946 |
DNA repair pathways, full network |
/GTF2H4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL4 |
| https://identifiers.org/wikipathways/WP3929_r119247 |
WP3929 |
Chemokine signaling pathway |
/CCL3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DVL1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DVL2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/DVL3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/APC |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/LRP6 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PLAU |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT4 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/PRKCG |
| https://identifiers.org/wikipathways/WP4484_r107333 |
WP4484 |
Control of immune tolerance by vasoactive intestinal peptide |
/VIP |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT2 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT6 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT7A |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT7B |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT11 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT2B |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD5 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD3 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT10A |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT5B |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD1 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD6 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD7 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD8 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/FZD9 |
| https://identifiers.org/wikipathways/WP428_r127397 |
WP428 |
Wnt signaling |
/WNT3A |
| https://identifiers.org/wikipathways/WP4720_r124747 |
WP4720 |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
/PPARG |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PABPC1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MTOR |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MTMR7 |
| https://identifiers.org/wikipathways/WP5219_r126795 |
WP5219 |
Diet-dependent trimethylamine/trimethylamine N-oxide metabolism |
/FMO3 |
| https://identifiers.org/wikipathways/WP5219_r126795 |
WP5219 |
Diet-dependent trimethylamine/trimethylamine N-oxide metabolism |
/CHDH |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/FCGR2B |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/FDFT1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/TBX5 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MTMR8 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SFRP1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/ERI1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MTMR9 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DUSP4 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/PTK2B |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/CSTA |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/NUMA1 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/GABARAPL1 |
| https://identifiers.org/wikipathways/WP5313_r127653 |
WP5313 |
Carnosine metabolism of glial cells |
/SLC15A4 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MTMR6 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/PDX1 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/WDR45B |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/HSPD1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MFHAS1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/TERF1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CER1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/FAM167A |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/NEIL2 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/ST6GALNAC6 |
| https://identifiers.org/wikipathways/WP5313_r127653 |
WP5313 |
Carnosine metabolism of glial cells |
/SLC15A2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SOX17 |
| https://identifiers.org/wikipathways/WP5219_r126795 |
WP5219 |
Diet-dependent trimethylamine/trimethylamine N-oxide metabolism |
/ALDH7A1 |
| https://identifiers.org/wikipathways/WP5405_r127147 |
WP5405 |
13q12 or CRYL1 copy number variation |
/CRYL1 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/GABARAP |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/XKR6 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/SOX7 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SOX7 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/C8orf74 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/B3GALT1 |
| https://identifiers.org/wikipathways/WP5313_r127653 |
WP5313 |
Carnosine metabolism of glial cells |
/CARNS1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/PPP1R3B |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/SLC35G5 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/RP1L1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/FAM167A-AS1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/PRSS55 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/HEPACAM2 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/S100A10 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/DEFB134 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/DEFB135 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/DEFB136 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/B3GALT4 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/FCGR2C |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/PRSS51 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/CLDN23 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/PINX1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/LHX1 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/FUT1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/LBR |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MITF |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTAFR |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/SPI1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/LMNB2 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/CYP11A1 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/CYP19A1 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/HSD3B1 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/SRD5A1 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/HSD3B2 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/HSD17B3 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/HSD17B2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ATP8B2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CUL4B |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TET1 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/HSD17B14 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NLK |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/GPR50 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/SLC33A1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/CEBPZ |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/CNR2 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/A3GALT2 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/FAM91A1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/RNF144B |
| https://identifiers.org/wikipathways/WP134_r126271 |
WP134 |
Pentose phosphate metabolism |
/PGLS |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/CACYBP |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/ATAD2 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/ST8SIA3 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/PLAC8 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/CHTF8 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/BRIX1 |
| https://identifiers.org/wikipathways/WP134_r126271 |
WP134 |
Pentose phosphate metabolism |
/RPE |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/S100A6 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/CHTF18 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/DSCC1 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/S1PR4 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/SNURF |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/MTDH |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/CD48 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/FOXI3 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/RB1CC1 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/ATG16L1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MAPK1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MAPK3 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/AXIN1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/CTSD |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/ATG101 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/RAF1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/BLK |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/TLR4 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/TLR2 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/TP53 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MEPE |
| https://identifiers.org/wikipathways/WP2826_r106727 |
WP2826 |
Cocaine metabolism |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/NKX6-1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/ATG13 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/ULK1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/MAP3K5 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/TNF |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TAB1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/CHUK |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/COL9A1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/COL9A3 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAPK14 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/CTSK |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/EGFR |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/AKT2 |
| https://identifiers.org/wikipathways/WP134_r126271 |
WP134 |
Pentose phosphate metabolism |
/RPIA |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TAB2 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/FOS |
| https://identifiers.org/wikipathways/WP134_r126271 |
WP134 |
Pentose phosphate metabolism |
/G6PD |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/UBE2T |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/IKBKB |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/MYC |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/NFATC1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/NFKB1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/NFKBIA |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TNFRSF11B |
| https://identifiers.org/wikipathways/WP134_r126271 |
WP134 |
Pentose phosphate metabolism |
/PGD |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/FANCI |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAPK8 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAPK9 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAP2K7 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTGER2 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/RAD17 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/RFC3 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/RFC4 |
| https://identifiers.org/wikipathways/WP1495_r126384 |
WP1495 |
Glycine metabolism |
/SHMT2 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/SRC |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/STAT1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP134_r126271 |
WP134 |
Pentose phosphate metabolism |
/TALDO1 |
| https://identifiers.org/wikipathways/WP134_r126271 |
WP134 |
Pentose phosphate metabolism |
/TKT |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/TP53 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TRAF3 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TRAF6 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/CALCR |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/IKBKG |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TNFSF11 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/CBL |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/SQSTM1 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/MYC |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/GLI2 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/CDH1 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/NFKB1 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/RUNX2 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/S1PR3 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTGER3 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/S1PR2 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/GABARAPL2 |
| https://identifiers.org/wikipathways/WP5313_r127653 |
WP5313 |
Carnosine metabolism of glial cells |
/SLC6A6 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/GATA4 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/FCGR2A |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/SLBP |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/CGAS |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/SGPL1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MSRA |
| https://identifiers.org/wikipathways/WP1495_r126384 |
WP1495 |
Glycine metabolism |
/MTHFR |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/MIRLET7E |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/B4GALNT1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/ICAM1 |
| https://identifiers.org/wikipathways/WP1495_r126384 |
WP1495 |
Glycine metabolism |
/SHMT1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TRAF5 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/VCAM1 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/CYP17A1 |
| https://identifiers.org/wikipathways/WP5320_r125916 |
WP5320 |
Male steroid hormones in cardiomyocyte energy metabolism |
/SRD5A2 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/LEF1 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/TRAF2 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/RB1 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/TERT |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/CTSB |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/BMP1 |
| https://identifiers.org/wikipathways/WP5412_r127218 |
WP5412 |
8q11.23 (RB1CC1) copy number variation |
/PTK2 |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/TNKS |
| https://identifiers.org/wikipathways/WP5346_r127110 |
WP5346 |
8p23.1 copy number variation syndrome |
/MCRS1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/UBE2C |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/LPAR1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/NFKB2 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/PLCG1 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/OTUD5 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTGDR |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTGER4 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTGIR |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/PTK2 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/RELA |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/RELB |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TRAF1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/TRAF2 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/CDC42 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/PDGFA |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/INHBA |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/PDGFRA |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/ST8SIA5 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/ST8SIA1 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/ST3GAL5 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/S1PR1 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTGER1 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/PTGFR |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/TBXA2R |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/TOP2A |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/ST3GAL1 |
| https://identifiers.org/wikipathways/WP1423_r124472 |
WP1423 |
Ganglio sphingolipid metabolism |
/ST3GAL2 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/MTNR1A |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/MTNR1B |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/GJB6 |
| https://identifiers.org/wikipathways/WP2839_r117746 |
WP2839 |
Hair follicle development: organogenesis - part 2 of 3 |
/TP63 |
| https://identifiers.org/wikipathways/WP247_r126341 |
WP247 |
Small ligand GPCRs |
/CNR1 |
| https://identifiers.org/wikipathways/WP2018_r126338 |
WP2018 |
RANKL/RANK signaling pathway |
/FHL2 |
| https://identifiers.org/wikipathways/WP2363_r117737 |
WP2363 |
Gastric cancer network 2 |
/AHCTF1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PAF1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/WNT8A |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/HOXA1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CAND1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/EPB41L5 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/HOXC11 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/RAB38 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/RTF1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DUSP5 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/HHEX |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/EOMES |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/LEO1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ONECUT1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/BPTF |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/GDF3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CTR9 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PAX9 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MIR375 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MIR141 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/FOXN3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/BTAF1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TOX3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/KDM4A |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/WDHD1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DDAH1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TOX |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/UBR5 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/RARG |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NME1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PAX3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PBX3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SP4 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CEBPZ |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MBTD1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ZBTB17 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DIP2A |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/RFX7 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TRIM71 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/AHDC1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/GRHL2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/EMSY |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ZFHX4 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NCAPG2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PHF6 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PARP8 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ASCC3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TAF4B |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ELP4 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ZNF462 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/WDFY2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TRERF1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ZIC5 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CEP250 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NAA15 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TRIM5 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TCEAL2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SFMBT1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MAD2L2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CDYL |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ZNF281 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SOX21 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PTHLH |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TGFB1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DKK1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NR3C1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/STAT1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/FOXA2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/FOXA1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/LAMC1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/GATA6 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SMAD4 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/OTX2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SOX2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/EXT1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/GLI2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/FOXO1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/VAV3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MIXL1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MIR373 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/JARID2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TCF7 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/EZH2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CDC73 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/GATA4 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/LEF1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ELK4 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/C1QBP |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/AEBP2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SLC2A12 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DNMT3B |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/MTF2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ELAVL1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/BMP7 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/BMPR1A |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/WNT3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/APC |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/APP |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DUSP2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/FOXH1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SMAD3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SMAD2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SIAH2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NOG |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PIAS1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/HPRT1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CTBP2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ACACA |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TAF5 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NKX2-1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PRDM14 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/HNF1B |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PBX1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/PLCH1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/CRTC1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/WWC1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TNRC6C |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/DAB2 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/POU5F1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TCF4 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/LRPPRC |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/BCORL1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/SESN1 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/TBX21 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NANOG |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NODAL |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/RGS10 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/ZIC3 |
| https://identifiers.org/wikipathways/WP2853_r116557 |
WP2853 |
Endoderm differentiation |
/NABP2 |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/EIF2AK2 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/MTOR |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ELOVL5 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/CYP24A1 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ACSL4 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/APOA5 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/VDR |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ACOT2 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ELOVL3 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/LDLR |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL1RN |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/ACOXL |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/HDAC3 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ELOVL2 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACSL4 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/HADHA |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACADS |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACADVL |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/PECR |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACSF2 |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/PDX1 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ELOVL1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/TFE3 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/GCKR |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/TULP1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/TTL |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/STRN |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/SOX4 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/CHCHD5 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/PSD4 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/NT5DC4 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/FBLN7 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/ZC3H8 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/MERTK |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/TMEM87B |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/C8orf34 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/CKAP2L |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/RGPD8 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ELOVL6 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/MIR4435-2HG |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/ZC3H6 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/RNU6-1180P |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/UCA1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/RPS14P4 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/HMGN2P23 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/RPL5P9 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/RN7SL297P |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/MIR4771-2 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/MIR4435-2 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/MERTK |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/OTC |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/ASS1 |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/ASL |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/CPS1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/CDKN1A |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/BAD |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/FAS |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PIK3CB |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PAK3 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/GSK3B |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/JAK2 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR2E |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/MAPK1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/MAPK1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR2F |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/SOS2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PAK5 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/TSC2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/AKT2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/RAPGEF1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/GATA3 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/MAPK8 |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/CBL |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL23A |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/CD86 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/STAT1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL1R1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/SOS1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/AKT3 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/CD80 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PIK3CA |
| https://identifiers.org/wikipathways/WP3890_r124504 |
WP3890 |
Nanomaterial-induced inflammasome activation |
/IL1B |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL1B |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PAK4 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/PDHA1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/LGALS3 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/RAF1 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/LDHA |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/FADS2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/RAC1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/RAC1 |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/IL6 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL6 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/IL10 |
| https://identifiers.org/wikipathways/WP3890_r124504 |
WP3890 |
Nanomaterial-induced inflammasome activation |
/TLR4 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/MYC |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PAK6 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/AKT1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/AKT1 |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/AKT1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR2K |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PAK1 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/FADS1 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ACSL1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/BCL2L11 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/HK3 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/PRKAA2 |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/JAK1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR2H |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/CSF2 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/TSC1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/CRK |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/STAT3 |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/STAT3 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/IL12A |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/FASN |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PIK3CD |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/HRAS |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/LPL |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/JUN |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR2L |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PTPN11 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PAK2 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/CSF1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/SOCS3 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/SOCS1 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/RXRA |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/SRC |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/PLCG2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/NRAS |
| https://identifiers.org/wikipathways/WP3890_r124504 |
WP3890 |
Nanomaterial-induced inflammasome activation |
/NFKB1 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACSL1 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/HADH |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/HDAC1 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/STK3 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/TEAD1 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/TEAD4 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/TEAD3 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/TEAD2 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/LATS1 |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/GLUD1 |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/INS |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/TNF |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/INSR |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/CD36 |
| https://identifiers.org/wikipathways/WP5181_r124851 |
WP5181 |
Roles of ceramides in development of insulin resistance |
/ACSL1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/ELOA |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/PLTP |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/PDIA2 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/DGAT2 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1H |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/IL11 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/CRKL |
| https://identifiers.org/wikipathways/WP3890_r124504 |
WP3890 |
Nanomaterial-induced inflammasome activation |
/PYCARD |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1F |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL1A |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1G |
| https://identifiers.org/wikipathways/WP4724_r124741 |
WP4724 |
Omega-9 fatty acid synthesis |
/ACSL3 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PRCC |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/CXCL13 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/APOA2 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/SIN3A |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1C |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/MIR21 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ECI1 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/EHHADH |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACSL3 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACADL |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/ARG1 |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/GATM |
| https://identifiers.org/wikipathways/WP497_r119105 |
WP497 |
Urea cycle and metabolism of amino groups |
/GAMT |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/HGF |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/SLC2A3 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1A |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/CDC42 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/ARAF |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/JAK3 |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/JAK3 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/GAB1 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/PFKFB4 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/RAP1A |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/APOA1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PLCG1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1B |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/RAP1B |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/KRAS |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/IL6ST |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/ETS1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1E |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/IL11RA |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/MTTP |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/RPL11 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/ANAPC1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/BRAF |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/IL6R |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/ARF6 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/PTK2 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/PTK2 |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/RELA |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/RELA |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/GRB2 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/GRB2 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/GAS6 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/POLR1D |
| https://identifiers.org/wikipathways/WP4141_r122432 |
WP4141 |
PI3K/AKT/mTOR - vitamin D3 signaling |
/HLA-DRA |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/INSL3 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/BUB1B-PAK6 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/SATB2 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACADM |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/MECP2 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/MET |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/NF1 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/SKIL |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/SEL1L |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/LMF1 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL37 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL36G |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL36A |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL36RN |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL36B |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/GPIHBP1 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/PRMT5 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/CPT1A |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/ING2 |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/ZEB1 |
| https://identifiers.org/wikipathways/WP4205_r127242 |
WP4205 |
MET in type 1 papillary renal cell carcinoma |
/ALK |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/CPT2 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/SLC25A20 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/CETP |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/APOA4 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/LRP1 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/ACSS1 |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/LIPC |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/MIR200A |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/MIR200C |
| https://identifiers.org/wikipathways/WP4337_r108190 |
WP4337 |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
/MIR200B |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/LCAT |
| https://identifiers.org/wikipathways/WP5111_r119173 |
WP5111 |
Familial hyperlipidemia type 4 |
/APOC2 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/LATS2 |
| https://identifiers.org/wikipathways/WP368_r126356 |
WP368 |
Mitochondrial long chain fatty acid beta-oxidation |
/SCP2 |
| https://identifiers.org/wikipathways/WP4533_r103380 |
WP4533 |
Transcription co-factors SKI and SKIL protein partners |
/SKI |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/EIF4EBP1 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/UGT1A10 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/MTOR |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/IDI1 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/HSPB1 |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/HK2 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/LMNA |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG3 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CEBPA |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/DUSP10 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ADRA1B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CTLA4 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/AWAT2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP24A1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP27B1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/EMD |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG5 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/HILPDA |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/HMGCR |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/HSD17B2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IGFBP1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IGFBP5 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/LMNA |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/NFKBIB |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/NFKBIE |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ATP2A2 |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/PAX2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TRPV6 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA2D3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TRPV5 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SALL4 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RARA |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG8 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG7 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG6 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/RYR2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SFRP1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/VDR |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA1C |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA1D |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA1F |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA1S |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA2D1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNB1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNB3 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNB4 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNG1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CBS |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA2D2 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNA2D4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KL |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ATP2C2 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP19A1 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B3 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B2 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B7 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B14 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/RHBDD2 |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/PGM3 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/DAPK2 |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/GCK |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/UGDH |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/PTPMT1 |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/UXS1 |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/GALE |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/LRAT |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/STYXL1 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/KIF1C |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/G3BP1 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/SSC4D |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/TMEM120B |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/TMEM120A |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/SNORA14A |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RBP7 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/CRABP1 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/CRABP2 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RDH12 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RDH10 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/SDR16C5 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/ALDH1A3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CD200 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RDH8 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/BCO1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/PNOC |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RETSAT |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RARB |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RARG |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RBP1 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RBP2 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RBP4 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RDH5 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RLBP1 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RPE65 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/S100A6 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/BCO2 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/ALDH1A2 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/DHRS3 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B1 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B8 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/UGT1A8 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRR5L |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/DDIT4L |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/DSC2 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/DSG2 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/FCER1A |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/PKP2 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/TIMP2 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/SELENBP1 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/CFLAR |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/BID |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/FAS |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/BAK1 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/CASP8 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/BAX |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/NFKBIA |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/TSC2 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/ZP2 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/IKBKB |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/GPI |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RHEB |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKAG2 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/NFKB1 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKAB1 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/VEGFA |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/HTRA2 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKAG3 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/FASLG |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/MAPKAP1 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/APAF1 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKAB2 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/RAF1 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKAA1 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/CASP9 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RAC1 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/CASP6 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RPTOR |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/AKT1 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/MDH2 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/ZP1 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKCA |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/AIFM1 |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/HK3 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKAA2 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/CASP3 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RICTOR |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/TSC1 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/CASP7 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/ENDOG |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/MLST8 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/FADD |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/FOS |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/BCL2 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/CYCS |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/ULK1 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/JUN |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRKAG1 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/DIABLO |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/PRR5 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/ZP3 |
| https://identifiers.org/wikipathways/WP661_r126226 |
WP661 |
Glucose homeostasis |
/INS |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/CDK2 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/CDK9 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TAB1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/YWHAQ |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CHUK |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP3K8 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CREBBP |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CTNNA1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CYBA |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/HBEGF |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/ELK1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/F2 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/F2R |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/ALDH1A1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TAB2 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/FOS |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TAB3 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/GJA1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/RAPGEF1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TBK1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/HCK |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/APAF1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/HRAS |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/HRAS |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/BIRC2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/BIRC3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/HSP90AA1 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/IFNG |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/IKBKB |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/IL1B |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/IL1R1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/IL2RG |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/IL3 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/IL5RA |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/IL6 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/CXCL8 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/IRAK1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA6 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGB1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGB3 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGB4 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGB5 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGB6 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGB7 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGB8 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/JAK1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/JAK1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/JAK2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/LPL |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP3K1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP3K3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP3K5 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/MMP9 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/MYD88 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/NFKB1 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/NFKB1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/NFKBIA |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/NRAS |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/PIK3CA |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/PIK3CD |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/PPP2CA |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/MAPK1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAPK8 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/MAPK8 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAPK9 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP2K7 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/DIABLO |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/BAD |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/BAD |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/PTPN6 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/PTPN11 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/BAX |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP4K2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/RAF1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/RAF1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/BCL2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ACTB |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RXRA |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CCL2 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/CCL2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/BID |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/ABCG5 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/ABCG8 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/SHC1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/SRC |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/SREBF1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/STAT1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/STAT3 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/STAT3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/TGFB1 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/TLR1 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/TLR2 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ACTG1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TNF |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TNFRSF1A |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TNFRSF1B |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/VAV1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CASP3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CASP7 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CASP8 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CASP9 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/IKBKG |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/CBL |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TRADD |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/RIPK1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/FADD |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CFLAR |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/CCNE1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/MAP3K14 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/CD86 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/CD36 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP2536_r117685 |
WP2536 |
Colchicine metabolic pathway |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/SRRM3 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/S100A9 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ACTN2 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/UGT2A2 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/PLA2G7 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/MAFK |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RRAGD |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/PGM1 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/EPB41L3 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RRAGB |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RRAGC |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/ULK3 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/RRAGA |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/YWHAG |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/CYP2A6 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CDH2 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/NLRP3 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/ADH1A |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/CRKL |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/ELK4 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/ICAM1 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/IL18 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/JUP |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/MAFG |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/LEF1 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/CYP26B1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/SMPD2 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/TCF7 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/YWHAB |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CACNB2 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ACTN4 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/DGAT1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ACTN1 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/SCARB1 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP2C8 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP2C9 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/CDC42 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/KEAP1 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/FKBP1A |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/NOS1 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/NFE2L2 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/DDIT4 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/ACOX2 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/MMP1 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/AKT1S1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CDC37 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/CCR3 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/CCR3 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/CYP2E1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/DSP |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA11 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/FYN |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/GRB2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/GRB2 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/GRB2 |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/ID1 |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/IL9R |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA2 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA2B |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA3 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA4 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA5 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA7 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA9 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGAV |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/KRAS |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/LAMA2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/NFKB2 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/PRKACA |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/PRKCZ |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/OTUD7B |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/PSMD2 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/PTGS2 |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/RB1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/REL |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/STAT5A |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/STAT5A |
| https://identifiers.org/wikipathways/WP22_r126261 |
WP22 |
IL-9 signaling pathway |
/STAT5B |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/STAT5B |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/SULT1A1 |
| https://identifiers.org/wikipathways/WP2865_r123108 |
WP2865 |
IL1 and megakaryocytes in obesity |
/TIMP1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TNFAIP3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TRAF1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/TRAF2 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/CUL1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA10 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ITGA8 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/UGT2B7 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/COMT |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/AKR1C3 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/SULT1E1 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B4 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP1B1 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/HSD17B10 |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL1F10 |
| https://identifiers.org/wikipathways/WP2507_r123897 |
WP2507 |
Nanomaterial induced apoptosis |
/PRF1 |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/GFPT1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CTNNA2 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/NPC1L1 |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/ID3 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/INPP5D |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/RBL1 |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/RBL2 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RXRB |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/RXRG |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/SELE |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/POR |
| https://identifiers.org/wikipathways/WP5394_r126941 |
WP5394 |
UDP-derived sugars synthesis in fibroblasts |
/HK1 |
| https://identifiers.org/wikipathways/WP5401_r127625 |
WP5401 |
7q11.23 distal copy number variation |
/SFN |
| https://identifiers.org/wikipathways/WP5222_r122737 |
WP5222 |
2q13 copy number variation syndrome |
/IL1RAP |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/DAG1 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/NOX1 |
| https://identifiers.org/wikipathways/WP2435_r120750 |
WP2435 |
Quercetin and Nf-kB / AP-1 induced apoptosis |
/MT-CO1 |
| https://identifiers.org/wikipathways/WP53_r126236 |
WP53 |
ID signaling pathway |
/MYOD1 |
| https://identifiers.org/wikipathways/WP286_r126282 |
WP286 |
IL-3 signaling pathway |
/ENPP3 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP2C19 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/DES |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/DMD |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/ACTN3 |
| https://identifiers.org/wikipathways/WP1471_r126354 |
WP1471 |
Target of rapamycin signaling |
/ULK2 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/ADH4 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/CYP26A1 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/CTNNA3 |
| https://identifiers.org/wikipathways/WP231_r124583 |
WP231 |
TNF-alpha signaling pathway |
/PYGL |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/SLC8A1 |
| https://identifiers.org/wikipathways/WP716_r126219 |
WP716 |
Vitamin A and carotenoid metabolism |
/SULT2B1 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP3A5 |
| https://identifiers.org/wikipathways/WP5276_r126877 |
WP5276 |
Estrogen metabolism |
/CYP3A7 |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/SGCA |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/SGCB |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/SGCD |
| https://identifiers.org/wikipathways/WP2118_r119252 |
WP2118 |
Arrhythmogenic right ventricular cardiomyopathy |
/SGCG |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCC2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/NLK |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CHD8 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/PORCN |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SFRP1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/DKK4 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SFRP4 |
| https://identifiers.org/wikipathways/WP4342_r106136 |
WP4342 |
Vitamins A and D - action mechanisms |
/VDR |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SFRP5 |
| https://identifiers.org/wikipathways/WP4342_r106136 |
WP4342 |
Vitamins A and D - action mechanisms |
/RARA |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/NKD1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SFRP2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/NKD2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CER1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/DKK2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WIF1 |
| https://identifiers.org/wikipathways/WP4818_r117691 |
WP4818 |
Conversion of angiotensinogen to angiotensin II |
/ACE |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SENP2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SOX17 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CXXC4 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SOX7 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CTNNBIP1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CSNK1A1L |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FRAT2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/NOTUM |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/MIR33B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKDC |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CSNK2A3 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FRAT1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CSNK1E |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP24A1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP27B1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCA1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/ROR1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/ROR2 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/NLK |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/RARA |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/RYK |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/VDR |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FOSL1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/KREMEN1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCG1 |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/PML |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/PRKDC |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT8A |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/MTDH |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/RARB |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/RARG |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/HES2 |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/CD68 |
| https://identifiers.org/wikipathways/WP3938_r120650 |
WP3938 |
miR-222 in exercise-induced cardiac growth |
/HMBOX1 |
| https://identifiers.org/wikipathways/WP3938_r120650 |
WP3938 |
miR-222 in exercise-induced cardiac growth |
/HIPK1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/HES3 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/MIR320A |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/MIR452 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/MIR18A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRT71 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ZNF257 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LRRC25 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CST1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CST6 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/DACT2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SERPINB1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CREG2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SLC37A2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TRAK1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IGSF9B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CASP14 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SOSTDC1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LCE2B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CRACR2B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/HLA-DQA1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/HLA-DQA2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP8-1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LCE1D |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LCE1F |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP12-2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRT13 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP10-4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP10-7 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP10-9 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP10-2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRT16 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP5-1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP5-4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRT34 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/NINJ1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/G0S2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDKAL1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KLK6 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/S100A2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/S100A4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CEACAM1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SPRR1B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TIMP2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/GXYLT2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SEMA3B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/S100G |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/STEAP4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CLMN |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ABCA11P |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CLPTM1L |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CRACR2A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRTAP4-1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KRT38 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ASAP2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CCNC |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IL1RL1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ADGRE5 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LPGAT1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDKN1A |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/BAD |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT16 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3C2A |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/BID |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK9 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3CB |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/CASP8 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK6 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CSNK2A2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/GLI2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3C3 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/BAX |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4966_r123489 |
WP4966 |
Fluoroacetic acid toxicity |
/ACO2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CSNK2A1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/BBC3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3CG |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF8 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/DKK1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK10 |
| https://identifiers.org/wikipathways/WP4966_r123489 |
WP4966 |
Fluoroacetic acid toxicity |
/ALDH2 |
| https://identifiers.org/wikipathways/WP3938_r120650 |
WP3938 |
miR-222 in exercise-induced cardiac growth |
/CDKN1B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK14 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/MAPK14 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/SMAD5 |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/CD86 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT5A |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/ZAP70 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/STAT1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/FASLG |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/SMAD9 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/APAF1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/RUNX2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/BMP4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/BMP2 |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/RAC2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SERPINF1 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/CASP9 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/KLF4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3C2G |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/TP53 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/SMAD4 |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/MCL1 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/MCL1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/ATM |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/BCL2L11 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCA |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK13 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/MAPK13 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/LRP5 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/CASP3 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/CASP7 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK7 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCB |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/SOST |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/FADD |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT10B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/SMAD1 |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/CD14 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3CD |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/BCL2 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/BCL2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKD1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK11 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/MAPK11 |
| https://identifiers.org/wikipathways/WP4342_r106136 |
WP4342 |
Vitamins A and D - action mechanisms |
/RXRA |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MAPK12 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/MAPK12 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3R4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/BMPR2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CSNK2B |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/TNF |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3R6 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/MIR214 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/NR1H3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDK2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDKN1B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDKN2A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SLC34A2 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/CREBBP |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP2B6 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP2B6 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP7A1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP7A1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP4864_r124634 |
WP4864 |
Host-pathogen interaction of human coronaviruses - apoptosis |
/AKT1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/FOXO1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ALOX5 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/G6PD |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/GSK3B |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/GSK3B |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/HCK |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/HDAC1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/HIF1A |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/IL6 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IL12A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ITGAM |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/JAK1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/JAK2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/JUN |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LGALS9 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LRP5 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/LRP5 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/MYC |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/MYC |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TNFRSF11B |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT16 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TREM1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/BAD |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/PTH |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/PTHLH |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/PTPN11 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CCND1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CCND1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/RXRA |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/PRDM1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/PRDM1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCG5 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/SHC1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IL25 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/BMP6 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/STAT1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/STAT3 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TGFB1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TGFB2 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/TYK2 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/VAV1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT5A |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT10B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/NRIP1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/AXIN1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TNFSF11 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/NCOA1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CCND2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CCNE1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/SOCS3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CD9 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CD14 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KLF4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CD40 |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/TP53 |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/CDK2 |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/MDM2 |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/IKBKG |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/LYZ |
| https://identifiers.org/wikipathways/WP3633_r123391 |
WP3633 |
Caffeine and theobromine metabolism |
/NAT2 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/MIR33A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ALPI |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ALPG |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/MX2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/S100A8 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/S100A9 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CA9 |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/CD74 |
| https://identifiers.org/wikipathways/WP4966_r123489 |
WP4966 |
Fluoroacetic acid toxicity |
/ALDH3A2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDX2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CLEC16A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/MXD1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/MED9 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCH |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCQ |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/TCF7 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/EZH2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/GLI3 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CSNK1A1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/SOX9 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/SMO |
| https://identifiers.org/wikipathways/WP4966_r123489 |
WP4966 |
Fluoroacetic acid toxicity |
/ACSS2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/LEF1 |
| https://identifiers.org/wikipathways/WP4966_r123489 |
WP4966 |
Fluoroacetic acid toxicity |
/ALDH9A1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/IHH |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCD |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCE |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/CD163 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PTCH1 |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/MIR34C |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/MIR34B |
| https://identifiers.org/wikipathways/WP3633_r123391 |
WP3633 |
Caffeine and theobromine metabolism |
/CYP2A6 |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/MIR34A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDKN2B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDKN2C |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDKN2D |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD10 |
| https://identifiers.org/wikipathways/WP4966_r123489 |
WP4966 |
Fluoroacetic acid toxicity |
/CS |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP2C9 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP2C9 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP4A11 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/GADD45A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IGFBP3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/JUNB |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/JUNB |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/DND1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ATP2B1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/PPARD |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/PPARD |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/PRKCD |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/PRKCQ |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/LRRC8A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CASP5 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CCND3 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/ELAVL1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGFR2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCZ |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGFR3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/LRP6 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF10 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/NOTCH3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGFR1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT11 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/DLL3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/JAG1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF9 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/BMPR1A |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT5B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF6 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD10 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT6 |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/F3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCG |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/DLL4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PPARG |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3C2B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT2B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT10A |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF5 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/BMPR1B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF7 |
| https://identifiers.org/wikipathways/WP3633_r123391 |
WP3633 |
Caffeine and theobromine metabolism |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PIK3R5 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT3A |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT7A |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD7 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF18 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD1 |
| https://identifiers.org/wikipathways/WP3633_r123391 |
WP3633 |
Caffeine and theobromine metabolism |
/XDH |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT9B |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CTBP1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGFR4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT4 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD5 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD6 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/RBPJ |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD4 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/CTBP2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD8 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/JAG2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FGF3 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT7B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/FZD9 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/DLL1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/NOTCH4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/RASGRP1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/COL13A1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/CRP |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ADRB2 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP2D6 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP2E1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP8B1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/AGT |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/DVL1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/DVL2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/DVL3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/EFNA5 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/EPHB4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ABCD1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCD2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD2 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/GAB1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/GRB2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/HLA-DRB1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/APC |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ID1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/IL6R |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/IL6ST |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/KNG1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/LRP6 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/STS |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/NFATC2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ORM1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ORM2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ABCB1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCB1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/PLAU |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT4 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/PPARA |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/PPARG |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/PTGER4 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCD3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/BDKRB1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SATB1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SPP1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/HNF1A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/THBD |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/TIMP1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TIMP3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TNFAIP3 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/VIP |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT2 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT3 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT6 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT7A |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT7B |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT11 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT2B |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD5 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/COLEC11 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD3 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/STAM |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT10A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/FGF23 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT5B |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD1 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD6 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD7 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD8 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/FZD9 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCB11 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCC3 |
| https://identifiers.org/wikipathways/WP4336_r127463 |
WP4336 |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
/WNT3A |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/NR1H4 |
| https://identifiers.org/wikipathways/WP4146_r107552 |
WP4146 |
Macrophage markers |
/CD83 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/NR2F6 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IRF8 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ID4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IRF4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CAMP |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CLDN2 |
| https://identifiers.org/wikipathways/WP3938_r120650 |
WP3938 |
miR-222 in exercise-induced cardiac growth |
/HIPK2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/MYOD1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/PRKCI |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/HEY1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/ADAMTS5 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP4B1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/DEFB4A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/DEFB4B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/NOX1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/MYO9B |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SULT2A1 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/NR1I2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/DNER |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/NR1I3 |
| https://identifiers.org/wikipathways/WP4016_r120667 |
WP4016 |
DNA IR-damage and cellular response via ATR |
/FOXM1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT8B |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/HEY2 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/WNT9A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/BCL6 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/BGLAP |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TPM1 |
| https://identifiers.org/wikipathways/WP4787_r127271 |
WP4787 |
Osteoblast differentiation and related diseases |
/HES6 |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/MIR16-1 |
| https://identifiers.org/wikipathways/WP4399_r102102 |
WP4399 |
MicroRNA network associated with chronic lymphocytic leukemia |
/MIR15A |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/BTLA |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP3A5 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP26A1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CYP2S1 |
| https://identifiers.org/wikipathways/WP364_r126289 |
WP364 |
IL6 signaling pathway |
/IRF1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/IRF5 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/DEFB132 |
| https://identifiers.org/wikipathways/WP299_r126284 |
WP299 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCB4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SLC8A1 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/SULT1C2 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/TNFSF4 |
| https://identifiers.org/wikipathways/WP2877_r119905 |
WP2877 |
Vitamin D receptor pathway |
/CDC34 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MMP2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MTOR |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/COX10 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/TFAP2B |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/MCOLN1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC6 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SALL4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PCCB |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/ACO1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BMP15 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CYP19A1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/LMNA |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ALDH7A1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PCCA |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FOXL2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MITF |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/XRCC6 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ERCC6 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA4B |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/LHX1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA1B |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB3 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB4A |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB4B |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA3E |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/AMT |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/HK2 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA1B |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA1L |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA2 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA6 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA9 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/HTR2B |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB2B |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/MDH1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PC |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA8 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/FBXW7 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB2A |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA1A |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBAL3 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB6 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA1C |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SPCS1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/WNT8A |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DLX5 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HOXA1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MSX2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/SNAI1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/PAX3 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/ZIC5 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GCK |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/GPR37 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/SIAH1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/UBE2L6 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/SNCAIP |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/OTC |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ASS1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ASL |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/CPS1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/LARS2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/EIF2B3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/WDR62 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PGRMC1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/NOBOX |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TWNK |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MCM9 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HARS2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/EIF2B4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SOHLH2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SIL1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MND1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/INHA |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/MOCS3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/AARS2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CLPP |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MGME1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/RCBTB1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PREPL |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SPATA22 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HAX1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ANKRD31 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/DIAPH2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SYCP2L |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/AFF2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HSF2BP |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/AIRE |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/RECQL4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MEIOB |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/LHX8 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HFM1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HELQ |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SFXN1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/OSR2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HDX |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SOHLH1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BNC1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ANTXR1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CNTNAP2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FOXE1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/GPR3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FIGLA |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/NANOS3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/GALT |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CPEB1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/GAS5 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/H3P23 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PGR-AS1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MIR22 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GLDC |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA4 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA14 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PGAM2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/FBP2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/HLCS |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SLC25A15 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/LHX5 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/PRTG |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/OLIG3 |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/HEPHL1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DMBX1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MIA |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BRCA1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/CDH1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/RAD51 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PRDM1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DCT |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/GSK3B |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ESR1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FMR1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/POLR2C |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TSC2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/NBN |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CXCL12 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FGF8 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/IL2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GAPDH |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FANCL |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MYB |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FOXO3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/KHDRBS1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/WNT1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/BMP4 |
| https://identifiers.org/wikipathways/WP5314_r125793 |
WP5314 |
Lactate shuttle in glial cells |
/LDHA |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/LAMC1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/IL6 |
| https://identifiers.org/wikipathways/WP690_r117170 |
WP690 |
Polyol pathway |
/ALDOB |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MYC |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/ASCL1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BRCA2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ESR2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PDPK1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/AKT1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ATM |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/ITGB1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FOXO1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FANCC |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MSX1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SPIDR |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/WRN |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CYP7A1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/GBX2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/SMAD1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FSHR |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/EXO1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BDNF |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SHMT2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FANCA |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FANCM |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ZP3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/XRCC2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BLM |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ATG7 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BMPR2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FANCG |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TNF |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/MAPK1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/DLD |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/ELK1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ENO1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/FBP1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ALDOB |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/G6PC1 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/GNAQ |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GOT2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GPI |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/HK3 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/HRAS |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA1A |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/HTR2A |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/HTR2C |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/LDHA |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/MDH2 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/NRAS |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PRKN |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PCK1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PDHA1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PFKL |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PGAM1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PGK1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PKM |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/MAPK3 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/RAF1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SLC2A1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/SRF |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/AXIN1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/CASP1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/CASP8 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/CASK |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GLUD1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ECHS1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SLC1A5 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GLS2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/PAX7 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/TLX2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/DCAF17 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC8 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/EIF4ENIF1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MIR449B |
| https://identifiers.org/wikipathways/WP690_r117170 |
WP690 |
Polyol pathway |
/AKR1B1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/DMC1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/PHOX2B |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PCMT1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/XPO5 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ERAL1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MRPS22 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/UBR2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MSH4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TGFBR3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BCKDHB |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/DAZL |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CAV1 |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/STEAP3 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/SOX9 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/EIF2S2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/GFAP |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/SOX5 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/GATA4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/IL21 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/POLG |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/RHOB |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CYP17A1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/XRCC4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PRDM9 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/IFI27 |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/FTH1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/CDH2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GPHN |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SHMT1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MBP |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MSH5 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/DLAT |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/ELK4 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/GATA4 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GOT1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SLC2A5 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/MAPKAPK2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ARG1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GATM |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/GAMT |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/SOX10 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/C14orf39 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TMEM150B |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/NEUROG1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/OLIG2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TG |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC9 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC7 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FGFR2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC4 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FGFR3 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/NOTCH3 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/NFKB2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FGFR1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/GNAS |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DLL3 |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/TF |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/COMT |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SIRT1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/POLR3H |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/BMP7 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FZD3 |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/HAMP |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SERPINE1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BMPR1A |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC5 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/NUP107 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PRLR |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HES1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ACVR2B |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/TWIST1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/ID1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/KDR |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DLL4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/FSHB |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HSD17B4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TSHB |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/ETS1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/LHCGR |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FGF2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BMPR1B |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/COL2A1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PARP1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PTH2R |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/RPL10 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/WNT3A |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/KIT |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FGF19 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/WNT4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TGFBR2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/RBPJ |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PTEN |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/CBX2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/CTBP2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/AGTR2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/NOG |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/HLA-DRB1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HES5 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DLL1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/COL11A2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/NOTCH4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/INSL3 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/RASGRP1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DVL1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DVL2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/DVL3 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ALDOA |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/ITPR1 |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/KRAS |
| https://identifiers.org/wikipathways/WP732_r125659 |
WP732 |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
/RASGRF1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SLC2A2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SLC2A3 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/AXIN2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/PMP22 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/CDH6 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/EIF2B2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/MOCS1 |
| https://identifiers.org/wikipathways/WP690_r117170 |
WP690 |
Polyol pathway |
/KHK |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/EIF2B5 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/TBX6 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/MPZ |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/MOCS2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/S1PR1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/SUOX |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HOXB1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/ZIC1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/OLIG1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/SNAI2 |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/TFRC |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TP63 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/AMH |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/TFR2 |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/SLC11A2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/DBH |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/NR5A1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/TFAP2A |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/SLC40A1 |
| https://identifiers.org/wikipathways/WP690_r117170 |
WP690 |
Polyol pathway |
/SORD |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/STAR |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ACSL6 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/GJB1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/WT1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/GJA4 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/TCF4 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/POU5F1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ENO2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ENO3 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/ALDOC |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/HK1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/LDHB |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/LDHC |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PFKM |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PFKP |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PGK2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/PKLR |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/TPI1 |
| https://identifiers.org/wikipathways/WP5314_r125793 |
WP5314 |
Lactate shuttle in glial cells |
/LDHB |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/CDO1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SOX8 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC10 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/AMHR2 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HEY2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PMM2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/GDF9 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HDAC11 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/ISL1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/STAG3 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/CDH7 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/LHX2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/MCM8 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PSMC3IP |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/SYCE1 |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/FOXD3 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/TRIM37 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/BMP8B |
| https://identifiers.org/wikipathways/WP2007_r106626 |
WP2007 |
Iron metabolism in placenta |
/IREB2 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/PCSK1 |
| https://identifiers.org/wikipathways/WP5316_r127621 |
WP5316 |
Primary ovarian insufficiency |
/ATG9A |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/MPC2 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/MPC1 |
| https://identifiers.org/wikipathways/WP5355_r127088 |
WP5355 |
Metabolic Epileptic Disorders |
/LDHAL6B |
| https://identifiers.org/wikipathways/WP2064_r117162 |
WP2064 |
Neural crest differentiation |
/HAND1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/MTOR |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TFAP2B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/WNK1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/DLG1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNC1I2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/HSPB11 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TFAP2C |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNLL1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MSH2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT27 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/DKK4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DCAF7 |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/PDX1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNC1LI1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/NFKBIE |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/STOM |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CBS |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNC1H1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/RYR2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNLL2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/FRAT1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FRAT1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/CSNK1E |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CSNK1E |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/CYP19A1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DDX1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/XRN2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DICER1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FBXW2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/LDLR |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/ROR1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/ROR2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/NLK |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/NLK |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/RYK |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRP54 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FOSL1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/NKD1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/NKD2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RHBDD2 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/EDAR |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/EDA |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM9 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/SOSTDC1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CLK2 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRE1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRE5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TFAP2D |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EIPR1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NME8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/WHRN |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TMED1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/GID8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/APMAP |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CDH23 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EHBP1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TFAP2E |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DNPEP |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/AAR2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ARL8B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CDR2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TIPRL |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CEP170 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC6B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RMND5B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DGKE |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPM1J |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RPGR |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PGRMC2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ZMYND19 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MAPRE2 |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/PTF1A |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/DLGAP1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RABEP2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MYL6B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/ZBTB33 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SUGP2 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRG2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CLASRP |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CLK1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CLK3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SREK1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DHX8 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRL1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/GCGR |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PSKH1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CELF4 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CLK4 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRL4 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SFSWAP |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRPF18 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRPF4B |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CDKN1A |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/BAD |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CREBBP |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/MAP3K9 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TNFRSF1B |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/BAK1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/CAMK2B |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CAMK2A |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/CAMK2A |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/MAP3K1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/FMR1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/TJP1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/STX1A |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/DKK1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DDX5 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NFKB1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/MAPK10 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/GLI1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CDKN1B |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/KAT2B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/HTRA2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/HDAC1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/APAF1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ECHS1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CDKN1C |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TRAF3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/UBE2D2 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/PCNA |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CASP9 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RAC1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/YAP1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/CAMK2D |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/GRM1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/MAPK13 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C1QC |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/H3-3A |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/NKX6-1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CASP3 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/SHH |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/BCL2 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CYCS |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C1QB |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C1QA |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TRAF6 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC7 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/ARC |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CALM1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TNF |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/AKT3 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/LRRK2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CREBBP |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/EGFR |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/EP300 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/AKT1 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/AKT2 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/ESR1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/GIPR |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/GJA1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/GSK3A |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/GSK3B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/GSK3B |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPL |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/HRAS |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRMT1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/JUN |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/RHOA |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/RHOA |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/LRP5 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/LRP5 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/ARRB2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/MYC |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/MYC |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNU13 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/NRAS |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT16 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PIK3CB |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PIK3CD |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PIK3CG |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2CA |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2CB |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R1A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R1B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R5C |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/PRKCA |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCA |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/PRKCB |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCB |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKD1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/MAPK3 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/MAPK8 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/MAPK9 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/MAPK9 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/MAPK10 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PTGER2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/CCND1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CCND1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SFPQ |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/SOX2 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/SRC |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/TP53 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/TSC1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/TSC2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT5A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT10B |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/CALCR |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SMC1A |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/AXIN1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/AXIN1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CCND2 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/CCNE1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/NRXN3 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/NRXN1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/NRXN2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT80 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT74 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CLUAP1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TDP2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNC2I2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT43 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/BBS9 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT81 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/BBS2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNLRB1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNC2I1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/LCA5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/BBS7 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/BBS4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ARHGDIA |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNLT1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/LCN2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NEK8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/BBS5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/LZTFL1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNLT3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TTC8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNLRB2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/AGPAT2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IQCB1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/BBS1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EFHC2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TRAF3IP1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DYNLT2B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/BBIP1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CELF1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/RACGAP1 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PTGER3 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PTGES2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RANBP9 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MAEA |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DCAF11 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TTC26 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT20 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ARMC8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT46 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT22 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MKLN1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/GID4 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/DLG2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RMND5A |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/SHANK1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/WDR26 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TTC30B |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPAB |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EHD3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DOCK5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/VIM |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TNK2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CTSA |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOSC7 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM6 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/TCF7 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/GLA |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM4 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/GRIN2D |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EFTUD2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM3 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/GADD45A |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOSC9 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ACSL3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/VAPB |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CNOT1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/SNRPB2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/LSM4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOSC2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CNOT6L |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/CAMK2G |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TNKS1BP1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/GRIN2C |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/WEE1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM7 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CD2BP2 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/YWHAG |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/GLB1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOSC4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CNOT10 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/PTCH1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA7 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/LTB |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NEFL |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RBM5 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/CDK6 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPR |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRRM1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3B4 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3A1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CD2BP2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/NXF1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRPF8 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CELF2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF10 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/TXNL4A |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PAPOLA |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RNPS1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3A3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/TMED10 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CLP1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3B2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/NUDT21 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DDX20 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/U2AF2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/CSNK1A1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CSTF1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CSTF2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CSTF3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DHX9 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DHX15 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DNAJC8 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/NCBP2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CSTF2T |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3B3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3B1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRPF6 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/FUS |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RBMX |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CPSF1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPA1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPA2B1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPC |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPD |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPH1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPH2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPK |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPU |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA8 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/HNRNPM |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/NCBP1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/YBX1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PCBP2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/LEF1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/LEF1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CDC40 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/LSM7 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CPSF3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CPSF2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPARD |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R2A |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRPF40A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCD |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCE |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCH |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCQ |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/METTL3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PTBP1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SUGP1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/LSM2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF4 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF5 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF6 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF7 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/TRA2B |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRNP70 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPA |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPA1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPB |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPB2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPD1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPD2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPD3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPE |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPF |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPG |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRPN |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/U2AF1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3A2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SF3B5 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SPOP |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DHX16 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PHF5A |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RBM17 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRSF9 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CCND3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRPF4 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRPF3 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/EFTUD2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SNRNP40 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/DHX38 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RNGTT |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EIF5B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/AIMP1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/GDI1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SUPT5H |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RNMT |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RNGTT |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/SPATA7 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/RPH3A |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CCDC40 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ANKS3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/XPNPEP3 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA3D |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PSMC4 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TRAF1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NUP133 |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/FGF10 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CDC42 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PSMD8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PSMC6 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PSMD7 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RAB2A |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NEFM |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/RELB |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C5 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/WNT3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NUP88 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD10 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC2 |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/HES1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/CR2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RAB14 |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/RBPJL |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/TRAF2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/APC |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TBC1D4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RB1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IQGAP1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RALB |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IQGAP2 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C1R |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/DVL3 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RAB8A |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/RBPJ |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/BMP1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C3AR1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CTBP2 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/GRIN1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C1S |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/GRIN2A |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IQGAP3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PSMD13 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/POM121 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/HDAC2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PSMD12 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/SYNGAP1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C5AR1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/C4B |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/GRIN2B |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/CALCRL |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD14 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/STUB1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/CPSF4 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADCYAP1R1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/CRHR1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/LINC02210-CRHR1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/CRHR2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/CTBP1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CTBP1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CTBP2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/DVL1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/DVL1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/DVL2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/DVL2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/DVL3 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/DVL3 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD2 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/GHRHR |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/GLP1R |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/APC |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/APC |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/HSPA5 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/KRAS |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/LRP6 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/LRP6 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/MMP1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/MMP7 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/NFATC2 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PLA1A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PLAU |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/POLR2A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT4 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/PPARG |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R2B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R2C |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R3A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R5E |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/PRKCG |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCG |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCZ |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMC1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMC2 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMC3 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMC4 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMC5 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMC6 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD2 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD3 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD4 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD5 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD7 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD8 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD9 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD10 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD11 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD12 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD13 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PTGER4 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PTGS2 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/PTH1R |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/PTH2R |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/SCTR |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/SIAH2 |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/BRAF |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/TEK |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA4A |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/VIPR1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/VIPR2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT3 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT6 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT7A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT7B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT11 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT2B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT9B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD5 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD3 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT10A |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT5B |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PABPN1 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/AXIN2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/AXIN2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD4 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD6 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD7 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD8 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FZD9 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/CUL1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/WNT3A |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/GLP2R |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/PSMD6 |
| https://identifiers.org/wikipathways/WP4147_r94394 |
WP4147 |
PTF1A related regulatory pathway |
/PROX1 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/HOMER1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS6 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/NLGN1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CTNND1 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRL2 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRL3 |
| https://identifiers.org/wikipathways/WP334_r117741 |
WP334 |
GPCRs, class B secretin-like |
/ADGRE2 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/NONO |
| https://identifiers.org/wikipathways/WP4483_r107927 |
WP4483 |
Relationship between inflammation, COX-2 and EGFR |
/PTGER1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/SNCA |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRPK2 |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/PIP5K1B |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/CD44 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/SNAP29 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NINL |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ZYG11B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/SSNA1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/SEPTIN5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TTC30A |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PRMT2 |
| https://identifiers.org/wikipathways/WP3930_r116431 |
WP3930 |
EDA signaling in hair follicle development |
/EDARADD |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/FUZ |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MKS1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT88 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT52 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT57 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/VPS4A |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/TFAP2A |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT172 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/LRPPRC |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC6 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MFAP1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT122 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/INTU |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COX6C |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/EXOC3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/IFT140 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CEP290 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/CYFIP1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/POU5F1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PRKCI |
| https://identifiers.org/wikipathways/WP363_r126288 |
WP363 |
Wnt signaling pathway |
/TCF4 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/NFYA |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS7A |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS7B |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ANKS6 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/CEP97 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS8 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RBM14 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/COPS5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/YPEL5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RANBP10 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/ESRRB |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/PAFAH1B1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM10 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NUDC |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MYL6 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/MCM8 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/FOXD3 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/UBE2J2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ARFGAP3 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PPP2R3B |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBB8 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PAFAH1B1 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/PTPA |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PTBP2 |
| https://identifiers.org/wikipathways/WP399_r119242 |
WP399 |
Wnt signaling pathway and pluripotency |
/NANOG |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NDUFA5 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NDUFA9 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/AFG3L2 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/UBE2H |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/RNF19A |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/UBE2J1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/UBA1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/UBE2G1 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/UBE2G2 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/UBE2L3 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/USH1C |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/UQCC1 |
| https://identifiers.org/wikipathways/WP3941_r123242 |
WP3941 |
Oxidative damage response |
/BAG4 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/PPM1G |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/SRPK1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RBM39 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RAB21 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/ERF |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/RAB3IL1 |
| https://identifiers.org/wikipathways/WP411_r126308 |
WP411 |
mRNA processing |
/RNU2-1 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/SMC4 |
| https://identifiers.org/wikipathways/WP4352_r102218 |
WP4352 |
Ciliary landscape |
/NEK7 |
| https://identifiers.org/wikipathways/WP2359_r123101 |
WP2359 |
Parkin-ubiquitin proteasomal system pathway |
/TUBA3C |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A10 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A9 |
| https://identifiers.org/wikipathways/WP2846_r128066 |
WP2846 |
PCSK9-mediated LDL receptor degradation |
/LDLR |
| https://identifiers.org/wikipathways/WP2846_r128066 |
WP2846 |
PCSK9-mediated LDL receptor degradation |
/PCSK9 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/ADIPOQ |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/MITF |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/FRAT1 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GPX4 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/IDH1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/LDLR |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/FOSL1 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/PGM3 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/TFE3 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGDH |
| https://identifiers.org/wikipathways/WP3655_r129299 |
WP3655 |
Hypothetical craniofacial development pathway |
/ARHGEF2 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM3 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A8 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/IPO8 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/HAVCR2 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/MIPEP |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/KIR3DX1 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/ATXN1 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/TNFRSF19 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/DTNA |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SACS |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/PGM5 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SNTB1 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SPATA13 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/C1QTNF9B |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/LINC00352 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/LINC00362 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/LINC00327 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/C1QTNF9 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/MIR2276 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GPRC5B |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GPRC5C |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2B10 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GPRC5A |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CDKN1A |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GGT1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BAD |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BAK1 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/MAPK9 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MAPK9 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/MAPK9 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/RHOA |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MAP3K4 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BAX |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MAP3K1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/ABL1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BIK |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/EP300 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/SOS2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TRADD |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TGFB1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/TGFB1 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/TGFB1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL12 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/MAPK8 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MAPK8 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/MAPK8 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CCL2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/NFKB1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CDKN1B |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/MAPK14 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/RAD1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/STAT1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/SOS1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/FASLG |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/FOXO3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CAT |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/IRF3 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/BECN1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/RAC2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TRAF3 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/TRAF3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/G6PC1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/MDM2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MDM2 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/RAC1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/RAC1 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/HUS1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TANK |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/RIPK1 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/MAP1LC3B |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/TP53 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/TP53 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/SMAD4 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/SMAD4 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PMAIP1 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/ATM |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/CHEK1 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/RAD9B |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BCL2L11 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/PINK1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/SHC1 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/SQSTM1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/JAK1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL5 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL1 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/TOPBP1 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/ATRIP |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/FADD |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/STAT3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/IRS1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL8 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/STAT2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/INSR |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BCL2 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/RAD9A |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/ATR |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TRAF6 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TBK1 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/PRKN |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/IRF7 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/HMGB1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/HMGB1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TLR7 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/ATG7 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/BMPR2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/CHUK |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CCL5 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/AKT1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/AKT2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/AKT3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BBC3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CDKN2A |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/NFKB1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/RAC3 |
| https://identifiers.org/wikipathways/WP3655_r129299 |
WP3655 |
Hypothetical craniofacial development pathway |
/RHOA |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/RPA1 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/RPA2 |
| https://identifiers.org/wikipathways/WP3875_r128592 |
WP3875 |
ATR signaling |
/RPA3 |
| https://identifiers.org/wikipathways/WP3655_r129299 |
WP3655 |
Hypothetical craniofacial development pathway |
/TGFB3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/G6PD |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/GSK3B |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3R4 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/HRAS |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/JUN |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/RHOA |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MYC |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/NRAS |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT16 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3C2A |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3C2G |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3C3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3CA |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3CB |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3CD |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3CG |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PPP2R5C |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MAPK1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MAPK10 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CCND1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT5A |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT10B |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/AXIN1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CCND2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TNF |
| https://identifiers.org/wikipathways/WP5414_r127286 |
WP5414 |
IDO metabolic pathway |
/TNF |
| https://identifiers.org/wikipathways/WP5414_r127286 |
WP5414 |
IDO metabolic pathway |
/IFNG |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2B11 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2A1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/IFIT2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PCK2 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2B28 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A5 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2A2 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2B4 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2B15 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2B17 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2A3 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SNTA1 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/TFEB |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/RTN4R |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/PGM1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TRAF5 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/TRAF5 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/MAG |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TP53I3 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/RTN4 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/FLNC |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL9 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CCNG2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/LEF1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/LARP1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL13 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/MLKL |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL11 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCR2 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/AGER |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GSTA5 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GCLM |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GPX1 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GPX2 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GPX3 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM2 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM4 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM5 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM7 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM8 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GSR |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GSTT2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/MX1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/LEF1 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A7 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A4 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL6 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/TCF7 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/IFITM1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CCND3 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GABBR2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/LAG3 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/NUP98 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/TRAF1 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/CDC42 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/CDC42 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/NOTCH3 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/PSEN1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/MAVS |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/DLL3 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/RAE1 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/JAG1 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/DDX58 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/BMPR1A |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/SHOC2 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/LOX |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/HES1 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/NFE2L2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CD160 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TRIM25 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/RRAS |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TRAF2 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/TRAF2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/DLL4 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/ACE2 |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/KRAS |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/APC |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/ADAM10 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/ERBB2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/PSEN2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PDK1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/IFNAR2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/MAML1 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/TGFBR2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/PPBP |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/PF4 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/GREM1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/SMAD3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/SMAD3 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/SMAD3 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/RBPJ |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/BMP1 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL10 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/IFNB1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PTEN |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/SMAD2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/GRB2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/JAG2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/HDAC2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/MAML3 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/DLL1 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/NOTCH4 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CCL4 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CCL3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/NFKB2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/DVL1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/DVL2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/DVL3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3R5 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GCLC |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GRM6 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GSTA1 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GSTM1 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GSTM2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/KRAS |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PIK3C2B |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PLAU |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT4 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A6 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A1 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT1A3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/PPP2R5E |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGT2B7 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT2 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT3 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT6 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT7A |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT7B |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT11 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT2B |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT10A |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT5B |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/WNT3A |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/RBL2 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/CXCL17 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/CASR |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GPRC5D |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/TP73 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/MFAP2 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SSPN |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/LOXL1 |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/LOXL2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/CNTN6 |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/TFAP2A |
| https://identifiers.org/wikipathways/WP3874_r128070 |
WP3874 |
Canonical and non-canonical TGF-B signaling |
/LOXL4 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/MFAP1 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/HK1 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/HEY1 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/PGM2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/DLK2 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/DAG1 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/MAML2 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/DLK1 |
| https://identifiers.org/wikipathways/WP3845_r127900 |
WP3845 |
Canonical and non-canonical Notch signaling |
/DNER |
| https://identifiers.org/wikipathways/WP3655_r129299 |
WP3655 |
Hypothetical craniofacial development pathway |
/ARHGAP29 |
| https://identifiers.org/wikipathways/WP3655_r129299 |
WP3655 |
Hypothetical craniofacial development pathway |
/IRF6 |
| https://identifiers.org/wikipathways/WP3655_r129299 |
WP3655 |
Hypothetical craniofacial development pathway |
/TFAP2A |
| https://identifiers.org/wikipathways/WP3655_r129299 |
WP3655 |
Hypothetical craniofacial development pathway |
/TP63 |
| https://identifiers.org/wikipathways/WP501_r117742 |
WP501 |
GPCRs, class C metabotropic glutamate, pheromone |
/GABBR1 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GGT5 |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/OPLAH |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/ANPEP |
| https://identifiers.org/wikipathways/WP100_r128959 |
WP100 |
Glutathione metabolism |
/GSS |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/BCL6 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/DMD |
| https://identifiers.org/wikipathways/WP5331_r126176 |
WP5331 |
Autophagy in pancreatic ductal adenocarcinoma |
/VMP1 |
| https://identifiers.org/wikipathways/WP710_r126217 |
WP710 |
DNA damage response (only ATM dependent) |
/SCP2 |
| https://identifiers.org/wikipathways/WP698_r126233 |
WP698 |
Glucuronidation |
/UGP2 |
| https://identifiers.org/wikipathways/WP5188_r122585 |
WP5188 |
Retinol metabolism |
/CYP3A7 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SGCG |
| https://identifiers.org/wikipathways/WP5039_r125309 |
WP5039 |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
/DHX58 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SGCA |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SGCB |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/LINGO1 |
| https://identifiers.org/wikipathways/WP5406_r127152 |
WP5406 |
13q12.12 copy number variation |
/SGCD |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/NLGN2 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/NLGN3 |
| https://identifiers.org/wikipathways/WP4875_r116427 |
WP4875 |
Disruption of postsynaptic signaling by CNV |
/NLGN4X |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/ABCC2 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/CP |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/ATP8B1 |
| https://identifiers.org/wikipathways/WP4292_r128219 |
WP4292 |
Methionine metabolism leading to sulfur amino acids and related disorders |
/CTH |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/HSD17B3 |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/CYP11A1 |
| https://identifiers.org/wikipathways/WP4292_r128219 |
WP4292 |
Methionine metabolism leading to sulfur amino acids and related disorders |
/CBS |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/HSD3B2 |
| https://identifiers.org/wikipathways/WP528_r128074 |
WP528 |
Acetylcholine synthesis |
/CHKA |
| https://identifiers.org/wikipathways/WP4292_r128219 |
WP4292 |
Methionine metabolism leading to sulfur amino acids and related disorders |
/AHCY |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/PDX1 |
| https://identifiers.org/wikipathways/WP4292_r128219 |
WP4292 |
Methionine metabolism leading to sulfur amino acids and related disorders |
/MAT1A |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/PLPP1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/KDM1A |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/SREBF1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/HDAC1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/TP53 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/CYP7A1 |
| https://identifiers.org/wikipathways/WP528_r128074 |
WP528 |
Acetylcholine synthesis |
/CHAT |
| https://identifiers.org/wikipathways/WP4220_r128514 |
WP4220 |
Neurotransmitter disorders |
/MAOA |
| https://identifiers.org/wikipathways/WP528_r128074 |
WP528 |
Acetylcholine synthesis |
/PDHA1 |
| https://identifiers.org/wikipathways/WP4220_r128514 |
WP4220 |
Neurotransmitter disorders |
/SLC18A2 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/MYC |
| https://identifiers.org/wikipathways/WP4156_r128201 |
WP4156 |
Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine |
/TH |
| https://identifiers.org/wikipathways/WP4220_r128514 |
WP4220 |
Neurotransmitter disorders |
/TH |
| https://identifiers.org/wikipathways/WP4220_r128514 |
WP4220 |
Neurotransmitter disorders |
/TPH1 |
| https://identifiers.org/wikipathways/WP4220_r128514 |
WP4220 |
Neurotransmitter disorders |
/DDC |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/H3-3A |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/H3-3B |
| https://identifiers.org/wikipathways/WP4156_r128201 |
WP4156 |
Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine |
/AANAT |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SGMS1 |
| https://identifiers.org/wikipathways/WP4220_r128514 |
WP4220 |
Neurotransmitter disorders |
/TPH2 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/HFE |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/FTL |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/CERS4 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/RBBP7 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/STEAP3 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/MBD2 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/LEF1 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/CERS2 |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/CYP17A1 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/CERS3 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/RBBP4 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SGPL1 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/FTH1 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/CERS6 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/UGT8 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/CERS1 |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/SRD5A2 |
| https://identifiers.org/wikipathways/WP528_r128074 |
WP528 |
Acetylcholine synthesis |
/PEMT |
| https://identifiers.org/wikipathways/WP528_r128074 |
WP528 |
Acetylcholine synthesis |
/PCYT1A |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/PLPP2 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/PLPP3 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/DEGS1 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SPTLC1 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SPTLC2 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/GBA |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/ASAH1 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/UGCG |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/DEGS2 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SGPP2 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/CERK |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SGPP1 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/GBA2 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SPHK2 |
| https://identifiers.org/wikipathways/WP4725_r128379 |
WP4725 |
Sphingolipid metabolism overview |
/SPHK1 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/ABCB11 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/SLC27A5 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/TF |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/CBX5 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/HSD3B7 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/E2F1 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/HAMP |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/AKR1D1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/INPP5K |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/HSD17B4 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/CYP27A1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/RB1 |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/AKR1C2 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/ACOX2 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/HJV |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/CHD3 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/CYP7B1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/MTA1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/HDAC2 |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/AKR1C4 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/AKR1C4 |
| https://identifiers.org/wikipathways/WP4156_r128201 |
WP4156 |
Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine |
/COMT |
| https://identifiers.org/wikipathways/WP4220_r128514 |
WP4220 |
Neurotransmitter disorders |
/COMT |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/SLCO1B3 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/AMACR |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/CYP8B1 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/SLCO1B1 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/CYBRD1 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/TFRC |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/BCS1L |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/HEPH |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/TFR2 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/CBX1 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/SLC11A2 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/PANK2 |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/SLC40A1 |
| https://identifiers.org/wikipathways/WP4524_r128554 |
WP4524 |
Alternative pathway of fetal androgen synthesis |
/STAR |
| https://identifiers.org/wikipathways/WP4292_r128219 |
WP4292 |
Methionine metabolism leading to sulfur amino acids and related disorders |
/ADK |
| https://identifiers.org/wikipathways/WP5172_r128276 |
WP5172 |
Iron metabolism disorders |
/UQCRFS1 |
| https://identifiers.org/wikipathways/WP528_r128074 |
WP528 |
Acetylcholine synthesis |
/ACHE |
| https://identifiers.org/wikipathways/WP528_r128074 |
WP528 |
Acetylcholine synthesis |
/PDHA2 |
| https://identifiers.org/wikipathways/WP4292_r128219 |
WP4292 |
Methionine metabolism leading to sulfur amino acids and related disorders |
/CDO1 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/ABCB4 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/MTA3 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/MBD3 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/SUV39H1 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/CHD4 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/CBX3 |
| https://identifiers.org/wikipathways/WP4320_r128823 |
WP4320 |
Effect of progerin on genes involved in progeria |
/MTA2 |
| https://identifiers.org/wikipathways/WP5176_r128232 |
WP5176 |
Disorders of bile acid synthesis and biliary transport |
/SCP2 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/EEF2K |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/EIF4EBP1 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/ABCC2 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/UGT1A10 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/UGT1A9 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/MTOR |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/MMP2 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/ATP1A2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/SPI1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/DLG1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/MKNK1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/DNM2 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC32A1 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/CCKBR |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/ITK |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/PARK7 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/DLG4 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/LMO2 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/TRPC6 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/TRPC3 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CACNA1A |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/TRPC1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CTLA4 |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/B3GALT1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/GATA2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PDCD1 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/RYR1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/DNM3 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/RYR2 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/RYR3 |
| https://identifiers.org/wikipathways/WP2943_r128729 |
WP2943 |
Hypoxia-mediated EMT and stemness |
/DICER1 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/ABCC1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/NFKBIB |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/NFKBIE |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/B3GALT2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAP3K14 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SYN1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAPK9 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SYT1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAP2K7 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC1A3 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/RIMS1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/GSK3B |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/B4GALT1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/MAPK1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/NFKBIA |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CD40LG |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAPK3 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/TSC2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/IKBKB |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC17A7 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/RAB3A |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/PIK3CG |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/STX1A |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/RHEB |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAP3K8 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/NFKB1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/IL2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CBL |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/IFNG |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PTPN6 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/IL4 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/IL5 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/IL5 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/ZAP70 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/SOS1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/SOS1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/RPS6KA1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/CREB1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MYB |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PIK3CA |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/NCKAP1L |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/IL1B |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/RAF1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SNAP25 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CDK4 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/IL6 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/IL10 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/VAV1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/AKT1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/AKT1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PAK1 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/GNAQ |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SYN2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/RUNX1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/SHC1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/IL3 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/CSF2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CSF2 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC18A2 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/TSC1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CPLX1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/FOS |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/FOS |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/HRAS |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/BDNF |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/JUN |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CD28 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/LCK |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/CSF1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SYN3 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC18A3 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/ARC |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CALM1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/UNC13B |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/NRAS |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CHUK |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/LAT |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/VAMP2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/TNF |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/IKBKG |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MIR29B1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MIR29B2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BCL2L11 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CDKN2A |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CHUK |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/CHUK |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/CSF2 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/DFFA |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/DFFB |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/AKT1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BBC3 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/APAF1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BIRC2 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/BIRC2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BIRC3 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/BIRC3 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/XIAP |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BIRC5 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/BIRC5 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IGF1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/FAS |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IKBKB |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/IKBKB |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/IL1B |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/IL2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/FASLG |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/IL6 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/CXCL8 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IRF3 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IRF7 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/ITGB3 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/JUN |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MCL1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MDM2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MAP3K1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/MMP9 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MYC |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/NFKB1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/NFKB1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/NFKBIA |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/PMAIP1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CYCS |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MAPK10 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/DIABLO |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BAD |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BAK1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BAX |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/CCND1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BCL2 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/BCL2A1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BCL2L2 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/BCL2L2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BID |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BOK |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TNF |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/TNF |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TNFRSF1A |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/TNFRSF1A |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TNFRSF1B |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TP53 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TRAF3 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/TRAF6 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/VEGFA |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP3 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP4 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP6 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP7 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP8 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP9 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CASP10 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IKBKG |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TRADD |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TNFRSF25 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/RIPK1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CRADD |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/HRK |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TNFSF10 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/FADD |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TNFRSF10B |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/CFLAR |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/CFLAR |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/CD40LG |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/INS |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/IGF1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/INSR |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/THRB |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/CDK4 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/CDK2 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/MAPK3 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/MAPK1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/AKT1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/AKT2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/FOSB |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/FOXO1 |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/SGMS1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/AKT3 |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/SPHK2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PRKCQ |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/NSF |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC17A6 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/LYL1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/NAPA |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC6A4 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC38A1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/STX2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/IL1A |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/B4GALNT1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC22A3 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CACNA1B |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/SPHK1 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/CCK |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CARD11 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/CES1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/ICAM1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/IL1A |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/LTA |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/VCAM1 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/CES2 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/ABCG2 |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/UGCG |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/UGT8 |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/SGPP2 |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/CERK |
| https://identifiers.org/wikipathways/WP4142_r128518 |
WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |
/SGPP1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/LEF1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/ITGA2B |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CD4 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/FYN |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/GAB2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/KITLG |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PTPRC |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/NFATC2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/NFATC2 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/DNM1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/CSF3 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/GAB1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/TPO |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/CXCR4 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CLTA |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/PLCG1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PLCG1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/RRAS |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/STAT5A |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/GNAI1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/EPO |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/KRAS |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/ACVR1B |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CLTC |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/NTRK2 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/ITPR1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/PDK1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CD8A |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/BRAF |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/NCK1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/ADCY1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CD3D |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/GP9 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/GRIN1 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/GRB2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/GRB2 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/PLCB1 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/SLCO1B1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/CXCL2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IGF1R |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/MMP1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/MMP3 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/NFKB2 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/UGT1A1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/PTGS2 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/REL |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/RELA |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/RELA |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/RELB |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TRAF1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TRAF2 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/SMAD7 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/KRAS |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/PDGFA |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/IGF1R |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/BRAF |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/FLT1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/TNXB |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/PGF |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/CRTC2 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/RASSF1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/AP2B1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC18A1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/AP2S1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/DNM1L |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/STX1B |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SYP |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/UNC13A |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/STXBP1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/UNC13C |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CPLX2 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC25A4 |
| https://identifiers.org/wikipathways/WP3676_r128137 |
WP3676 |
BDNF-TrkB signaling |
/HOMER1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/SLC17A8 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CLN8 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/AP2A2 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/AP2A1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CPLX3 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/EGLN2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TNFRSF21 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/GZMB |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/HELLS |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IGF2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IRF2 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IRF4 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/PRF1 |
| https://identifiers.org/wikipathways/WP3617_r128736 |
WP3617 |
Photodynamic therapy-induced NF-kB survival signaling |
/SELE |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/BNIP3L |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/SCAF11 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/CLTCL1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/GRAP2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/GATA1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/AP2M1 |
| https://identifiers.org/wikipathways/WP2267_r128068 |
WP2267 |
Synaptic vesicle pathway |
/STX3 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/DAG1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IRF6 |
| https://identifiers.org/wikipathways/WP2943_r128729 |
WP2943 |
Hypoxia-mediated EMT and stemness |
/ZEB1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TP73 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/TP63 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MUC1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/DLK1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/FOXM1 |
| https://identifiers.org/wikipathways/WP5385_r128454 |
WP5385 |
Growth factors and hormones in beta cell proliferation |
/RAB43 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/CD38 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/LCP2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/KCNH2 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/AHSA1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/RIOK3 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/KLF1 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/CNR1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MXI1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/NFE2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/CBFA2T3 |
| https://identifiers.org/wikipathways/WP3679_r128772 |
WP3679 |
Cell-type dependent selectivity of CCK2R signaling |
/DAGLA |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/TRIM29 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/BCL10 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/FLI1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/ICOS |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/GYPA |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/MALT1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/ABO |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/IKZF1 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/CHP1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR3074 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR128-1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR181A1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR150 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR221 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR16-1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR130A |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/TRAJ10 |
| https://identifiers.org/wikipathways/WP3863_r127932 |
WP3863 |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
/TRBJ1-4 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR15A |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/MIR29A |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/MIR223 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/CYP3A5 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IRF1 |
| https://identifiers.org/wikipathways/WP254_r128148 |
WP254 |
Apoptosis |
/IRF5 |
| https://identifiers.org/wikipathways/WP229_r128658 |
WP229 |
Irinotecan pathway |
/BCHE |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/SEC14L2 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/PIM1 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/CD34 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/CIITA |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/HMGN5 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/IRF5 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/RHOH |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/HES6 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/TRAF3IP3 |
| https://identifiers.org/wikipathways/WP2849_r129244 |
WP2849 |
Hematopoietic stem cell differentiation |
/ZNF835 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ATP2C2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MSH2 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/SFRP1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MSH3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MSH6 |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/LDLR |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/APOE |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/ALPL |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/ABCA1 |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/PCSK9 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/ZEB2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CSNK1A1L |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/CEBPA |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ORAI1 |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/AHCY |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/AHCYL2 |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/MAT1A |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/NFATC4 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/PPP3CB |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C4A |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/AGPS |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/GNPAT |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/APOE |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/DHRS7B |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/FAR1 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/FAR2 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/CEPT1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/GAL |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CDKN1A |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BAD |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BAK1 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/CDH1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MAPK9 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RHOA |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL4R |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/PGR |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/GSK3B |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BAX |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BIRC5 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/ITGA6 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ESR1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TGFB2 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/JAK2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/JAK2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MAPK1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/YY1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/AXIN1 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/GPI |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/AKT2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BBC3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TGFB1 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/TGFB1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/TGFB1 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/TGFB1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/TYK2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/USF2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/GATA3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MAPK8 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MAPK10 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CCND1 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/CCND1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/CCND1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL23A |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IFNG |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL17F |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL4 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL5 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/NR3C1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/STAT1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/STAT1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/AKT3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TGFB3 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/TNFSF11 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/POLK |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RAC2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/NFATC1 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/G6PC1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RAF1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CASP9 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RAC1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL6 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/IL10 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL10 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/TLR4 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/ALDOB |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MYC |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/MYC |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/MYC |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/TLR2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/TLR2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ESR2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TP53 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/SMAD4 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/TNFRSF11A |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/PMAIP1 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/PFKL |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/AKT1 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/AKT1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/EGFR |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/IL2RG |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL2RG |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/ITGB1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/EIF4E |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BCL2L11 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/JAK1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CASP3 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/ALDH1A1 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/FBP1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/STAT3 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL12A |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/IL13 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL13 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RAC3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/FOS |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/STAT2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BCL2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CYCS |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/LPL |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/JUN |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/JUN |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TBK1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/SOCS1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/PTPN1 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/VDAC1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IRF9 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/TNF |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/TNF |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/TNF |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/CHUK |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/MAPK14 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/CTF1 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/ACSL1 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/FOS |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/JUN |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/RHOA |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/PPP3CA |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/PRKCB |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/MAPK1 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/MAPK8 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/MAPK11 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/PRL |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/RAC1 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/STAT3 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C1QA |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C1QB |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C1QC |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/CALM1 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/CAMK2D |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/NFATC1 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/IFNG |
| https://identifiers.org/wikipathways/WP5235_r127926 |
WP5235 |
Estradiol regulation in porto-sinusoidal vascular disease |
/CALM1 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/GATA3 |
| https://identifiers.org/wikipathways/WP5372_r128695 |
WP5372 |
Involvement of δ-secretase in neurodegenerative diseases |
/AKT1 |
| https://identifiers.org/wikipathways/WP5372_r128695 |
WP5372 |
Involvement of δ-secretase in neurodegenerative diseases |
/AKT2 |
| https://identifiers.org/wikipathways/WP5372_r128695 |
WP5372 |
Involvement of δ-secretase in neurodegenerative diseases |
/AKT3 |
| https://identifiers.org/wikipathways/WP5187_r129216 |
WP5187 |
mRNA vaccine activation of dendritic cell and induction of IFN-1 |
/TNFRSF11A |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/PNCK |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/TTC9 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/CSN2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ELF5 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/NTN1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ERBB3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/MLH1 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/PGM1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TCF7 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/SLC5A1 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/CAV1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/CSNK1A1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL1A |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL18RAP |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/GADD45A |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/NPC2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL22 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL21 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/LEF1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL18 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/MX1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/STAT6 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/MAF |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/NRG3 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFIT1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFITM1 |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/DNMT1 |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/DNMT3A |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/DNMT3B |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/GATA4 |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/MTHFD1 |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/MTHFR |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/MTR |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/MTRR |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/CFP |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/PRKCE |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/SHMT1 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/MAF |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/ARSA |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/UGT8 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RALA |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFNGR1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IFNGR1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/PIAS1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/PTGS2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/ARAF |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL12RB2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL12RB1 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL21R |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/EXOC2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/PRLR |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/KRAS |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/DDB2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/APC |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/STAT4 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ERBB2 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RALB |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/BRAF |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFNAR2 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFNGR2 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C1R |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/RALGDS |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/IL23R |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/TGFBR2 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/SLC2A2 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/TERT |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/SMAD3 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/NOD2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/NOD2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/AXIN2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/CEBPB |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/SMAD2 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/SMAD2 |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/ERBB4 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/ERBB4 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/TLR5 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/PSMB8 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/MASP2 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/CD55 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/CFD |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/AGT |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/EDN1 |
| https://identifiers.org/wikipathways/WP5150_r128047 |
WP5150 |
Spina bifida |
/MAT2B |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/APOB |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/IL6ST |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/LIFR |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/MASP1 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/REL |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/SORT1 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/CFB |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C1S |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C2 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C3 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C4B |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C5 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C6 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C7 |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C8A |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C8G |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C9 |
| https://identifiers.org/wikipathways/WP5372_r128695 |
WP5372 |
Involvement of δ-secretase in neurodegenerative diseases |
/APP |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/PEX19 |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/MTTP |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/PEX3 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/PEX16 |
| https://identifiers.org/wikipathways/WP5372_r128695 |
WP5372 |
Involvement of δ-secretase in neurodegenerative diseases |
/LGMN |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/APC2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/GADD45G |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/KHK |
| https://identifiers.org/wikipathways/WP5235_r127926 |
WP5235 |
Estradiol regulation in porto-sinusoidal vascular disease |
/KCNN3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/APPL1 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/GLYCTK |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/CLDN4 |
| https://identifiers.org/wikipathways/WP5372_r128695 |
WP5372 |
Involvement of δ-secretase in neurodegenerative diseases |
/BACE1 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/FOXP3 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/FOXP3 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/GADD45B |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/TPI1 |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/SORD |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/RORC |
| https://identifiers.org/wikipathways/WP5178_r128233 |
WP5178 |
Disorders of fructose metabolism |
/HK1 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/ACSL6 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/GJB2 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/ACSL5 |
| https://identifiers.org/wikipathways/WP1528_r129017 |
WP1528 |
Physiological and pathological hypertrophy of the heart |
/MYEF2 |
| https://identifiers.org/wikipathways/WP2817_r128957 |
WP2817 |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
/TPM3 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/OSBPL5 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFI35 |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/RORA |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/TBX21 |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/CETP |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/OAS1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IFIT3 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/FABP3 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/IRF1 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/LDLRAP1 |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/SLC27A4 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/TAP1 |
| https://identifiers.org/wikipathways/WP4197_r129046 |
WP4197 |
Immune response to tuberculosis |
/PTPN2 |
| https://identifiers.org/wikipathways/WP4216_r128152 |
WP4216 |
Chromosomal and microsatellite instability in colorectal cancer |
/DCC |
| https://identifiers.org/wikipathways/WP5323_r128432 |
WP5323 |
Fatty acids and lipoproteins transport in hepatocytes |
/LPA |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/MIR429 |
| https://identifiers.org/wikipathways/WP5174_r128414 |
WP5174 |
Ulcerative colitis signaling |
/HLA-DMA |
| https://identifiers.org/wikipathways/WP5198_r129326 |
WP5198 |
Inflammatory bowel disease signaling |
/HLA-DMA |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/MIR200A |
| https://identifiers.org/wikipathways/WP2813_r128673 |
WP2813 |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
/MIR200B |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/LCAT |
| https://identifiers.org/wikipathways/WP545_r128162 |
WP545 |
Complement activation |
/C8B |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/PEDS1 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/PEX7 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/PEX1 |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/LIPC |
| https://identifiers.org/wikipathways/WP4627_r129311 |
WP4627 |
Lipids measured in liver metastasis from breast cancer |
/LPIN1 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/LPIN1 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/PEX5L |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/LPCAT1 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/LPIN2 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/GAL3ST1 |
| https://identifiers.org/wikipathways/WP5275_r128241 |
WP5275 |
Ether lipid biosynthesis |
/LPIN3 |
| https://identifiers.org/wikipathways/WP4522_r128956 |
WP4522 |
Metabolic pathway of LDL, HDL and TG, including diseases |
/LIPG |
| https://identifiers.org/wikipathways/WP1577_r125586 |
WP1577 |
Amino acid conjugation of benzoic acid |
/GLYATL2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/FMO3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TCF3 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/PTGS1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ATP1A3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/IL1RN |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SSTR1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SP3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SSTR2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CHRM3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CHRM4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CHRM5 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CHRNA4 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CHRNB2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CSK |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/DDB1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GATA2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HADHA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HSPD1 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/MVD |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PRKAR1A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PRKAR1A |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PRKAR1B |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PRKAR1B |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PRKAR2A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PRKAR2A |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PRKAR2B |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PRKAR2B |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/BDKRB2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/RYR2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/C4A |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/WAS |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CUL4A |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/AJUBA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GCK |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGD1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ARHGEF4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ARHGEF1 |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/ALX1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA11 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA4 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA8 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA9 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGAE |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGAV |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB4 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB6 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB7 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB8 |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/CREBBP |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CREBBP |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/TEAD3 |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/TNFRSF1A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CHAT |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/TEAD2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SLC1A3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MEF2C |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/MAPK1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HIF1A |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/RPS6KA5 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/HTR2A |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/FBL |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/NFKB1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NFKB1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GAPDH |
| https://identifiers.org/wikipathways/WP5229_r123080 |
WP5229 |
Nephrotoxcicity adverse outcome pathway |
/SLC22A2 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/VEGFA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/VEGFA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NR3C1 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/PLCD4 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/PLEK |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HDAC1 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/CREB1 |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/CREB1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CREB1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MYB |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/NCOA3 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/WNT1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/IL1B |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/ELK1 |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/G6PC1 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/RAF1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SNAP25 |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/PCNA |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/ARNTL |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/BHLHE40 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NGF |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/CLOCK |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/PPP3CA |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/SMAD4 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/EGFR |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/EGFR |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/HTR2C |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/CRH |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/FOXO1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/THRB |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GJA1 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/GRM1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NEUROD1 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/CASP3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CASP3 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/CASP7 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/PRKCB |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/IL13 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/FOS |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/INSR |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/HRAS |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/BDNF |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/BDNF |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/JUN |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/HTR1A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TH |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SOX2 |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/SP1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SP1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/TEAD1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/TEAD4 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/ARC |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/VAMP2 |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/TNF |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA6 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGAM |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB3 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGB5 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP5023_r128731 |
WP5023 |
Hypoxia-dependent self-renewal of myoblasts |
/MAPK14 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PAK4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PAK4 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/YAP1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/GNA13 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PPARGC1A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/YWHAQ |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TPH2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CRK |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CTNNA1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/DDC |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/DOCK1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/EGFR |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/EN1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/EP300 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ESR2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/F2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/F2R |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF8 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FN1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GABRA1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/WWTR1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GATA3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/GNA12 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GNB3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ARHGAP35 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3R4 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/HRAS |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HTR1A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HTR2A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/IL6 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CXCL8 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/IL10 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RHOA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/LMX1B |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MAOA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ASCL1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/MST1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/MYC |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/NF2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NKX2-2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/NRAS |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/NRAS |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PAK1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PAK1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PAK2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PAK2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PAK3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PAK3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3C2A |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3C2G |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3C3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3CA |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3CB |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3CD |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3CG |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MAPK1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MAPK3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MAPK4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MAPK6 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/GNG12 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PAK6 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PAK6 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PAK5 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PAK5 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PXN |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RAC1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RAC2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RAC3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RAF1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CCND1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/RET |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ACTB |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/SAV1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/SOS1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/SOS2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/STK3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ACTG1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TNF |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TPH1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/VAV1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/LATS1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CD14 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/BCAR1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH1 |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/DDX21 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TLX3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/DIAPH3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MAZ |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/DLX2 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/H19 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MBD1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GPD1L |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PKNOX1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SCN3B |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HTR3A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SCN4B |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TSPYL1 |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/MAFK |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NOS1AP |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/DEAF1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CTCF |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CFL2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CHRNB4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIP5KL1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/KCNJ8 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PHOX2A |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/MIR98 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MOS |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NKX3-1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/SSH1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/POU3F2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/FEV |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CC2D1A |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/SSH3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CDCA7L |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RDX |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SNTA1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/VIL1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/EZR |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/SSH2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PHOX2B |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PPP1R14A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/RUNX3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MAP2 |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/ICAM1 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/GRIN2D |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/IL1A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TACR1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/EGR1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PLP1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/YWHAG |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TPPP |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/AQP4 |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/MAFF |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/MAFG |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/MAFG |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/DIAPH1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIP5K1C |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/GSN |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MSN |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MYL1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MYLK |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PPP1R12A |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PPP1R12A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/YBX1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PLCB4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ROCK1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SLC6A4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/SLC9A1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/YWHAB |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/YWHAE |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/YWHAZ |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CAV3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ACTN1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ROCK2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/RBX1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FLT4 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HDAC9 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/NGFR |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FGFR2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FGFR3 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/PTGS2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NFKB2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FGFR1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TF |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FLT1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/MET |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PDGFRB |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HES1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SPTBN1 |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/NFE2L2 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/CRHR1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/TEK |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FLT3 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/ABCC4 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/KDR |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/ACE2 |
| https://identifiers.org/wikipathways/WP4269_r129196 |
WP4269 |
Ethanol metabolism production of ROS by CYP2E1 |
/CYP2E1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PDGFRA |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/POLR1E |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HADHB |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/EGF |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/IGF1R |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/EPHA2 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/NTRK2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/NTRK2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ALDOA |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/PDK1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SST |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/KIT |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FGFR4 |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/NOS3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HSP90B1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MECP2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CEBPB |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CHRNA7 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/GRIN1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CSF1R |
| https://identifiers.org/wikipathways/WP4707_r128647 |
WP4707 |
Aspirin and miRNAs |
/PPARA |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/NTRK1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA10 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA2B |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA3 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA5 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGA7 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGAD |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGAL |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/ITGAX |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH11 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CFL1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CHRM1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CHRM2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CHRM2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ADCYAP1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ADCYAP1R1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PPARGC1B |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CCN2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/EGF |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF5 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF6 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF7 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF9 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF10 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF11 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF12 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF13 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF14 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGFR1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGFR3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGFR2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGFR4 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RRAS2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MRAS |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3R5 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF20 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF21 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF22 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/APC |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ACADM |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/IL6R |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CXCL10 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/AR |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ITGA1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/KRAS |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/KRAS |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/HES5 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NTRK2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PDGFA |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PDGFB |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PDGFRA |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PDGFRB |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PFN1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIK3C2B |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PPP1CA |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PPP1CB |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PPP1CC |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/AVP |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PRKACA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PRKACA |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PRKACB |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PRKACB |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PRKACG |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/PTK2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PTK2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/BDKRB1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RRAS |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/BRAF |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/TMSB4X |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/C4B |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/VCL |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/VIPR1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/VIPR2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF23 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF18 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF17 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF16 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/IQGAP1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/FGF19 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CDC42 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TAC1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/REST |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CREM |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/CPT1A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SLC25A4 |
| https://identifiers.org/wikipathways/WP5367_r129307 |
WP5367 |
Rubinstein-Taybi syndrome 1 |
/IRF2 |
| https://identifiers.org/wikipathways/WP3944_r129057 |
WP3944 |
Serotonin and anxiety-related events |
/NLGN1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PBX1 |
| https://identifiers.org/wikipathways/WP3853_r129064 |
WP3853 |
ERK pathway in Huntington's disease |
/HTT |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH3 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH4 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH5 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH6 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH8 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH9 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH16 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH17 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH18 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/APC2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/GIT1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/LIN28B |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIP4K2A |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH22 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SLC9A3 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIP4K2C |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/RASSF7 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIP5K1A |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIP5K1B |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/PIP4K2B |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ARHGEF7 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ARHGEF6 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CD44 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/VGLL4 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/TP73 |
| https://identifiers.org/wikipathways/WP5229_r123080 |
WP5229 |
Nephrotoxcicity adverse outcome pathway |
/SLC31A1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/POU5F1 |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/NOX1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ARPC5 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH13 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ABI2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/WASF2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/BAIAP2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/NCKAP1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/ECE1 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/FOXM1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/FOXM1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/CYFIP2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/LIMK1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/PAH |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/BRK1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/YWHAH |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/WASF1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/POU2F2 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MYL3 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NFYA |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/SCN5A |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/NANOG |
| https://identifiers.org/wikipathways/WP5258_r128499 |
WP5258 |
Role of ROS in COVID-19 endothelial dysfunction |
/IFNA1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MIR210 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MIR130A |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH7 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH10 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH12 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH15 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/AMOT |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/LATS2 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH20 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH19 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/KCNH2 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/KCNQ1 |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/MIR16-1 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/MYH10 |
| https://identifiers.org/wikipathways/WP51_r128023 |
WP51 |
Regulation of actin cytoskeleton |
/ENAH |
| https://identifiers.org/wikipathways/WP706_r129309 |
WP706 |
Sudden infant death syndrome (SIDS) susceptibility pathways |
/RORA |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/CDH24 |
| https://identifiers.org/wikipathways/WP4541_r128259 |
WP4541 |
Hippo-Merlin signaling dysregulation |
/DCAF1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/EIF2AK2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/EIF4EBP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/MTOR |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MMP2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MTOR |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/SPI1 |
| https://identifiers.org/wikipathways/WP3408_r128627 |
WP3408 |
Evolocumab mechanism to reduce LDL cholesterol |
/LDLR |
| https://identifiers.org/wikipathways/WP3408_r128627 |
WP3408 |
Evolocumab mechanism to reduce LDL cholesterol |
/PCSK9 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BDKRB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CEBPA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EDNRA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EDNRB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FRAT1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FRAT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAX |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MITF |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MSH2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MSH3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MSH6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PML |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RARA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RUNX1T1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SPI1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TXNRD2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ZBTB16 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SPRY1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/NDRG1 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ACSL4 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PTK2B |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/HADHA |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HSD3B1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HSD3B2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HSD17B3 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HSD17B2 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ACADS |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HSD17B7 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/PECR |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ARID1B |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMARCA4 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMARCC1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMARCC2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMARCD1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMARCD2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMARCD3 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ACSF2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ARID1A |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PRKDC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ARHGEF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ARHGEF11 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ARHGEF12 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DAPK2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLEKHG5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RARB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT8A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ZBTB17 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HSD17B1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MYOF |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MIR744 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MIR92A2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CKS1B |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MIR92A1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CALML1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CALML2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTT1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CDKN1A |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/KLK3 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/BRCA1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/BIRC3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/MEF2C |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/BIRC5 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/EP300 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/HIF1A |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/HIF1A |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/NFKBIA |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MAPK3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IKBKB |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/TGFB1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/TYK2 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/MAPK8 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/SMC3 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/NFKB1 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/NFKB1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CCND1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MAPK14 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MAPK14 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/MAPK14 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/TBP |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/VEGFA |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/STAT1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/SOS1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/FASLG |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/CREB1 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IRF3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/ELK1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/TRAF3 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CASP9 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/RAC1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/IL6 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MYC |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/RIPK1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/TP53 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/SMAD4 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/AKT1 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/AKT1 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/NCAM1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/VAV2 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/JAK1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/JAK1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CASP3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/CASP3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/RAD21 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CASP7 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/STAT3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/STAT3 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CXCL8 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/FOS |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/STAT2 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/BCL2 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/MYD88 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/TRAF6 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/JUN |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/JUN |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/PTPN11 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/TBK1 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/RXRA |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/TLR7 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/CHUK |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IRF9 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IKBKE |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IKBKG |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MAP4K1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CRK |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/TICAM1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/DOCK1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ELK1 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ACSL1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/FKBP5 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/FOS |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/RICTOR |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/RAPGEF1 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/HADH |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HRAS |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/JUN |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MYC |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PAK1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PIK3CA |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MAPK1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MAPK3 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MAPK8 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PTPN11 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PXN |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/RAF1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/RASA1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SOS1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SP1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/STAT3 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/TP53 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CDK4 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CDK2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/AKT1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MDM2 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/OAS3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/BATF |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/FRZB |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/EBF1 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/CTCF |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ETV4 |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/PON1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/E2F2 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/SPHK2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CDC25B |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/PON2 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/OAS2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CPN1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/LEF1 |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/CES5A |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CXCR1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/RRM2 |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/CES2 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/CHD2 |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/CES1 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/CERS1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/MIR21 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MIR34A |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CRKL |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CYP17A1 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ECI1 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/EHHADH |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ACSL3 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ACADL |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/KLK2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ATF1 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/CERK |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/BCL11A |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/ESD |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/RFX5 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SPINK1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/NOS2 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/FYN |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/HSPA5 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/PTGS2 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/PLD1 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/FGFR1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/MAVS |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/DDX58 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IFIH1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/COL4A2 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/HNF1A |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/IGF1R |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/UCHL1 |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/IFNAR2 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/IL6R |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/CDC25A |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/HSP90B1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PLK1 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/SMAD3 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/PTK2 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/PRNP |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/GRB2 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MMP1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ABCC4 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/F13B |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/GAB1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/GRB2 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HGF |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/HSD17B4 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/ACADM |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/AR |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ACTL6B |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/PTEN |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/RAP1A |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/RAP1B |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ACTL6A |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMAD3 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SMAD2 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/IRF4 |
| https://identifiers.org/wikipathways/WP5192_r128742 |
WP5192 |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
/S1PR1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/SPRY2 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/CPT1A |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/PON3 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/PODXL |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/PAX5 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/CPT2 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/POU2F2 |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/SLC22A5 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CD44 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/CTTN |
| https://identifiers.org/wikipathways/WP4880_r128661 |
WP4880 |
Host-pathogen interaction of human coronaviruses - interferon induction |
/OAS1 |
| https://identifiers.org/wikipathways/WP136_r128192 |
WP136 |
Phase I biotransformations, non-P450 |
/LIPA |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/CASP12 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MIR155 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MIR24-2 |
| https://identifiers.org/wikipathways/WP3646_r128258 |
WP3646 |
Hepatitis C and hepatocellular carcinoma |
/MIR24-1 |
| https://identifiers.org/wikipathways/WP2263_r127838 |
WP2263 |
Androgen receptor network in prostate cancer |
/ERG |
| https://identifiers.org/wikipathways/WP5123_r128205 |
WP5123 |
Mitochondrial fatty acid oxidation disorders |
/SCP2 |
| https://identifiers.org/wikipathways/WP3995_r128423 |
WP3995 |
Prion disease pathway |
/PDIA3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/NFKBIB |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/TXNRD2 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/CBLIF |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/TFE3 |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/P2RY4 |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/OTC |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/ASS1 |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/ASL |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/CPS1 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NOX5 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/TXN2 |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/SLC25A15 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/CDKN1A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ABL1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AGT |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/APC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AR |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ARAF |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BRAF |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCNA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCNE1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCNE2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDK6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDKN1A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CREBBP |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CSF2RB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DLL3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DLL4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DVL1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EGFR |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EP300 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EPAS1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ESR2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FOXO1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD9 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GLI3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNA13 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNAI1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNB5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSK3B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HDAC2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ITGAV |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/JAG2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/JAK2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/JUN |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/KLK3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MMP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NCOA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NOTCH3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLCG1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLD1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLD2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PRKCA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PRKCB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RALBP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ROCK1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ROCK2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RPS6KA5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SKP2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SOS1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/STAT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT16 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT2B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT3A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/APAF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/APPL1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CASP7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CASP9 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CTBP2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DVL3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNA12 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HEY1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/KNG1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LRP6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PDGFRB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTCH2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RALB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RALGDS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT9B |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/CREBBP |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/FH |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/TGFB2 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/EP300 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/HIF1A |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/NFKBIA |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/BIRC7 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IKBKB |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/TGFB1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/VEGFA |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/EPAS1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/SFPQ |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/SLC2A1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/TGFB3 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/CTSK |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/TGFA |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/CYBB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SP1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CHUK |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IKBKG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AKT1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AKT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AKT3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AXIN1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BAD |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BAK1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BAX |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BBC3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BCL2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BCL2L11 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BID |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BIRC2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BIRC3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BIRC5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BIRC7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BMP2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BMP4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BRCA2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CAMK2A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CAMK2B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CAMK2D |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CASP3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CASP8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CBL |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCNA2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCND1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCND2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDH1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDK2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDK4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDKN1B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDKN2A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CHUK |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CRK |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CSF2RA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CTNNA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CXCL12 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CXCL8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CYCS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ELK1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ESR1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/F2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/F2R |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/F2RL3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FADD |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FAS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FASLG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FH |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FN1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FOS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GLI1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GLI2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNA11 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNAQ |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNB3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNB4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG10 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG11 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG12 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG13 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNG8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNGT1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNGT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HDAC1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HIF1A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HRAS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HSP90AA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HSP90AB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IGF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IKBKB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IKBKG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL12A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL12B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL13 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL23A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL2RA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL2RB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL2RG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL4R |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL5RA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ITGA6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ITGB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/JAK1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMA5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMC1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMC2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LRP5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAPK1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAPK10 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAPK3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAPK8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MAPK9 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MDM2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MST1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MYC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NCOA3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NFKBIA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NRAS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIK3CA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIK3CB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIK3CD |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLCG2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PMAIP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/POLK |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTGER2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RAC1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RAC3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RAD51 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RAF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RET |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RHOA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RPS6KB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RUNX1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RXRA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SHH |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SLC2A1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SMAD4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SOS2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/STAT1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/STAT3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TGFA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TGFB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TGFB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TGFB3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TP53 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TRAF3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TRAF6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/VEGFA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/VEGFB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/VEGFC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/VEGFD |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT10B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT5A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/XIAP |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/AKT3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR6 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TAB1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TIRAP |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP3K8 |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/ADORA2A |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/ADORA2B |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK14 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/MAPK14 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TICAM1 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/AKT2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TAB2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/FOS |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/FOS |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/LY96 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TAB3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TBK1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TICAM2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IL1B |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IL6 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CXCL8 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IL12A |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IL12B |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IRAK1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IRF3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IRF7 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/MAOA |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MYD88 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/NFKB1 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NFKB1 |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/P2RY2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IRAK4 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR7 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/PGA5 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3CA |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3CB |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3CD |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3CG |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR9 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TOLLIP |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK8 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK11 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK9 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK10 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/MAPK10 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK13 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP2K7 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RAC2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAPK12 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CCL5 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/PGA3 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/PGA4 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/SP1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/STAT1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR4 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TNF |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TRAF3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TRAF6 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CASP8 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/CAT |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/RIPK1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/FADD |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CD14 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CD80 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CD86 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CD40 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IKBKE |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/GLUD1 |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/GLS2 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/EGLN3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EGLN3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTO2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTT2B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MGST1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTGER3 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/MGST1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/TFEB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EML4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NKX3-1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/RBX1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/DIAPH1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/VHL |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/PRCC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CAMK2G |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCND3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CDKN2B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CRKL |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/E2F2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/E2F3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ERBB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD10 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GADD45A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTA3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTA4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTA5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTM3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTM4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTM5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HHIP |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL13RA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/JUP |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/KIF7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LEF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MGST2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MGST3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MLH1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLCB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLCB3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLCB4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PPARD |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTCH1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RBX1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SMO |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/STAT6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SUFU |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TCF7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TFG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TRAF5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TXNRD1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TXNRD3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/VHL |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/LTB4R |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/GPX1 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/GPX3 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/GSR |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/GSTT2 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/JUNB |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CXCL9 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NOX4 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CXCL11 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/SOD2 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/SOD3 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/TXNRD1 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/CCK |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/ARG1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCDC42 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/DVL2 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/PDGFB |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NFE2L2 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/ARNT |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/RELA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ADCY9 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AGTR1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ARNT |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/AXIN2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BDKRB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CALML3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CALML4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CALML5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CALML6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/COL4A1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/COL4A2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/COL4A4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/COL4A6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CSF1R |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CSF3R |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CTBP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CUL1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CXCR4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DDB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DLL1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DVL2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/E2F1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EDN1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EGF |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EPO |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EPOR |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ETS1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FGF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FGFR1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FGFR2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FGFR3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FGFR4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FLT3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FLT3LG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FLT4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/FZD7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNAI2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNAI3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GNAS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GRB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTA2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTM1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTM2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HES1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HES5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HGF |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HMOX1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HSP90B1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNAR2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNGR1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNGR2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IGF1R |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL12RB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL12RB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL15RA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL3RA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL6R |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL6ST |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL7 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL7R |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ITGA2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ITGA2B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ITGA3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/JAG1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/JAK3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/KEAP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/KIT |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/KITLG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/KRAS |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMA2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMA3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMA4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMB3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMC3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LPAR1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LPAR2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LPAR3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LPAR4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LPAR5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LPAR6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MET |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MMP3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NFE2L2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NFKB2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NOS2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NOTCH4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NQO1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NTRK1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PAX8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PDGFA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PDGFB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PDGFRA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PGF |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PLCB1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PPARG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PRKACA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PRKACB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PRKACG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PRKCG |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTEN |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTGER4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTGS2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTK2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RALA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RASGRP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RASGRP2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RASGRP3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RASGRP4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RASSF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RASSF5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RELA |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SKP1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SMAD2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/SMAD3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/STAT4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/STAT5A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/STAT5B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TERC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TERT |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TGFBR2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TPR |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TRAF1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TRAF2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT10A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT11 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT5B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT7A |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT7B |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/LPAR6 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NQO1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/PIK3R5 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/GCLC |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/LPAR4 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/HMOX1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA7 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNAR2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNB1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CXCL10 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/LBP |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR8 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/UGT1A6 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/SCT |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CCL3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/CCL4 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/SOD1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/SPP1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR3 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/TLR5 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/VIP |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/XDH |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/NOS2 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/EGLN1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/CADM2 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/EGLN2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/APC2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CTNNA2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EGLN1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/EGLN2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GADD45G |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IGF2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIM2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PTGER1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RXRB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/RXRG |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/ADORA1 |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/ADORA3 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/GRP |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/P2RY1 |
| https://identifiers.org/wikipathways/WP80_r128041 |
WP80 |
Nucleotide GPCRs |
/P2RY6 |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/GAST |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NOX3 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NFIX |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/PGC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DAPK1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DAPK3 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/NOX1 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/ELOB |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/ELOC |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/SETD2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ALK |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/COL4A3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/COL4A5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ELOB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ELOC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GADD45B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IL15 |
| https://identifiers.org/wikipathways/WP408_r128982 |
WP408 |
Oxidative stress response |
/MT1X |
| https://identifiers.org/wikipathways/WP2596_r129122 |
WP2596 |
Gastric acid production |
/MUC6 |
| https://identifiers.org/wikipathways/WP4595_r128208 |
WP4595 |
Urea cycle and associated pathways |
/LDHB |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HEY2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TPM3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT8B |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/WNT9A |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/CUL2 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/ARNT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/ARNT2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CTNNA3 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CUL2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/DCC |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/GSTO1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA10 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA13 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA14 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA16 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA17 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA2 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA21 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA5 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/IFNA8 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/NCOA4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/PIM1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA1 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA2 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA4 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA5 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA6 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA8 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA10 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA13 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA14 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA16 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA17 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IFNA21 |
| https://identifiers.org/wikipathways/WP75_r128034 |
WP75 |
Toll-like receptor signaling pathway |
/IRF5 |
| https://identifiers.org/wikipathways/WP4241_r128737 |
WP4241 |
Type 2 papillary renal cell carcinoma |
/COL21A1 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/HEYL |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/TRAF4 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/CCDC6 |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/MECOM |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/BCR |
| https://identifiers.org/wikipathways/WP5434_r129136 |
WP5434 |
Pathways in cancer |
/LAMB4 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/MTOR |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ELOVL5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FOXC1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGS1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT27 |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/PRKAR1A |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/HMGCS1 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/HMGCR |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DROSHA |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/PRKAR2A |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/INVS |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DGCR8 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/LDLR |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ALOX5AP |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DRD2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CLDN1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/HDAC3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FOXC2 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ALOX15B |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RP1L1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TXNRD2 |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/PRKAR1B |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ELOVL2 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/MIR33B |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/CPOX |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/ABCA1 |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/ALAD |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/ALAS1 |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/ALAS2 |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/FECH |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/HMBS |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/PPOX |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/UROD |
| https://identifiers.org/wikipathways/WP5169_r128214 |
WP5169 |
Hemesynthesis defects and porphyrias |
/UROS |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TULP1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ALDH1A2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PAX3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ARL2BP |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/SLCO2A1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/CDKN1A |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ALOX5 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/NR1H3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SREBF1 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/SREBF1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/GLI2 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/SIRT6 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CHRD |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ACTA2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FGF8 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/PPARGC1A |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGES3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SRF |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGER2 |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/IL1B |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FOXA2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PAK4 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RAF1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ARNTL |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/FADS2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TP53 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/TP53 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/EGFR |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GLUD1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/FADS1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ACTC1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SHH |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ALDH1A1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GBX2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/BCL2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/NKX2-5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PRKN |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/MAPK11 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PIK3R4 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SREBF2 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/SREBF2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/H4C1 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/FASN |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/GLI1 |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/ARNTL |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/PRKAA1 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/SCD |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/SHH |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PKD1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGER3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/SDCCAG8 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT80 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CNGB1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/AKR1B1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/EFHC1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/P2RX6 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RP2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CLUAP1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP41 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP164 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/MAK |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CILK1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RAB23 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ARL6 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NPHP3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP104 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PKD2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DYNC2I2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TRIM32 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT43 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS9 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT81 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/MKKS |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DYNC2I1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/LCA5 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NEK1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGES2 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGES |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/NAT2 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PRXL2B |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/NAT1 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/MIR33A |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SLC25A1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/MRPL40 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CYP26B1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CUL3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RTN4R |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/GSTP1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CDC45 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CRKL |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/GGT1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RBX1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/DECR1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/MAG |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RTN4 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/EPHX2 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/CBR1 |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/NLRP3 |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/SIN3A |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/GLI3 |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/IHH |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/PTCH1 |
| https://identifiers.org/wikipathways/WP47_r128016 |
WP47 |
Hedgehog signaling pathway |
/SMO |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGR2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FGFR2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/UFD1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FGF10 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CDC42 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGS2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FGFR1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/XPO1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/COMT |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CBX5 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/SIRT1 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/SIRT1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SERPIND1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/SERPINE1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SHOC2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/KPNB1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/VWF |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/HES1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGIS |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ABCC4 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RAN |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/RB1 |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/PRKACB |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGIR |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/HPGDS |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PLK1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GP9 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGER4 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GP5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/POLR2A |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GP1BA |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/PPARA |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RELN |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/AKR1C3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GP1BB |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PPP1CB |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/GPX1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PLA2G4A |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/OAT |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ZDHHC8 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGER1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/HPGD |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CLDN3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GSC2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DGCR2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ARVCF |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TRMT2A |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/MED15 |
| https://identifiers.org/wikipathways/WP2011_r127883 |
WP2011 |
SREBF and miR33 in cholesterol and lipid homeostasis |
/MED15 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SNAP29 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/LZTR1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SLC7A4 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PRODH |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ESS2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/HIRA |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DEPDC5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/NPRL3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ASF1A |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/NPRL2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TSKS |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DGCR6L |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SEPTIN11 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/HIRIP3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/USP41 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/EMC10 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PITX2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SEPTIN8 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/BCRP2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FAM230E |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TANGO2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/AIFM3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TBX1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/THAP7 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SEPTIN5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ZNF74 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/GNB1L |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/LRRC74B |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/FAM230G |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/P2RX6P |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TSSK2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RNU6-225P |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RTL10 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/BCRP7 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/POM121L4P |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SMPD4P1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TMEM191A |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ABHD17AP4 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TSSK1A |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/KRT18P62 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CCDC188 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/BCRP5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/LINC00896 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/KRT18P5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/LINC01637 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SLC9A3P2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/POM121L7P |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CA15P1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/C22orf39 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RN7SL812P |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RN7SL168P |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SCARF2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TUBA3GP |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CCDC74BP1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RNY1P9 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/LINC01311 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/SNORA77B |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DGCR5 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/DGCR11 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/IGLL4P |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/LINC00895 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/DPEP1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CLTCL1 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/GGT5 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/PTGDS |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ALOX12 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/LTA4H |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/NCOR1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RORC |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ALOX15 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/DPEP2 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/ALOXE3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CLDN5 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/CYP4F8 |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/LTC4S |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/RAPGEF3 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RANBP1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/PI4KA |
| https://identifiers.org/wikipathways/WP5424_r129383 |
WP5424 |
Omega-6-fatty acids in senescence |
/TBXAS1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/TNPO1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CYP26A1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RANGAP1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CDH15 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/HAND2 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/MALT1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/RCC1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/CYP26C1 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/KLHL22 |
| https://identifiers.org/wikipathways/WP4657_r128796 |
WP4657 |
22q11.2 copy number variation syndrome |
/ALDH4A1 |
| https://identifiers.org/wikipathways/WP5440_r128375 |
WP5440 |
EPAC1 and PKA reduction of retinal inflammation |
/NEK7 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/EIF2AK2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/EIF2AK1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/EIF2AK3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MMP2 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/LTBP1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/FCGR2B |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/PAX2 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/SLC32A1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/SALL1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/EYA1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/SFRP1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/NFKBIB |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MSH6 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/SIX1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/HSPA2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/RARA |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/REN |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/RSPO3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN1 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/SHISA5 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/FBN1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/ZEB2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/HSPA6 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FOXC2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/FAT4 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/HSPA1B |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/HSPA1L |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN23 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CSNK2A3 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/LHX1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GAD2 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GAD1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT8A |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/RARB |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SNAI1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/ALDH1A2 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/SIAH1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PKP2 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR320A |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDKN1A |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/BAD |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT16 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3C2A |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/BRCA1 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/BID |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/BID |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRA1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/FAS |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/BAK1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CDH1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3CB |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PIK3CB |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/PIK3CB |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/CASP8 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CASP8 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CSNK2A2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAP2K7 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/GSK3B |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/BAX |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/BAX |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TGFB2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAPK1 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL2RB |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/EP300 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SOS2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/HIF1A |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/NFKBIA |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MMP9 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CSNK2A1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TRADD |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAPK3 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAPK3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/TSC2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TJP1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IKBKB |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CCNE1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CCNE1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/AKT2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/AKT2 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/BBC3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/BBC3 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/TGFB1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TGFB1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TYK2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3CG |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAPK8 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/ACTA2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/FGF8 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/FGF8 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/VTN |
| https://identifiers.org/wikipathways/WP4876_r128078 |
WP4876 |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CCND1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CCND1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CBL |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDKN1B |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CDKN1B |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/MAPK14 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAPK14 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL12B |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/SMAD5 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/WNT5A |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT5A |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CBLB |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FN1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/STAT1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SOS1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MEF2D |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/AKT3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/AKT3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/FASLG |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/FOXO3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CCND2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CCND2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TGFB3 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/APAF1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/APAF1 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/TNFRSF10B |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/PIK3CA |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDK2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CDK2 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/RUNX2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/BMP4 |
| https://identifiers.org/wikipathways/WP4876_r128078 |
WP4876 |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
/IL1B |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL1B |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/CITED1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IRF3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP4876_r128078 |
WP4876 |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
/TRAF3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/RAF1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/RAF1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3-3B |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/CASP9 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDK4 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MDM2 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MDM2 |
| https://identifiers.org/wikipathways/WP4876_r128078 |
WP4876 |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
/CASP1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAP2K5 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3C2G |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/BRCA2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PDPK1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/TP53 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/TP53 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TP53 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/SMAD4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SMAD4 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/PMAIP1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/AKT1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/AKT1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/EGFR |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDKN2A |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/SESN3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PAK1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/ATM |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/ATM |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/FOXO1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCA |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAPK13 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C8 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/SHC1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SHC1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/LRP5 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3-3A |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/CASP3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/TSC1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCB |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/IRS1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT10B |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/SMAD1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3CD |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PIK3CD |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/HRAS |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/HRAS |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TRAF6 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C13 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/CHEK2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAPK11 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MAPK12 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/SRC |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C12 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C11 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/OCLN |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4-16 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PLCG2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MDM4 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C14 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C15 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/NRAS |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C12 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C8 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C6 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C6 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C13 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C11 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C9 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C5 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C4 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C7 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C2 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H3C10 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PKD1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/TLX1 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/TP53AIP1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/EGLN3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DYNC2LI1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ARL3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS7 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS4 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/WDPCP |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DCDC2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/INPP5E |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/SCLT1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/FLCN |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CFAP418 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PDE6D |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FMNL2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PKD1L1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CFAP410 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NEK8 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS5 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/LZTFL1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TMEM67 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TTC8 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PKHD1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IQCB1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP19 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TMEM107 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PCARE |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS10 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBS12 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TMEM216 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TOPORS |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CNGA1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TRAF3IP1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DYNLT2B |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/BBIP1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/DCN |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/NRP2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CCDC65 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DRC1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FOXQ1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/SIX2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/FOXD1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCH |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/NTN1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/ERBB3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCQ |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/TGFBR3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/EVC |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/EED |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/EED |
| https://identifiers.org/wikipathways/WP4876_r128078 |
WP4876 |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
/PYCARD |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDK6 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/EZH2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/EZH2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/GLI3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/SUFU |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/EZH1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRG2 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/EPHA4 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDKN2C |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/SMO |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/SLC6A11 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/POSTN |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TMPRSS4 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/AEBP2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/GAS8 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/GPR161 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/ALDH9A1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/CDKN2B |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/RBBP4 |
| https://identifiers.org/wikipathways/WP4876_r128078 |
WP4876 |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
/NLRP3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCD |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/KIF7 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CDH2 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GPHN |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/EVC2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/JUP |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MIR21 |
| https://identifiers.org/wikipathways/WP4518_r128245 |
WP4518 |
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases |
/GGT1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/SLC6A1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PKP1 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/ENG |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/GLIS2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/NUBPL |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ZMYND10 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/SPATA7 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/KATNIP |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAAF6 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/KIZ |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RPGRIP1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/HNF4A |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RP1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/SPAG1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TUSC3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ODAD1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAH11 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RSPH4A |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/TBX18 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAH6 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/ERRFI1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DDX59 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/TCF21 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/VSX2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NEK9 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAL1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAI1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAAF11 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RSPH3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ATXN10 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/KCTD1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/POC1B |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/AK7 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CCDC40 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/OSR1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TBC1D32 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/EI24 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CCNO |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAAF1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/HYDIN |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RAB28 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CFAP298 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CCDC28B |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RSPH1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/POC1A |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAAF5 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAAF2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TUB |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CFAP52 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CCDC103 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAAF3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ANKS3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ODAD2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TAPT1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/FAM161A |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAI2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CFAP53 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RSPH9 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NME9 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAJB13 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/XPNPEP3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ODAD3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/HYLS1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/KIAA0753 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ODAD4 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR548C |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR548B |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR182 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR1305 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/MCIDAS |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DNAAF4 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CCNQ |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR4491 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR4482 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CCDC39 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/STRAP |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/TNC |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/FGFR2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCZ |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/LRP6 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/NOTCH3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/FGFR1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/ARAF |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/COL4A4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT11 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/DLL3 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/ANGPT2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/DSP |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/BMP7 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/JAG1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/JAG1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/E2F1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MMP15 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/MET |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT2 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/LFNG |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/SERPINE1 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/SERPINE1 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TGFBR1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT3 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/GAB1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT5B |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD10 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SPARC |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/PDGFRB |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PDGFRB |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/HES1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT6 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/ID2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NEK2 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/CCN2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TWIST1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PLCG1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/USP9X |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/ID1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCG |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/KDR |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/DLL4 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/EPO |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PIK3C2B |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/KRAS |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/KRAS |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT2B |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/DDB2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PDGFRA |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/COL4A2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/HNF1A |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT10A |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/RB1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/FGF7 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/IGF1R |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/ERBB2 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/AGTR1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD7 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/WNT3A |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT3A |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT7A |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD7 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/KIT |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/BRAF |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT9B |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/ITGA5 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/WNT4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD5 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/TGFBR2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TGFBR2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD6 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/SMAD3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SMAD3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/RBPJ |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/GDNF |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/AXIN2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PTEN |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/PTEN |
| https://identifiers.org/wikipathways/WP4876_r128078 |
WP4876 |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
/RELA |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ADCY6 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD4 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/SMAD2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SMAD2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD8 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/GRB2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/GRB2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SUZ12 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD2 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/FOXO4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/JAG2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/COL4A1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT7B |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FZD9 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/NF1 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/FLNA |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/COL4A6 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/DLL1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/DLL1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/NOTCH4 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/PECAM1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/AP2B1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/AP2B1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN11 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/AP2S1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN18 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PALS1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CRX |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN15 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN16 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PROX1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SET |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/OCRL |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CRB3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN10 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/EGLN1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/SPRY2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CTDSP1 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/TBX6 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SUV39H2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN17 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN8 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN12 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN14 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN19 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN20 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN22 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/HES7 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN7 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN6 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/PBX1 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/MESP2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN4 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/AP2A1 |
| https://identifiers.org/wikipathways/WP2854_r128433 |
WP2854 |
Gene regulatory network modeling somitogenesis |
/RIPPLY2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN9 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/EGLN2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/HNF1B |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/EHMT2 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/AP2A2 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRP |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRE |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ALMS1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TTBK2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PLK4 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NME7 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP78 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRG1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT2D |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/C2CD3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP83 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/CYS1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/MKS1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRA3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/SNAI2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ZIC2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/OFD1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT2C |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/POMGNT1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT52 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/RPGRIP1L |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRA4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/FOXM1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT57 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/NPHS2 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT2A |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/WDR35 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TTC21B |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NPHP4 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT172 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/NPHP1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRB2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/ZEB1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRA2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/WDR19 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/AP2M1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/NPHS1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRB1 |
| https://identifiers.org/wikipathways/WP2261_r128529 |
WP2261 |
Glioblastoma signaling pathways |
/PRKCI |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT122 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/INTU |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/NSD1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRB3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/COL4A3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/GALNT11 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/EHMT1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD2 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRG3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN5 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/WT1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/DLK1 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRA5 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/DYNC2H1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/IFT140 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/COL4A5 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP290 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRQ |
| https://identifiers.org/wikipathways/WP4518_r128245 |
WP4518 |
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases |
/DPEP1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CC2D2A |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT8B |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/PIBF1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/KIAA0586 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ZNF423 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CSPP1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/B9D1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/UNC119 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TTLL5 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TCTN3 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/AHI1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SMYD2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/WNT9A |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TMEM138 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD9 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TMEM237 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/EIF5A2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ANKS6 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TCTN2 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CEP120 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/RSPO1 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/EMX2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/DES |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT5A |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TMEM17 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CPLANE1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TCTN1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/TMEM231 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/MIR27B |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/TWIST2 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SUV39H1 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/CENPF |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/B9D2 |
| https://identifiers.org/wikipathways/WP5236_r129234 |
WP5236 |
Markers of kidney cell lineage |
/NT5E |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETDB1 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/LATS2 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD5 |
| https://identifiers.org/wikipathways/WP4803_r128947 |
WP4803 |
Ciliopathies |
/ARL13B |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/NR2C2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/NR2C2 |
| https://identifiers.org/wikipathways/WP4159_r128692 |
WP4159 |
GABA receptor signaling |
/GABRD |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/PERP |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/LTBP2 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/FBN2 |
| https://identifiers.org/wikipathways/WP3668_r128974 |
WP3668 |
Hypothesized pathways in pathogenesis of cardiovascular disease |
/FBN3 |
| https://identifiers.org/wikipathways/WP3982_r128740 |
WP3982 |
miRNA regulation of p53 pathway in prostate cancer |
/ZMAT3 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT2E |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD1A |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD6 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/DOT1L |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT5B |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SMYD1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/ASH1L |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/PRDM2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/GDF15 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT5C |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SMYD5 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETDB2 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CDKL2 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD1B |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETBP1 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETMAR |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD3 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SMYD3 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/CLDN24 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SETD4 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/SMYD4 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/PDCD6 |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/KMT2B |
| https://identifiers.org/wikipathways/WP2369_r128464 |
WP2369 |
Histone modifications |
/H4C7 |
| https://identifiers.org/wikipathways/WP4239_r128751 |
WP4239 |
Epithelial to mesenchymal transition in colorectal cancer |
/MIR9-2 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/EIF4EBP1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/MTOR |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/WAPL |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/PDS5B |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/PDS5A |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CCR7 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/TRPC3 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/MFGE8 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/CACNA1A |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/MAT1A |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/ATP2B2 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CXCR5 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/ZEB2 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CCL19 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/PDCD1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/RYR3 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/CEBPA |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CD22 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/SLAMF7 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/TSPAN14 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/MAD2L2 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RGR |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CD19 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/SELL |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CD69 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/ICOSLG |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/PRDM1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GNA15 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SMC1A |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GNA11 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CD40 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CXCL12 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SMC3 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IL2 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/VEGFA |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IL4 |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/POMC |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/STAG1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/TNFSF11 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CD80 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/BMP2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TRAF3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CASP9 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL2RA |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CDK4 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL6 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IL6 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IL10 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TLR4 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/TLR4 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TLR2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TP53 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL2RG |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/GLUD1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/FOXO1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GRM1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GNA14 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GNAQ |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/ITGB2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/JAK1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CASP3 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RAD21 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/SYK |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/FADD |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/STAT3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL12A |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IL12A |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/STAT2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/PIK3CD |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/BCL2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CYCS |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/LEP |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CD28 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IRF7 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TLR7 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/TLR7 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/HSPA1A |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CSNK2B |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CHUK |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IRF9 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TLR9 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IKBKG |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/IRF9 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/CREB1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/CRK |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/MAPK14 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/EIF4E |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TAB2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/FOS |
| https://identifiers.org/wikipathways/WP5213_r129313 |
WP5213 |
Amino acid metabolism in triple-negative breast cancer cells |
/GLS |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RAPGEF1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TBK1 |
| https://identifiers.org/wikipathways/WP5213_r129313 |
WP5213 |
Amino acid metabolism in triple-negative breast cancer cells |
/PSAT1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PRMT1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IRAK1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/IRS1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/JAK1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/JUN |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/LCK |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/MAP3K1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MYD88 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IRAK4 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PIK3CD |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MAPK9 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MAPK10 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP5213_r129313 |
WP5213 |
Amino acid metabolism in triple-negative breast cancer cells |
/PSPH |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RPTOR |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PTPN6 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PTPN11 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RAC1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RPS6 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/MLST8 |
| https://identifiers.org/wikipathways/WP5213_r129313 |
WP5213 |
Amino acid metabolism in triple-negative breast cancer cells |
/SLC1A5 |
| https://identifiers.org/wikipathways/WP5213_r129313 |
WP5213 |
Amino acid metabolism in triple-negative breast cancer cells |
/SLC2A1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/STAT1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/STAT2 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/STAT3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TRAF6 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/TYK2 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/VAV1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/ZAP70 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/MAPKAP1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/SOCS1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/IRS2 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/CBL |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RPS6KA4 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/SOCS3 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RPS6KA5 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IKBKE |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/TNF |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IFNG |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/ACTN2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/OAS3 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IFIT2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/EIF2AK4 |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/PYY |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SH3GL3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/ADAR |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SIRT4 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SUSD2 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/XBP1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/PLCB4 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CDK6 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/HSPA8 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/HSPA8 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/OAS2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CCND3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IL1A |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GRIA2 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GRIA3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/EIF2S1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CCL21 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/PLCB2 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SF3B4 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MSN |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/PLCB3 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GRIA4 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MX1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/TNFSF13 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CCNE2 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/NRG3 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IFITM1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/CRKL |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/EIF4A1 |
| https://identifiers.org/wikipathways/WP5213_r129313 |
WP5213 |
Amino acid metabolism in triple-negative breast cancer cells |
/SLC7A11 |
| https://identifiers.org/wikipathways/WP5213_r129313 |
WP5213 |
Amino acid metabolism in triple-negative breast cancer cells |
/PHGDH |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/MAF |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/TNFSF13B |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/EIF3H |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/GPR15 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/ZMYND11 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RSPH14 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RSPH6A |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RSPH4A |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/NME5 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/LDB3 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SHLD2 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/PRXL2A |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RSPH3 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/ROPN1L |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/CDHR1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/LRIT1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/ADIRF |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RSPH1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/IQUB |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/GHITM |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/DYDC1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/RSPH9 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/MMRN2 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/GRID1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/DNAJB13 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/C10orf99 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/PTPRC |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/MAVS |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/EBI3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/JAK3 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/DDX58 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/BMPR1A |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/GCG |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFIH1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CR2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CD46 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TNFAIP3 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CXCR4 |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/NPY |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/STAT5A |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/STAT5A |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/PRKCG |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/PPARG |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CRP |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/ETS1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/ADAM10 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/ITGAX |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/ITPR1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/PDK1 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/GRIA1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/BUB1B |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNAR2 |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/AGRP |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CD3G |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/MC4R |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CD3D |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/PTCRA |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNB1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/RELA |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/STAT5B |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/ERBB4 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/PLCB1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/ISG15 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CD3E |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CR1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA7 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PIAS3 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/EIF4B |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/FYN |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/IFNAR2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/NFKB2 |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PTPRC |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/RAP1A |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/REL |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/STAT5A |
| https://identifiers.org/wikipathways/WP585_r129287 |
WP585 |
Interferon type I signaling pathways |
/PIAS1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/C3 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/OPN4 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/MAS1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IRF4 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IRF8 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/NECTIN4 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/GPR183 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/TP73 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/PAX5 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IGHV4-34 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/BCL6 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/TBX21 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/OAS1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA6 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA8 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA21 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA5 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA16 |
| https://identifiers.org/wikipathways/WP5445_r129193 |
WP5445 |
Hunger and satiety |
/GHRL |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/ICOS |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA10 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/RACK1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA14 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA13 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA17 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/IFNA4 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/AFG3L2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/RCHY1 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/TMSB10 |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/HOMER3 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CD82 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CD209 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/BLNK |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/CLEC4M |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/CD79A |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/CCSER2 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/BACH2 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/SLAMF1 |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/RAB9B |
| https://identifiers.org/wikipathways/WP4630_r129207 |
WP4630 |
Measles virus infection |
/RAB9A |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/DYDC2 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/FCRL5 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/MS4A1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SHLD1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SNCG |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SH2D4B |
| https://identifiers.org/wikipathways/WP4760_r128777 |
WP4760 |
PKC-gamma calcium signaling pathway in ataxia |
/CA8 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/BCR |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/FAM25A |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/MIR346 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/LRIT2 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/LINC00858 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/NEAT1 |
| https://identifiers.org/wikipathways/WP5402_r129008 |
WP5402 |
10q22q23 copy number variation |
/SHLD3 |
| https://identifiers.org/wikipathways/WP5218_r129276 |
WP5218 |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
/IFNG-AS1 |
| https://identifiers.org/wikipathways/WP1049_r117517 |
WP1049 |
G protein signaling pathways |
/PDE8B |
| https://identifiers.org/wikipathways/WP1090_r117446 |
WP1090 |
Eicosanoid synthesis |
/ALOX12 |
| https://identifiers.org/wikipathways/WP1090_r117446 |
WP1090 |
Eicosanoid synthesis |
/PLA2G6 |
| https://identifiers.org/wikipathways/WP1090_r117446 |
WP1090 |
Eicosanoid synthesis |
/ALOX15B |
| https://identifiers.org/wikipathways/WP1086_r117457 |
WP1086 |
Heme biosynthesis |
/ALAS2 |
| https://identifiers.org/wikipathways/WP1086_r117457 |
WP1086 |
Heme biosynthesis |
/UROS |
| https://identifiers.org/wikipathways/WP1090_r117446 |
WP1090 |
Eicosanoid synthesis |
/LTC4S |
| https://identifiers.org/wikipathways/WP1086_r117457 |
WP1086 |
Heme biosynthesis |
/FECH |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/NR1I2 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/AGT |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/EGFR |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/EPAS1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/SPOCK1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/WASL |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/EPS15 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/NCOA1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/MAP3K4 |
| https://identifiers.org/wikipathways/WP1112_r117448 |
WP1112 |
EPO receptor signaling |
/PDK1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/RB1 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/ITM2B |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/FOXO1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/FOXO1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/GTF3A |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/PTPN11 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PTPN11 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/EPS8 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/WNK1 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/STAM |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/GRB14 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PIK3C2B |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/MEF2A |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/HTT |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/ZPR1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PLD2 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/PRKCZ |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PRKCZ |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/VAV3 |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCD3 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PRKAR1A |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/MAP3K3 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/STAT2 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/STAT2 |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP27B1 |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCG5 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/SHB |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCB4 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/FZD1 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP1112_r117448 |
WP1112 |
EPO receptor signaling |
/SOS1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/SFRP4 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/PIK3CG |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PIK3CG |
| https://identifiers.org/wikipathways/WP1112_r117448 |
WP1112 |
EPO receptor signaling |
/PIK3CG |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/GAB1 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/JAK2 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/JAK2 |
| https://identifiers.org/wikipathways/WP1112_r117448 |
WP1112 |
EPO receptor signaling |
/JAK2 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/GATA2 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/INPPL1 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/IRS2 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/IRS2 |
| https://identifiers.org/wikipathways/WP1112_r117448 |
WP1112 |
EPO receptor signaling |
/IRS2 |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/CYP8B1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/TRIB3 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PLCG1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/LPIN3 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/DOK2 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/IRS1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/IRS1 |
| https://identifiers.org/wikipathways/WP1112_r117448 |
WP1112 |
EPO receptor signaling |
/IRS1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/NCOR2 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PXN |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/SP1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/SP1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/WNT1 |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/VDR |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/GATA3 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/CSK |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCG1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/TNK2 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PLD1 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/NR2F1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/DUSP1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/MAPK7 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/HIP1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PRKCB |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PKN2 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/ELF3 |
| https://identifiers.org/wikipathways/WP1091_r117468 |
WP1091 |
IL-2 signaling pathway |
/MAPKAPK2 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/RALBP1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/RPS6KA5 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PRKCA |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/MAP3K14 |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCC3 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/GIT1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/ARAF |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/MIF |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/PAK1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/VAV2 |
| https://identifiers.org/wikipathways/WP1105_r87031 |
WP1105 |
Adipogenesis |
/PNPLA3 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/JUND |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/SH3GL2 |
| https://identifiers.org/wikipathways/WP1113_r122663 |
WP1113 |
Cytokines and inflammatory response |
/CSF1 |
| https://identifiers.org/wikipathways/WP1096_r117445 |
WP1096 |
EGFR1 signaling pathway |
/CBLC |
| https://identifiers.org/wikipathways/WP1099_r107084 |
WP1099 |
Nuclear receptors in lipid metabolism and toxicity |
/NR1H4 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/LDLR |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/LDLR |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/EP300 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/EP300 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/ZBTB33 |
| https://identifiers.org/wikipathways/WP1126_r122665 |
WP1126 |
Tryptophan metabolism |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/DVL1 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/CDKN1A |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/KLK3 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/AR |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/EGFR |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/LMNB1 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/MPDZ |
| https://identifiers.org/wikipathways/WP1126_r122665 |
WP1126 |
Tryptophan metabolism |
/OGDH |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/NCOA1 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/RB1 |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/RB1 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/KAT2B |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/FOXO1 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/PTPN11 |
| https://identifiers.org/wikipathways/WP1126_r122665 |
WP1126 |
Tryptophan metabolism |
/HADH |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/GSK3B |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/GSK3B |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/GSK3B |
| https://identifiers.org/wikipathways/WP1141_r117456 |
WP1141 |
Hedgehog signaling pathway |
/STK36 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/APC |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/APC |
| https://identifiers.org/wikipathways/WP1134_r117463 |
WP1134 |
Ketone bodies synthesis and degradation |
/OXCT1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/PRKCZ |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/PRKCZ |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/CREBBP |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/CREBBP |
| https://identifiers.org/wikipathways/WP1141_r117456 |
WP1141 |
Hedgehog signaling pathway |
/CREBBP |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/ROCK1 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/CSF2RB |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/WNT3A |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/WNT3A |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/FZD1 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/FZD1 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/ROCK2 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/SOS1 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/DOK1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/WNT2B |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/WNT2B |
| https://identifiers.org/wikipathways/WP1141_r117456 |
WP1141 |
Hedgehog signaling pathway |
/GLI3 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/SFRP4 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/PIK3CG |
| https://identifiers.org/wikipathways/WP1118_r117439 |
WP1118 |
Biogenic amine synthesis |
/AANAT |
| https://identifiers.org/wikipathways/WP1126_r122665 |
WP1126 |
Tryptophan metabolism |
/AANAT |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/JAK2 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/CCNE1 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/NR2C2 |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/MAPKAPK3 |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/LMNB2 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/PLCG1 |
| https://identifiers.org/wikipathways/WP1126_r122665 |
WP1126 |
Tryptophan metabolism |
/AADAT |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/NCOR2 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/SP1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/RACGAP1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/WNT1 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/WNT1 |
| https://identifiers.org/wikipathways/WP1126_r122665 |
WP1126 |
Tryptophan metabolism |
/CYP7B1 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/FGR |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/WNT6 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/WNT6 |
| https://identifiers.org/wikipathways/WP1141_r117456 |
WP1141 |
Hedgehog signaling pathway |
/IHH |
| https://identifiers.org/wikipathways/WP1122_r117440 |
WP1122 |
Blood clotting cascade |
/F12 |
| https://identifiers.org/wikipathways/WP1141_r117456 |
WP1141 |
Hedgehog signaling pathway |
/SKI |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/FZD9 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/FZD9 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/SH2B2 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/PRKCB |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/PRKCB |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/PRKCB |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/MAPKAPK2 |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/PARP1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/PRKCH |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/PRKCH |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/PRKCA |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/PRKCA |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/PRKCA |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/FZD2 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/FZD2 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/ABL1 |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/PAK1 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/VAV2 |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/FAF1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/JUN |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP1138_r117076 |
WP1138 |
FAS pathway and stress induction of HSP regulation |
/JUN |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/FBXW2 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/FBXW2 |
| https://identifiers.org/wikipathways/WP1121_r117459 |
WP1121 |
Kit receptor signaling pathway |
/MATK |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/TCF7L1 |
| https://identifiers.org/wikipathways/WP1129_r117465 |
WP1129 |
Wnt signaling pathway and pluripotency |
/WNT2 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/WNT2 |
| https://identifiers.org/wikipathways/WP1135_r118616 |
WP1135 |
Wnt signaling pathway |
/WNT16 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/PLPP1 |
| https://identifiers.org/wikipathways/WP1133_r115921 |
WP1133 |
Androgen receptor signaling pathway |
/BMF |
| https://identifiers.org/wikipathways/WP1151_r117438 |
WP1151 |
ACE inhibitor pathway |
/AGT |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/EGFR |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/HDAC2 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/AKAP9 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/AKAP12 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/TLE1 |
| https://identifiers.org/wikipathways/WP1168_r120693 |
WP1168 |
ID signaling pathway |
/RB1 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/KAT2B |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/CNTN1 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/GNAI1 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/GSK3B |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/ADCY2 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/CIR1 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PRKCZ |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PRKAR1A |
| https://identifiers.org/wikipathways/WP1157_r117462 |
WP1157 |
Statin pathway |
/LRP1 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/MAML1 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PDE7B |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/JAK2 |
| https://identifiers.org/wikipathways/WP1148_r117469 |
WP1148 |
Notch signaling pathway |
/DLL3 |
| https://identifiers.org/wikipathways/WP1168_r120693 |
WP1168 |
ID signaling pathway |
/CCNE1 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/GNA15 |
| https://identifiers.org/wikipathways/WP1168_r120693 |
WP1168 |
ID signaling pathway |
/TCF3 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/TCF3 |
| https://identifiers.org/wikipathways/WP1176_r117467 |
WP1176 |
Matrix metalloproteinases |
/MMP24 |
| https://identifiers.org/wikipathways/WP1168_r120693 |
WP1168 |
ID signaling pathway |
/IRS1 |
| https://identifiers.org/wikipathways/WP1157_r117462 |
WP1157 |
Statin pathway |
/SCARB1 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/NCOR2 |
| https://identifiers.org/wikipathways/WP1168_r120693 |
WP1168 |
ID signaling pathway |
/TCF7L2 |
| https://identifiers.org/wikipathways/WP1176_r117467 |
WP1176 |
Matrix metalloproteinases |
/MMP15 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/ADCY7 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/APH1B |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/FURIN |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PDE8B |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/SKP2 |
| https://identifiers.org/wikipathways/WP1176_r117467 |
WP1176 |
Matrix metalloproteinases |
/MMP1 |
| https://identifiers.org/wikipathways/WP1176_r117467 |
WP1176 |
Matrix metalloproteinases |
/MMP27 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PRKCB |
| https://identifiers.org/wikipathways/WP1176_r117467 |
WP1176 |
Matrix metalloproteinases |
/MMP25 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/AKAP6 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PRKCH |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/JAG2 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/GNA13 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PRKCA |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/HES6 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/DLL4 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/GNB5 |
| https://identifiers.org/wikipathways/WP1168_r120693 |
WP1168 |
ID signaling pathway |
/PAX2 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/JUN |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/AKAP11 |
| https://identifiers.org/wikipathways/WP1176_r117467 |
WP1176 |
Matrix metalloproteinases |
/MMP17 |
| https://identifiers.org/wikipathways/WP1165_r117450 |
WP1165 |
G protein signaling pathways |
/PDE4C |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/NOTCH3 |
| https://identifiers.org/wikipathways/WP1151_r117438 |
WP1151 |
ACE inhibitor pathway |
/ACE |
| https://identifiers.org/wikipathways/WP1168_r120693 |
WP1168 |
ID signaling pathway |
/MYF6 |
| https://identifiers.org/wikipathways/WP1180_r117992 |
WP1180 |
Delta-Notch signaling pathway |
/NUMBL |
| https://identifiers.org/wikipathways/WP1182_r117449 |
WP1182 |
Eukaryotic transcription initiation |
/POLR1B |
| https://identifiers.org/wikipathways/WP1184_r117466 |
WP1184 |
Nuclear receptors |
/NR1I2 |
| https://identifiers.org/wikipathways/WP1184_r117466 |
WP1184 |
Nuclear receptors |
/AR |
| https://identifiers.org/wikipathways/WP1184_r117466 |
WP1184 |
Nuclear receptors |
/ESR2 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/TBC1D8 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/ORC3 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/HDAC2 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/DBF4 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGB8 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/BRAF |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/ORC4 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/SHC3 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/RB1 |
| https://identifiers.org/wikipathways/WP1189_r117452 |
WP1189 |
Glycogen metabolism |
/PYGB |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGA9 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CCNA1 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGB7 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/MAPK6 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGA11 |
| https://identifiers.org/wikipathways/WP1189_r117452 |
WP1189 |
Glycogen metabolism |
/GSK3B |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/GSK3B |
| https://identifiers.org/wikipathways/WP1186_r117442 |
WP1186 |
Cholesterol biosynthesis |
/HMGCS1 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/VAV3 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CDC14A |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CDC7 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/CAPN2 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ROCK1 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGAE |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/HDAC6 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/MCM3 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ZYX |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ROCK2 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/SOS1 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGB4 |
| https://identifiers.org/wikipathways/WP1186_r117442 |
WP1186 |
Cholesterol biosynthesis |
/DHCR7 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/CAPN1 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/PAK4 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CCNE1 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/MCM2 |
| https://identifiers.org/wikipathways/WP1184_r117466 |
WP1184 |
Nuclear receptors |
/NR2C2 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/CAPN5 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CDC25B |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/PXN |
| https://identifiers.org/wikipathways/WP1184_r117466 |
WP1184 |
Nuclear receptors |
/VDR |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/HDAC7 |
| https://identifiers.org/wikipathways/WP1193_r106064 |
WP1193 |
Monoamine GPCRs |
/ADRA2A |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/DOCK1 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CCNE2 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGA8 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/MAD2L2 |
| https://identifiers.org/wikipathways/WP1193_r106064 |
WP1193 |
Monoamine GPCRs |
/CHRM5 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/CSK |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGB6 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGA4 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ITGAV |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/TNS1 |
| https://identifiers.org/wikipathways/WP1193_r106064 |
WP1193 |
Monoamine GPCRs |
/DRD5 |
| https://identifiers.org/wikipathways/WP1184_r117466 |
WP1184 |
Nuclear receptors |
/NR2F1 |
| https://identifiers.org/wikipathways/WP1193_r106064 |
WP1193 |
Monoamine GPCRs |
/DRD1 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/SKP2 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/MAPK7 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP1186_r117442 |
WP1186 |
Cholesterol biosynthesis |
/MVD |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/YWHAG |
| https://identifiers.org/wikipathways/WP1184_r117466 |
WP1184 |
Nuclear receptors |
/NR5A2 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/RAPGEF1 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/ABL1 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/ARAF |
| https://identifiers.org/wikipathways/WP1189_r117452 |
WP1189 |
Glycogen metabolism |
/PHKA1 |
| https://identifiers.org/wikipathways/WP1182_r117449 |
WP1182 |
Eukaryotic transcription initiation |
/ERCC2 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/MAPK12 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/HDAC4 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/PAK1 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/VAV2 |
| https://identifiers.org/wikipathways/WP1182_r117449 |
WP1182 |
Eukaryotic transcription initiation |
/CDK7 |
| https://identifiers.org/wikipathways/WP1182_r117449 |
WP1182 |
Eukaryotic transcription initiation |
/POLR3E |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/CAPN11 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CHEK1 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/CDK6 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/MCM5 |
| https://identifiers.org/wikipathways/WP1200_r111030 |
WP1200 |
Cell cycle |
/E2F5 |
| https://identifiers.org/wikipathways/WP1193_r106064 |
WP1193 |
Monoamine GPCRs |
/CHRM4 |
| https://identifiers.org/wikipathways/WP1185_r71477 |
WP1185 |
Integrin-mediated cell adhesion |
/CAPNS1 |
| https://identifiers.org/wikipathways/WP1182_r117449 |
WP1182 |
Eukaryotic transcription initiation |
/POLR2E |
| https://identifiers.org/wikipathways/WP3163_r117506 |
WP3163 |
Estrogen receptor pathway |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3163_r117506 |
WP3163 |
Estrogen receptor pathway |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP3183_r117550 |
WP3183 |
Mesodermal commitment pathway |
/MIR375 |
| https://identifiers.org/wikipathways/WP3159_r117556 |
WP3159 |
Interleukin-11 signaling pathway |
/PDPK1 |
| https://identifiers.org/wikipathways/WP2912_r107057 |
WP2912 |
Vascular smooth muscle contraction |
/PRKX |
| https://identifiers.org/wikipathways/WP2912_r107057 |
WP2912 |
Vascular smooth muscle contraction |
/PLA2G10 |
| https://identifiers.org/wikipathways/WP3205_r117862 |
WP3205 |
Aryl hydrocarbon receptor pathway |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP3205_r117862 |
WP3205 |
Aryl hydrocarbon receptor pathway |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP3208_r117500 |
WP3208 |
Ectoderm differentiation |
/MIR34C |
| https://identifiers.org/wikipathways/WP3208_r117500 |
WP3208 |
Ectoderm differentiation |
/STX16 |
| https://identifiers.org/wikipathways/WP3208_r117500 |
WP3208 |
Ectoderm differentiation |
/MIR361 |
| https://identifiers.org/wikipathways/WP852_r117392 |
WP852 |
Fatty acid omega-oxidation |
/ADH4 |
| https://identifiers.org/wikipathways/WP852_r117392 |
WP852 |
Fatty acid omega-oxidation |
/ADH6 |
| https://identifiers.org/wikipathways/WP852_r117392 |
WP852 |
Fatty acid omega-oxidation |
/ADH7 |
| https://identifiers.org/wikipathways/WP852_r117392 |
WP852 |
Fatty acid omega-oxidation |
/ADH1A |
| https://identifiers.org/wikipathways/WP880_r116816 |
WP880 |
MAPK signaling pathway |
/HSPA2 |
| https://identifiers.org/wikipathways/WP880_r116816 |
WP880 |
MAPK signaling pathway |
/CACNG8 |
| https://identifiers.org/wikipathways/WP880_r116816 |
WP880 |
MAPK signaling pathway |
/FGF5 |
| https://identifiers.org/wikipathways/WP880_r116816 |
WP880 |
MAPK signaling pathway |
/CACNA1B |
| https://identifiers.org/wikipathways/WP880_r116816 |
WP880 |
MAPK signaling pathway |
/HSPA1L |
| https://identifiers.org/wikipathways/WP880_r116816 |
WP880 |
MAPK signaling pathway |
/PLA2G4B |
| https://identifiers.org/wikipathways/WP880_r116816 |
WP880 |
MAPK signaling pathway |
/RPS6KA3 |
| https://identifiers.org/wikipathways/WP860_r117388 |
WP860 |
EGFR1 signaling pathway |
/RPS6KA3 |
| https://identifiers.org/wikipathways/WP886_r117405 |
WP886 |
Kit receptor signaling pathway |
/GRAPL |
| https://identifiers.org/wikipathways/WP886_r117405 |
WP886 |
Kit receptor signaling pathway |
/SH3KBP1 |
| https://identifiers.org/wikipathways/WP860_r117388 |
WP860 |
EGFR1 signaling pathway |
/SH3KBP1 |
| https://identifiers.org/wikipathways/WP887_r117382 |
WP887 |
Blood clotting cascade |
/PLAU |
| https://identifiers.org/wikipathways/WP923_r117383 |
WP923 |
Calcium regulation in cardiac cells |
/FXYD2 |
| https://identifiers.org/wikipathways/WP912_r117407 |
WP912 |
Notch signaling pathway |
/NUMB |
| https://identifiers.org/wikipathways/WP906_r95768 |
WP906 |
mRNA Processing |
/SNRPA1 |
| https://identifiers.org/wikipathways/WP923_r117383 |
WP923 |
Calcium regulation in cardiac cells |
/CACNA1B |
| https://identifiers.org/wikipathways/WP923_r117383 |
WP923 |
Calcium regulation in cardiac cells |
/CHRM4 |
| https://identifiers.org/wikipathways/WP923_r117383 |
WP923 |
Calcium regulation in cardiac cells |
/ANXA6 |
| https://identifiers.org/wikipathways/WP906_r95768 |
WP906 |
mRNA Processing |
/RBM39 |
| https://identifiers.org/wikipathways/WP942_r117406 |
WP942 |
Matrix metalloproteinases |
/MMP12 |
| https://identifiers.org/wikipathways/WP959_r95751 |
WP959 |
G1 to S cell cycle control |
/CDKN1C |
| https://identifiers.org/wikipathways/WP964_r111047 |
WP964 |
Cell cycle |
/MPEG1 |
| https://identifiers.org/wikipathways/WP951_r71672 |
WP951 |
Integrin-mediated cell adhesion |
/CAPN5 |
| https://identifiers.org/wikipathways/WP955_r117395 |
WP955 |
Glycogen metabolism |
/CALM3 |
| https://identifiers.org/wikipathways/WP964_r111047 |
WP964 |
Cell cycle |
/HDAC8 |
| https://identifiers.org/wikipathways/WP957_r106945 |
WP957 |
Monoamine GPCRs |
/CHRM4 |
| https://identifiers.org/wikipathways/WP964_r111047 |
WP964 |
Cell cycle |
/PTTG2 |
| https://identifiers.org/wikipathways/WP897_r115894 |
WP897 |
Androgen receptor signaling pathway |
/CDKN1A |
| https://identifiers.org/wikipathways/WP897_r115894 |
WP897 |
Androgen receptor signaling pathway |
/KLK3 |
| https://identifiers.org/wikipathways/WP946_r117386 |
WP946 |
Delta-Notch signaling pathway |
/NUMB |
| https://identifiers.org/wikipathways/WP899_r117412 |
WP899 |
Wnt signaling pathway |
/PLAU |
| https://identifiers.org/wikipathways/WP897_r115894 |
WP897 |
Androgen receptor signaling pathway |
/PLPP1 |
| https://identifiers.org/wikipathways/WP897_r115894 |
WP897 |
Androgen receptor signaling pathway |
/BMF |
| https://identifiers.org/wikipathways/WP917_r69316 |
WP917 |
Homologous recombination |
/RAD54B |
| https://identifiers.org/wikipathways/WP948_r117391 |
WP948 |
Eukaryotic transcription initiation |
/POLR2E |
| https://identifiers.org/wikipathways/WP946_r117386 |
WP946 |
Delta-Notch signaling pathway |
/NOTCH2 |
| https://identifiers.org/wikipathways/WP869_r87027 |
WP869 |
Adipogenesis |
/CYP26B1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/BCAR1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/APPL1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/SH2D3C |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/PTPN12 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/APPL2 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/EPS8 |
| https://identifiers.org/wikipathways/WP755_r109452 |
WP755 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCG1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/GAB2 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/ITCH |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/ELK4 |
| https://identifiers.org/wikipathways/WP755_r109452 |
WP755 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCB1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/ELF3 |
| https://identifiers.org/wikipathways/WP755_r109452 |
WP755 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCG5 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/MAP3K4 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/PTK2B |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/MCF2 |
| https://identifiers.org/wikipathways/WP763_r117213 |
WP763 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACSL4 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/GAB1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/HTT |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/PTPN5 |
| https://identifiers.org/wikipathways/WP755_r109452 |
WP755 |
Nuclear receptors in lipid metabolism and toxicity |
/ABCB11 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/GRB14 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/MAP3K2 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/RALB |
| https://identifiers.org/wikipathways/WP763_r117213 |
WP763 |
Mitochondrial long chain fatty acid beta-oxidation |
/ACSL3 |
| https://identifiers.org/wikipathways/WP763_r117213 |
WP763 |
Mitochondrial long chain fatty acid beta-oxidation |
/EHHADH |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/PLSCR1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/CASP9 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/RALGDS |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/WNK1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/ASAP1 |
| https://identifiers.org/wikipathways/WP752_r117193 |
WP752 |
EGFR1 signaling pathway |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP775_r117189 |
WP775 |
Blood clotting cascade |
/F5 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/FZD8 |
| https://identifiers.org/wikipathways/WP785_r117218 |
WP785 |
Wnt signaling pathway |
/FZD8 |
| https://identifiers.org/wikipathways/WP790_r117206 |
WP790 |
Hedgehog signaling pathway |
/PTCH2 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/WNT6 |
| https://identifiers.org/wikipathways/WP785_r117218 |
WP785 |
Wnt signaling pathway |
/WNT6 |
| https://identifiers.org/wikipathways/WP774_r117208 |
WP774 |
Kit receptor signaling pathway |
/ABL1 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/NLK |
| https://identifiers.org/wikipathways/WP788_r117196 |
WP788 |
FAS pathway and stress induction of HSP regulation |
/APAF1 |
| https://identifiers.org/wikipathways/WP774_r117208 |
WP774 |
Kit receptor signaling pathway |
/EP300 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/EP300 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/LRP6 |
| https://identifiers.org/wikipathways/WP774_r117208 |
WP774 |
Kit receptor signaling pathway |
/HCK |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/DVL1 |
| https://identifiers.org/wikipathways/WP785_r117218 |
WP785 |
Wnt signaling pathway |
/DVL1 |
| https://identifiers.org/wikipathways/WP788_r117196 |
WP788 |
FAS pathway and stress induction of HSP regulation |
/DFFA |
| https://identifiers.org/wikipathways/WP785_r117218 |
WP785 |
Wnt signaling pathway |
/SFRP4 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/PRKCE |
| https://identifiers.org/wikipathways/WP785_r117218 |
WP785 |
Wnt signaling pathway |
/PRKCE |
| https://identifiers.org/wikipathways/WP782_r123954 |
WP782 |
Triacylglyceride synthesis |
/GNPAT |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP788_r117196 |
WP788 |
FAS pathway and stress induction of HSP regulation |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP799_r119598 |
WP799 |
Nod-like receptor (NLR) signaling pathway |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP775_r117189 |
WP775 |
Blood clotting cascade |
/F11 |
| https://identifiers.org/wikipathways/WP782_r123954 |
WP782 |
Triacylglyceride synthesis |
/GPAM |
| https://identifiers.org/wikipathways/WP788_r117196 |
WP788 |
FAS pathway and stress induction of HSP regulation |
/CASP7 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/CTBP2 |
| https://identifiers.org/wikipathways/WP788_r117196 |
WP788 |
FAS pathway and stress induction of HSP regulation |
/CASP10 |
| https://identifiers.org/wikipathways/WP790_r117206 |
WP790 |
Hedgehog signaling pathway |
/STK36 |
| https://identifiers.org/wikipathways/WP775_r117189 |
WP775 |
Blood clotting cascade |
/F13B |
| https://identifiers.org/wikipathways/WP784_r117187 |
WP784 |
Ketone bodies synthesis and degradation |
/HMGCS2 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/PPP2R3A |
| https://identifiers.org/wikipathways/WP774_r117208 |
WP774 |
Kit receptor signaling pathway |
/INPP5D |
| https://identifiers.org/wikipathways/WP782_r123954 |
WP782 |
Triacylglyceride synthesis |
/MOGAT1 |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/DVL3 |
| https://identifiers.org/wikipathways/WP785_r117218 |
WP785 |
Wnt signaling pathway |
/DVL3 |
| https://identifiers.org/wikipathways/WP801_r117188 |
WP801 |
ACE inhibitor pathway |
/KNG1 |
| https://identifiers.org/wikipathways/WP788_r117196 |
WP788 |
FAS pathway and stress induction of HSP regulation |
/CASP9 |
| https://identifiers.org/wikipathways/WP782_r123954 |
WP782 |
Triacylglyceride synthesis |
/LIPC |
| https://identifiers.org/wikipathways/WP801_r117188 |
WP801 |
ACE inhibitor pathway |
/AGTR2 |
| https://identifiers.org/wikipathways/WP774_r117208 |
WP774 |
Kit receptor signaling pathway |
/STAP1 |
| https://identifiers.org/wikipathways/WP774_r117208 |
WP774 |
Kit receptor signaling pathway |
/FES |
| https://identifiers.org/wikipathways/WP799_r119598 |
WP799 |
Nod-like receptor (NLR) signaling pathway |
/ERBIN |
| https://identifiers.org/wikipathways/WP779_r125337 |
WP779 |
Wnt signaling pathway and pluripotency |
/WNT9B |
| https://identifiers.org/wikipathways/WP774_r117208 |
WP774 |
Kit receptor signaling pathway |
/SH2B2 |
| https://identifiers.org/wikipathways/WP782_r123954 |
WP782 |
Triacylglyceride synthesis |
/AGPAT2 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/ROCK2 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/ROCK2 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/PPP3CA |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/AKAP13 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/ITGA11 |
| https://identifiers.org/wikipathways/WP823_r117214 |
WP823 |
Matrix metalloproteinases |
/MMP15 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/BCAR1 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/BCAR1 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/ADCY7 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/ZFPM1 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/SLC25A20 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/MAML1 |
| https://identifiers.org/wikipathways/WP830_r118407 |
WP830 |
Eukaryotic transcription initiation |
/POLR3E |
| https://identifiers.org/wikipathways/WP823_r117214 |
WP823 |
Matrix metalloproteinases |
/MMP17 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/NCOR2 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/RAPGEF1 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/ITGB4 |
| https://identifiers.org/wikipathways/WP823_r117214 |
WP823 |
Matrix metalloproteinases |
/MMP28 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/SSH2 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/NCOR1 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/AKAP1 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/EP300 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/MFNG |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/PIK3C2G |
| https://identifiers.org/wikipathways/WP830_r118407 |
WP830 |
Eukaryotic transcription initiation |
/GTF2E1 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/AKAP11 |
| https://identifiers.org/wikipathways/WP830_r118407 |
WP830 |
Eukaryotic transcription initiation |
/GTF2F2 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/CAPN5 |
| https://identifiers.org/wikipathways/WP815_r117207 |
WP815 |
Inhibitor of DNA binding (ID) signaling pathway |
/RBL1 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/ITCH |
| https://identifiers.org/wikipathways/WP823_r117214 |
WP823 |
Matrix metalloproteinases |
/MMP23B |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/SPEN |
| https://identifiers.org/wikipathways/WP805_r106122 |
WP805 |
Retinol metabolism |
/BCO2 |
| https://identifiers.org/wikipathways/WP815_r117207 |
WP815 |
Inhibitor of DNA binding (ID) signaling pathway |
/ELK4 |
| https://identifiers.org/wikipathways/WP815_r117207 |
WP815 |
Inhibitor of DNA binding (ID) signaling pathway |
/MSC |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/CAPN7 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/PDE1C |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/ADCY1 |
| https://identifiers.org/wikipathways/WP815_r117207 |
WP815 |
Inhibitor of DNA binding (ID) signaling pathway |
/BMP6 |
| https://identifiers.org/wikipathways/WP805_r106122 |
WP805 |
Retinol metabolism |
/ABCG5 |
| https://identifiers.org/wikipathways/WP805_r106122 |
WP805 |
Retinol metabolism |
/ABCG8 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/PRKCE |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/CAPN9 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/AKAP12 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/WASF1 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/ADCY3 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/CAPN6 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/MAML3 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/SAP30 |
| https://identifiers.org/wikipathways/WP830_r118407 |
WP830 |
Eukaryotic transcription initiation |
/POLR1A |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/DLL4 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/AKAP6 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/SNW1 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/SORBS1 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/DOCK1 |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/DOCK1 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/WDR12 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/ABI2 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/PDE1A |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/ITGB6 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/PDE7A |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/AKAP7 |
| https://identifiers.org/wikipathways/WP830_r118407 |
WP830 |
Eukaryotic transcription initiation |
/CCNH |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/PDE8B |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/MAML2 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/FGF23 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/HEY1 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/KAT2B |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/PIK3R4 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/FGF20 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/PAK6 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/GNA14 |
| https://identifiers.org/wikipathways/WP823_r117214 |
WP823 |
Matrix metalloproteinases |
/TIMP4 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/PRKAR2B |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/GNA12 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/GNA12 |
| https://identifiers.org/wikipathways/WP824_r117210 |
WP824 |
Regulation of actin cytoskeleton |
/PDGFRB |
| https://identifiers.org/wikipathways/WP830_r118407 |
WP830 |
Eukaryotic transcription initiation |
/CDK7 |
| https://identifiers.org/wikipathways/WP813_r117197 |
WP813 |
G protein signaling pathways |
/GNG4 |
| https://identifiers.org/wikipathways/WP827_r117192 |
WP827 |
Delta-Notch signaling pathway |
/JAG2 |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/ABL1 |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/EP300 |
| https://identifiers.org/wikipathways/WP835_r117200 |
WP835 |
Glycogen metabolism |
/PHKA2 |
| https://identifiers.org/wikipathways/WP835_r117200 |
WP835 |
Glycogen metabolism |
/GYG2 |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/TFDP1 |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/RBL1 |
| https://identifiers.org/wikipathways/WP833_r117191 |
WP833 |
Cholesterol biosynthesis |
/CYP51A1 |
| https://identifiers.org/wikipathways/WP835_r117200 |
WP835 |
Glycogen metabolism |
/PPP2R5D |
| https://identifiers.org/wikipathways/WP839_r106131 |
WP839 |
Monoamine GPCRs |
/ADRA1D |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/ORC4 |
| https://identifiers.org/wikipathways/WP835_r117200 |
WP835 |
Glycogen metabolism |
/AGL |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/CDC7 |
| https://identifiers.org/wikipathways/WP835_r117200 |
WP835 |
Glycogen metabolism |
/PPP2R3A |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/ATR |
| https://identifiers.org/wikipathways/WP833_r117191 |
WP833 |
Cholesterol biosynthesis |
/MVD |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/CCNH |
| https://identifiers.org/wikipathways/WP835_r117200 |
WP835 |
Glycogen metabolism |
/GBE1 |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/TBC1D8 |
| https://identifiers.org/wikipathways/WP839_r106131 |
WP839 |
Monoamine GPCRs |
/HTR5A |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/PAK6 |
| https://identifiers.org/wikipathways/WP839_r106131 |
WP839 |
Monoamine GPCRs |
/ADRA2A |
| https://identifiers.org/wikipathways/WP832_r109471 |
WP832 |
Integrin-mediated cell adhesion |
/SHC3 |
| https://identifiers.org/wikipathways/WP833_r117191 |
WP833 |
Cholesterol biosynthesis |
/MVK |
| https://identifiers.org/wikipathways/WP844_r109474 |
WP844 |
Cell cycle |
/TTC28 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3C2A |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAP4K3 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/TYROBP |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAP4K5 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/CTNNA1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3CB |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/CYBA |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PKM |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MEF2A |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAP4K4 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/GLI2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/ENO1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3C3 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/TIGAR |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MEF2C |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB5 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/FH |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/TREM2 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/NCF4 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/ACO2 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/HCK |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PGK1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAP4K1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/GPI |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/SLC1A5 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/TGFB1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3CG |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB8 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/FGF8 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/PITX3 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/GLI1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/GAPDH |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PTPN6 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB6 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/STAT1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/GLS |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MEF2D |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/NCF2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/SDHB |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/SLC2A1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/CCND2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/DLST |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3CA |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/NCKAP1L |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/TREM1 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/WNT1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/GOT2 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/FOXA2 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/NKX2-2 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/ELK1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PAICS |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PPAT |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/RAC2 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/CDKN1C |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/ARPC1B |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/IDO1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/ACLY |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PDHA1 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/DDC |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB4 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/VAV3 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/LDHA |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PSAT1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/RAC1 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/KLF4 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/ALDOB |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/LMX1B |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/ASCL1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB7 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MYOCD |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/SLC16A3 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PFKL |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/VAV1 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/SLC6A3 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PGD |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PYCR2 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/CAMK2D |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/MDH2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PSPH |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/GLUD1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/FCGR1A |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/NR4A2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/RPIA |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/NCF1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/FCER1G |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/GART |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/C1QC |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/G6PD |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/ITGB2 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB2 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/VAV2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/HK3 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/LMX1A |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/NEUROD1 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/EN1 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/MSX1 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/NKX6-1 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/TKT |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/SHH |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/EN2 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/SYK |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/ALDH1A1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/CYBB |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/OTX2 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/SLC18A2 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/RET |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/IDH3A |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAP4K2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PDHB |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/GBX2 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/STAT3 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/SIGLEC7 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/FASN |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/RAC3 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/ITGAM |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PGAM1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3CD |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/SUCLG2 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/C1QB |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/C1QA |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/TALDO1 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/NEUROG2 |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/TH |
| https://identifiers.org/wikipathways/WP2855_r126378 |
WP2855 |
Dopaminergic neurogenesis |
/SOX2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/IDH2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/SHMT2 |
| https://identifiers.org/wikipathways/WP4290_r118611 |
WP4290 |
Metabolic reprogramming in colon cancer |
/PYCR1 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/NKX2-5 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/IDO2 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PLCG2 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MIR199A1 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/LAT |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MEF2B |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/LYN |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ITGB3 |
| https://identifiers.org/wikipathways/WP3937_r120792 |
WP3937 |
Microglia pathogen phagocytosis pathway |
/PIK3R6 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MIR145 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MIR214 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MIR133A1 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MIR143 |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/MIR133A2 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/AHR |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/PAK4 |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/IRF9 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/YAP1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/YWHAQ |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/INMT |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/TPH2 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/AFMID |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/ACMSD |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/AANAT |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/IFNLR1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/DDC |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/DLD |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/ECHS1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/ALDH2 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/HAAO |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/SGMS1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/WWTR1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/AOC1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/GCDH |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/IFNL2 |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/IFNL3 |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/IFNL1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/AOX1 |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/IL10RB |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/JAK1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/ACAT1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/MAOA |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/ASMT |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MST1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/NF2 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/PAK1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/PAK2 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/PAK3 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAPK9 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/MAPK10 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/KYAT3 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/PAK6 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/PAK5 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ACTA1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ACTA2 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ACTB |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/SAV1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/ALDH8A1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/SRC |
| https://identifiers.org/wikipathways/WP1991_r117830 |
WP1991 |
SRF and miRs in smooth muscle differentiation and proliferation |
/SRF |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/STAT1 |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/STAT2 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/STK3 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/TDO2 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ACTC1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/TEAD1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/TEAD4 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/TEAD3 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ACTG1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/ACTG2 |
| https://identifiers.org/wikipathways/WP2113_r105848 |
WP2113 |
Type III interferon signaling |
/TYK2 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/TEAD2 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/CAT |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/KMO |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/KYNU |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/LIMD1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/LATS1 |
| https://identifiers.org/wikipathways/WP4534_r127231 |
WP4534 |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
/CDH1 |
| https://identifiers.org/wikipathways/WP465_r122957 |
WP465 |
Tryptophan metabolism |
/TPH1 |
| https://identifiers.org/wikipathways/WP2366_r123102 |
WP2366 |
Butyrate-induced histone acetylation |
/AKT1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/MTOR |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/PML |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/PRKDC |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/ZMPSTE24 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CEBPA |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CEBPD |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/PTK2B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/FOXC2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GATA2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LMNA |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/PPP3R1 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/TRPV5 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RARA |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SFRP4 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/ADIPOQ |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/ALOX15B |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/ALOX5AP |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PTGS1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDKN1A |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CDKN1A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RAD52 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/WNT16 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CAMKK1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/LAMP2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CRY1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/BRCA1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/BID |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/IGF1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/RB1CC1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/FAS |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RAD51 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG5 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CAMK2B |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CASP8 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MEF2A |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CAMK2A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/SMC1A |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SEMA3A |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/PIK3C3 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MEF2C |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG16L1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/BAX |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ARHGAP4 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CHRD |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/JAK2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/ABL1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/MAPK1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/RPS6KA5 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/MAP1LC3A |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/PGK1 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/TJP1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCNE1 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/GPI |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/TJP3 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/BBC3 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/TGFB1 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PRKAG2 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/MAPK8 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/DKK1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/PPARGC1A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCND1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/AMBRA1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CALCA |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CAMKK2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDKN1B |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/GAPDH |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PRKAB1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/MAPK14 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BMP5 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/SRF |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCNG1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RAD1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RAD50 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SMAD5 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/WNT5A |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PRKAG3 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/BCL9 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MEF2D |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/SLC2A1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/RPS6KA1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RPA2 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CCND2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCND2 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/TJP2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/TNFSF11 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SMAD9 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/APAF1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/TNFRSF10B |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/GJA8 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/GJA3 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BHLHE41 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDK2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG101 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/RUNX2 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/RUNX2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/EFNB2 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/AMELX |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BMP4 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG4C |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BMP2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BECN1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/TRAP1 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/AFDN |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/NFATC1 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/CHD1L |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/FMO5 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PRKAB2 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PRKAA1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SERPINF1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CASP9 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ARNTL |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BHLHE40 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/NGF |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/LDHA |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CLOCK |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDK4 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MDM2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/IL6 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/KLF4 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/MAP1LC3B |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/TP53 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SMAD4 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/TNFRSF11A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/PMAIP1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/AKT1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CTSK |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/FANCD2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG3 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG12 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/NCAM1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/ATM |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CHEK1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CTF1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/PTH |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG10 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CAMK4 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/MEPE |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/GJA1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BMP3 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RAD17 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BMP6 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/PRKCA |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/DRAM2 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/F11R |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/G6PD |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SQSTM1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/LRP5 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PRKAA2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/PRKAA2 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/ACP6 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PYGO2 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/FYCO1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CASP3 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/IL3 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/TNFRSF11B |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CTHRC1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/VCP |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SOST |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/STAT3 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/WNT10B |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDK1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SMAD1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SP7 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/NPAS2 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PYGO1 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/PGAM1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BCL2 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/BCL2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CYCS |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/PRL |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RAD9A |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/LEP |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/NR1D2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/ATR |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/TRAF6 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG13 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/BDNF |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/TALDO1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ULK1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/PER1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/NRXN1 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PDIA3P1 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PRKAG1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CHEK2 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/KIRREL1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/CSF1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/DRD1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/SEMA4D |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/H2AX |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/HMGB1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/ATG7 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/OCLN |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CALM1 |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/RORB |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/RNU1-151P |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/BMPR2 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR199A1 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/DIO2 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MEF2B |
| https://identifiers.org/wikipathways/WP5205_r122560 |
WP5205 |
Clock-controlled autophagy in bone metabolism |
/PLEKHM1 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/CCT8P1 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/OR13Z1P |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/RPL7AP15 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/PFN1P8 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/GJA5 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/NBPF12 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/OR13Z2P |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/OR13Z3P |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR145 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR145 |
| https://identifiers.org/wikipathways/WP4905_r124898 |
WP4905 |
1q21.1 copy number variation syndrome |
/RN7SL261P |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR29B1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR214 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR133A1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR143 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR133A2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NR1H3 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/CDKN1B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NCOA2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PPARGC1A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CREB1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CREB1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CTNNB1 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/CTSK |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/AHR |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/EPAS1 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/AKT1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/AKT1 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/AKT2 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ALDH1A1 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ALDH2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/FOXO1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/WWTR1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GATA3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NR3C1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/GSK3B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/HIF1A |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/IGF1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/FAS |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/IL2RA |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/IL2RG |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/IL6 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/INS |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/INS |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/IRS1 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/ITGB3 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/JAK1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LEP |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LPL |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/MEF2A |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/MEF2B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/MEF2C |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/MEF2D |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MRE11 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MYC |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/MYC |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/NBN |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/NFKB1 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/TNFRSF11B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PCK1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/PIDD1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/MAPK1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/MAPK3 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/BAD |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/CCND1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/BCL2L1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RFC1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RXRA |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SCD |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/BMP2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/BMP3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/BMP4 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/SOX2 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/STAT1 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/STAT3 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/STAT3 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/TGFB1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/ATRIP |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/TNFSF11 |
| https://identifiers.org/wikipathways/WP5315_r125120 |
WP5315 |
Sebaleic acid formation and metabolism |
/FADS1 |
| https://identifiers.org/wikipathways/WP5315_r125120 |
WP5315 |
Sebaleic acid formation and metabolism |
/FADS2 |
| https://identifiers.org/wikipathways/WP5315_r125120 |
WP5315 |
Sebaleic acid formation and metabolism |
/ALOX5 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/ALOX5 |
| https://identifiers.org/wikipathways/WP5231_r123335 |
WP5231 |
Hippocampal synaptogenesis and neurogenesis |
/CREB1 |
| https://identifiers.org/wikipathways/WP5315_r125120 |
WP5315 |
Sebaleic acid formation and metabolism |
/ACSL1 |
| https://identifiers.org/wikipathways/WP5315_r125120 |
WP5315 |
Sebaleic acid formation and metabolism |
/CYP4F3 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/PAX7 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/TLX1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/TLX2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/TP53AIP1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/TLK2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCNB3 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/TLX3 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/HUS1B |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR449A |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR16-2 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR26A1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR302C |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR373 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR302D |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR421 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR146B |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR181D |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR181A2 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR181C |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR222 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR222 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR449B |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR181B2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR3591 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR3591 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR26A2 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/MIR125B2 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR302A |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR9-1 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/MIR125B1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR181B1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR199A2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR106B |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR302E |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR486-1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR486-2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR20A |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR20A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR195 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR106A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR424 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR17 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR17 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR330 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PTGES |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PRXL2B |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PTGES2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDK6 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/EZH2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCND3 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/GADD45A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCNB2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDC25C |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDK5 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCNE2 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR206 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR34B |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR21 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/MIR21 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR29C |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ADH1A |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ADH7 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/CYP2A6 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/CYP4A11 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MCM7 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/SLC9A1 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/CBR1 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/GGT1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/E2F1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/HDAC5 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/ID2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CCNB1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/DDB2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RB1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/LEFTY2 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/SLC2A2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/CDC25A |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/CYP2D6 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/CYP2E1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/FYN |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/IFNAR1 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/IFNB1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/IL7 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/IL7R |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/PDGFB |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/RASGRF1 |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/SPP1 |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/STAT5A |
| https://identifiers.org/wikipathways/WP205_r126339 |
WP205 |
IL-7 signaling pathway |
/STAT5B |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PLA2G6 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PLA2G4B |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PTGS2 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PLA2G5 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/AKR1C3 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PLA2G4A |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PTGIS |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/GADD45G |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/GPR68 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/RRM2B |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/PFKP |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/SESN1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/GADD45B |
| https://identifiers.org/wikipathways/WP12_r126682 |
WP12 |
Osteoclast signaling |
/AIMP2 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/TPI1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MYOD1 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/PGK2 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/SFN |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/TLK1 |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/HK1 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/MYEF2 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/LTA4H |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/ALOX15 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/DPEP1 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/ALOX12 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/PTGDS |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/LTC4S |
| https://identifiers.org/wikipathways/WP1946_r126409 |
WP1946 |
Cori cycle |
/GPT |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/MIR1-1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR1-1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR210 |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/MIR133B |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR133B |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR203A |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR203A |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR3074 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR128-1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR181A1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR181A1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR150 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR221 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR221 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR16-1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR16-1 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/LEFTY1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR15A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR29A |
| https://identifiers.org/wikipathways/WP1559_r126397 |
WP1559 |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
/MIR29A |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR24-1 |
| https://identifiers.org/wikipathways/WP1530_r126392 |
WP1530 |
miRNA regulation of DNA damage response |
/MIR223 |
| https://identifiers.org/wikipathways/WP2023_r117676 |
WP2023 |
Cell differentiation - expanded index |
/MIR223 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ADH1B |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ADH1C |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ADH4 |
| https://identifiers.org/wikipathways/WP206_r117723 |
WP206 |
Fatty acid omega-oxidation |
/ADH6 |
| https://identifiers.org/wikipathways/WP167_r124883 |
WP167 |
Eicosanoid synthesis |
/TBXAS1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/EIF4EBP1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/EIF4G1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/EIF4G3 |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/EIF2AK1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MTOR |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/MTOR |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TRAM1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNC1I2 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNLL1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGS1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT27 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/NFATC4 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DCTN6 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/IGFBP5 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/INVS |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/DLG4 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DCTN4 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/ALOX5AP |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNC1LI2 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNC1LI1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PDCD4 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNC1I1 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/HK2 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/ALPL |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DCTN5 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DCTN2 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/ALOX15B |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/ADIPOQ |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/PDCD1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNC1H1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DCTN1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/MIR33B |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/CEBPD |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/CEBPA |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNLL2 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOA5 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/ABCA1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/FDFT1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/HMGCR |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOE |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/LDLR |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/SOAT1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/SQLE |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/BAD |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/ALOX5 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAP2K3 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIK3CB |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TAB2 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CAMK2B |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAP2K4 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CAMK2A |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPS6KA2 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAP2K7 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TAB1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPS6KA5 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NFKBIA |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/CSNK2A1 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/XIAP |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/AKT2 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIK3CG |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAP2K6 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NFKB1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/NFKB1 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/PPARGC1A |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/IFNG |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/IFNG |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAPK14 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/VEGFA |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/VEGFA |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/NR3C1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/ZAP70 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/AKT3 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/SLC2A1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPS6KA1 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/CREB1 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CREB1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/CREB1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIK3CA |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/PIK3CA |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGER2 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/IL1B |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IRF3 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/NFATC1 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TRAF3 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CASP9 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/ARNTL |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/IL6 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IL6 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TLR4 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/MYC |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPS6 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAP2K5 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/ADCY3 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPTOR |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/AKT1 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CAMK2D |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/NOTCH1 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TIRAP |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/FOXO1 |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/FOXO1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PRKCA |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/GNAQ |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPS6KA4 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/STAT3 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/IRS1 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/INSR |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/PPID |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/BCL2 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CYCS |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/MYD88 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/LEP |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TRAF6 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/RPS6KB2 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/JUN |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/PTPN11 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/NRIP1 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP4030_r123403 |
WP4030 |
SCFA and skeletal muscle substrate metabolism |
/SLC2A4 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/LCK |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TBK1 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IRAK1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/MAPK11 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IRF7 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/IRS2 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/RXRA |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IRAK4 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CALM1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/VAMP2 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/TNF |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/TNF |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/FBP1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/AKT3 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/CYP7A1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/EIF4E |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/AKT1 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/AKT1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/AKT2 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/FOXO1 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/G6PC1 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/GJA5 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/HIF1A |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/LDHA |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/LPL |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/PGAM1 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/PGK1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAPK1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAPK3 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/MAPK4 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/MAPK6 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/MAPK7 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAPK9 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAPK10 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAP2K1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/MAP2K2 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/MAPK12 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/ABCG5 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/ABCG8 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SP1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SREBF1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/STAT1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/STAT2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/STAT3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/TGFB1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/TNF |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/WNT1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/WNT10B |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/USP7 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NRIP1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/IRS4 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NCOA1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SOCS1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/IRS2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SOCS3 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IKBKB |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/CHUK |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/MAP3K7 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TNF |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/TNF |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/IFNG |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/TP53 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/CXCL8 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/NFKBIA |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/AHR |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/RIPK1 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IKBKE |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/TICAM1 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IRAK3 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IKBKG |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/PKD1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGER3 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/SDCCAG8 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT80 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CNGB1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CNGB1 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/ACTN2 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/EFHC1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT74 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/TSPO |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/PCK2 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/RP2 |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/KLF5 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/NFAT5 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CLUAP1 |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/QPRT |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CEP41 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CEP164 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/SOX6 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/ARHGDIB |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/AKAP9 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/SAT1 |
| https://identifiers.org/wikipathways/WP4030_r123403 |
WP4030 |
SCFA and skeletal muscle substrate metabolism |
/PYY |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CNGA4 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNC2LI1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/ARHGDIA |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CNGA3 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGES |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/BATF |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CNGB3 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CNGA2 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/PDE2A |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/PDCD1LG2 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CNGA1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/MIR33A |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/ARHGDIG |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/AGPAT2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CELF1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PLIN2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/EBF1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/S1PR3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/FRZB |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/BSCL2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GDF10 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/KLF15 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/RACGAP1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GTF3A |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/MBNL1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/ASIP |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NDN |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PCK2 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/SIRT7 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/OTUD6B |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/PLTP |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/S1PR5 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CISD1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SPOCK1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/KLF5 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NR2F1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/MIXL1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/KLF7 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/S1PR2 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PRXL2B |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/NFATC3 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/NSF |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GRIN2D |
| https://identifiers.org/wikipathways/WP4030_r123403 |
WP4030 |
SCFA and skeletal muscle substrate metabolism |
/PPARD |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/VHL |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/CAMK2G |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GRIN2C |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PRKCD |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/AQP4 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NEFL |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/U2AF2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GADD45A |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/DDIT3 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/EIF4A1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/EIF4A2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GATA4 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/HMGA1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOA2 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOC1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/ASAH1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/MIF |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/PLCB2 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/PLCB3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PPARD |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CYP26B1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/SPHK2 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/SMPD2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/STAT6 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PNPLA3 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/DGAT1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/SPHK1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/SCARB1 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NOS2 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/CREB3L3 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/FGFR3 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PRKACA |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/PRKACA |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGS2 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/GNAS |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/GNAS |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NOS1 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/DLL3 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/SIRT1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/NFATC2 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/AVP |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/JAG1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/STX4 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/PLAT |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/CREB3 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/RAB5C |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/RAB5B |
| https://identifiers.org/wikipathways/WP4030_r123403 |
WP4030 |
SCFA and skeletal muscle substrate metabolism |
/GCG |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NPPB |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/TWIST1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGIS |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/AVPR2 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/GNAI1 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/KDR |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/CALU |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/DLL4 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/PPARG |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/PRKG2 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/RB1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/PRKACB |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/CREB3L4 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/RAB5A |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/CREB5 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PDK1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/CD8A |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/CREB3L1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/CD3G |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/ADCY9 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NOS3 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/PRKACG |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/CD3D |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NPR1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGER4 |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/IFNB1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/CD8B |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/CEBPB |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/PDE3A |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/RELA |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/ADCY6 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/NPPA |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GRIN1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/CREB3L2 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GRIN2A |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/JAG2 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/RAB11B |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/HLA-DRB1 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/LPAR1 |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/DLL1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/CD3E |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/HLA-A |
| https://identifiers.org/wikipathways/WP3413_r116601 |
WP3413 |
NOTCH1 regulation of endothelial cell calcification |
/ITGA1 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GRIN2B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CEBPB |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/USP19 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CNTFR |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/KLF6 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CFD |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/AGT |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/DVL1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/E2F1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/EIF4B |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/PLCB1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GH1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/GNAI1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/GNAI2 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/GNAI3 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOA1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOB |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/IL6ST |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LIF |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LIFR |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LIPE |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SMAD3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/OSM |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/SERPINE1 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/PIK3C2B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PLIN1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PPARA |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PPARG |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PRLR |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/OTUD7B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/PTGIS |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/USP28 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/USP37 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/TRIB3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RB1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/BMP1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/STAT5A |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/STAT5B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/HNF1A |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/TWIST1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/UCP1 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/OTUB2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/WNT5B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/FZD1 |
| https://identifiers.org/wikipathways/WP5216_r126981 |
WP5216 |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
/USP44 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NCOR2 |
| https://identifiers.org/wikipathways/WP5044_r127649 |
WP5044 |
Kynurenine pathway and links to cell senescence |
/IFNB1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PLA2G4A |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIM2 |
| https://identifiers.org/wikipathways/WP4030_r123403 |
WP4030 |
SCFA and skeletal muscle substrate metabolism |
/FFAR2 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGER1 |
| https://identifiers.org/wikipathways/WP4030_r123403 |
WP4030 |
SCFA and skeletal muscle substrate metabolism |
/FFAR3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NAMPT |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/E2F4 |
| https://identifiers.org/wikipathways/WP26_r126281 |
WP26 |
S1P receptor signal transduction |
/S1PR1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/ID3 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOC3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RBL1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RBL2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RXRG |
| https://identifiers.org/wikipathways/WP3851_r121712 |
WP3851 |
TLR4 signaling and tolerance |
/INPP5D |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GUCY1B1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/RAB11A |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/PTGDS |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/ALOX12 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/LTA4H |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GUCY1B2 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GUCY1A2 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/ALOX15 |
| https://identifiers.org/wikipathways/WP4008_r125786 |
WP4008 |
NO/cGMP/PKG mediated neuroprotection |
/GUCY1A1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/DYNC2H1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/LTC4S |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/GADD45B |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RETN |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/DLK1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/NCOR1 |
| https://identifiers.org/wikipathways/WP5122_r119484 |
WP5122 |
Prostaglandin and leukotriene metabolism in senescence |
/TBXAS1 |
| https://identifiers.org/wikipathways/WP4585_r127234 |
WP4585 |
Cancer immunotherapy by PD-1 blockade |
/CD274 |
| https://identifiers.org/wikipathways/WP3599_r105845 |
WP3599 |
Transcription factor regulation in adipogenesis |
/LPIN1 |
| https://identifiers.org/wikipathways/WP4566_r127382 |
WP4566 |
Translation inhibitors in chronically activated PDGFRA cells |
/PIM1 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/AQP3 |
| https://identifiers.org/wikipathways/WP5085_r119785 |
WP5085 |
Vasopressin-regulated water reabsorption |
/AQP2 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/CETP |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/CYP26A1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/EGR2 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LPIN1 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOA4 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/APOC2 |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/LCAT |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/LIPC |
| https://identifiers.org/wikipathways/WP430_r122069 |
WP430 |
Statin inhibition of cholesterol production |
/LRP1 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/RORA |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LPIN3 |
| https://identifiers.org/wikipathways/WP236_r105873 |
WP236 |
Adipogenesis |
/LPIN2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A10 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A9 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP51A1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/LIG3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/FMO3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP24A1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CACNB1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/ERI1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2C18 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/ASIC2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL7 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP27B1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PPP1R1B |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCT6B |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP19A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP11A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GPX4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP11B2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4F2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4F12 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/LHX1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL3L1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL3L3 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/SRD5A1 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/CYP11B2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/RFFL |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/MAPK1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTZ1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/MAPK3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL2 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/NSD2 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/CBL |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/SOS1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/MED1 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/IRF3 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/POLN |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/FMO5 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAT10 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/TLR4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP1A1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/PIK3R1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP7A1 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/MYD88 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/TRAF6 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/RAD51D |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4F3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2B6 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/TLR9 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/INMT |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL5 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/DDX52 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST14 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/H3-3A |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/TNF |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/IFNG |
| https://identifiers.org/wikipathways/WP5376_r127460 |
WP5376 |
17p13.3 (YWHAE) copy number variation |
/TH |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/CYP3A4 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/NFKB1 |
| https://identifiers.org/wikipathways/WP5376_r127460 |
WP5376 |
17p13.3 (YWHAE) copy number variation |
/DDC |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/BECN1 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/MAP1LC3A |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS3ST1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/LASP1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/MGST1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/TACC3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR7A2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTO2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/KCNAB2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NDST1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/NLE1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/FNDC8 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/FMO4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1B1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAT14 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/NELFCD |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/FBXL20 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAT9 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAA40 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/MAK |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CILK1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/RAB23 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/ARL6 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/NPHP3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST10 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CEP104 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/PKD2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP20A1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/DYNC2I2 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/TRIM32 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT43 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAA50 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS9 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT81 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST8 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS3ST3B1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/MKKS |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/DYNC2I1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTT2B |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2A3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2B28 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/LCA5 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST5 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST12 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS6ST1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/NEK1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/DYNC2LI1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/ARL3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NDST4 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS7 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTCD |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAA30 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS4 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/UNC45B |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/MIEN1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/ARL5C |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/STAC2 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/WDPCP |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAT8 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/DCDC2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST7 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/INPP5E |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/SCLT1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS2ST1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS3ST3A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GAL3ST2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SLFN13 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/FLCN |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAT2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2B4 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CFAP418 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/PDE6D |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/PKD1L1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CFAP410 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/NEK8 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PLXDC1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PGAP3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/IKZF3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS3ST6 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR7A3 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS5 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/LZTFL1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NDST3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SLC35G3 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/TMEM67 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/TTC8 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NDST2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SLFN5 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CDK12 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/LETM1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/TMEM129 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/KCNAB1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/KCNAB3 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/PKHD1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS6ST2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAT1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/NEUROD2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SLFN12 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SLFN11 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IQCB1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAA20 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2A1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/FAM53A |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GAL3ST3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/TMEM107 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/PCARE |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS10 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST13 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBS12 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS3ST4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST6 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/EFHC2 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/NELFA |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS6ST3 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/NAT8L |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAT8L |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4Z1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4X1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP27C1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/TMEM216 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2B15 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TMEM132E-DT |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTK1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GPX1P1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2B17 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1B10 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CNGA1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/ZNF830 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/TRAF3IP1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/NELFE |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/FBXO47 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/DYNLT2B |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2B11 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/BBIP1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GPX5 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TLK2P1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SLFN14 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/C4orf48 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NAA80 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/SCARNA22 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS3ST5 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3G |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/HEATR9 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TAF15 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/GAS2L2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/C17orf50 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/RASL10B |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/MMP28 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3K |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/EPOP |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/ZNHIT3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SOCS7 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3H |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3L |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3B |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3I |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/MLLT6 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SYNRG |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/C17orf98 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/AATF |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/LYZL6 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/ARHGAP23 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/DUSP14 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TADA2A |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PIGW |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/SRCIN1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/GPR179 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CISD3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/RDM1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/MYO19 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TBC1D3C |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/GGNBP2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/C17orf78 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/DHRS11 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/MRM1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/MRPL45 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/MIR943 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A5 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2A2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST9 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/SCAPER |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP26B1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/EVC |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTP1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/MGST2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTT2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSR |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/GLI3 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/SUFU |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL8 |
| https://identifiers.org/wikipathways/WP5376_r127460 |
WP5376 |
17p13.3 (YWHAE) copy number variation |
/YWHAE |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/EPHX2 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/SMO |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTM5 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTM3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2J2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2C9 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2C8 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/GPR161 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/MGST3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP17A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GLYAT |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GLYATL2 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/SLBP |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/KIF7 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GLYATL1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTM4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTA4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST11 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/EVC2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTA3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GPX2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TMEM132E |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTA5 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/PTCH1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GAL3ST4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GPX3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2A6 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CWC25 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL15 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A7 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A4 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/CBR1 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/SRD5A2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP3A43 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP46A1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/FGFR3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/COMT |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2D6 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PEX12 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/SULT1E1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/GAB1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1D1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/PLCG1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/USP9X |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/RPL23 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2E1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTM1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP27A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/BAAT |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP1B1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/FGF2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP1A2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/ERBB2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/EPHX1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP39A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1C2 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/FRS2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A6 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT2B7 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL11 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP7B1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/GRB2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP8B1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1C1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1C3 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/SULT1A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1C4 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTM2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTA1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSTA2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL4 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PCGF2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL3 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/ACACA |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/UGT1A3 |
| https://identifiers.org/wikipathways/WP5336_r126593 |
WP5336 |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
/IFNB1 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/AKR1C4 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/AKR1C3 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/AKR1D1 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/AKR1C2 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/AKR1C1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/AP2B1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CRX |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/OCRL |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HS3ST2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/TPMT |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/HNMT |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/NNMT |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/TCAP |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL13 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/NELFB |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL16 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL18 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/HNF1B |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL4L2 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PIP4K2B |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/CCL14 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/FUZ |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/MKS1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/ZIC2 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/CLTCL1 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/BCS1L |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GSS |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT52 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/SULT2A1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT57 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/AKR1A1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/WDR35 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/TTC21B |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT172 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CHST4 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/GRB7 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/PNMT |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4B1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2U1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/WDR19 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP11B1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT122 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2C19 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4F11 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4F22 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP4F8 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/DYNC2H1 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/IFT140 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/CEP290 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP21A2 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/CYP21A2 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/CYP11B1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/FMO1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP2W1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/SULT2B1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/FMO2 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP26A1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/CYP3A5 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/GAL3ST1 |
| https://identifiers.org/wikipathways/WP702_r127768 |
WP702 |
Metapathway biotransformation Phase I and II |
/SULT4A1 |
| https://identifiers.org/wikipathways/WP5287_r126824 |
WP5287 |
17q12 copy number variation syndrome |
/STARD3 |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/UBE2J2 |
| https://identifiers.org/wikipathways/WP5234_r123515 |
WP5234 |
Bardet-Biedl syndrome |
/ARL13B |
| https://identifiers.org/wikipathways/WP5365_r127455 |
WP5365 |
4p16.3 copy number variation |
/CKAP5 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/HSD11B1 |
| https://identifiers.org/wikipathways/WP5280_r127387 |
WP5280 |
Glucocorticoid biosynthesis |
/HSD11B2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/EIF4G1 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/EIF4EBP2 |
| https://identifiers.org/wikipathways/WP3612_r124813 |
WP3612 |
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling |
/ABCC2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/MTOR |
| https://identifiers.org/wikipathways/WP2870_r106411 |
WP2870 |
Extracellular vesicle-mediated signaling in recipient cells |
/MTOR |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/TFAP2B |
| https://identifiers.org/wikipathways/WP3580_r127752 |
WP3580 |
Methionine de novo and salvage pathway |
/CHDH |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/MKNK1 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/DNM2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/DICER1 |
| https://identifiers.org/wikipathways/WP3580_r127752 |
WP3580 |
Methionine de novo and salvage pathway |
/AHCY |
| https://identifiers.org/wikipathways/WP3876_r123398 |
WP3876 |
BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation |
/SFRP1 |
| https://identifiers.org/wikipathways/WP2805_r106523 |
WP2805 |
exRNA mechanism of action and biogenesis |
/ERI1 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/DUSP3 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/PRKAR1A |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/ALDH5A1 |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/SMARCA4 |
| https://identifiers.org/wikipathways/WP2805_r106523 |
WP2805 |
exRNA mechanism of action and biogenesis |
/DGCR8 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/GAD1 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/DLG4 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/TARBP2 |
| https://identifiers.org/wikipathways/WP3580_r127752 |
WP3580 |
Methionine de novo and salvage pathway |
/MAT1A |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/NR3C2 |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/ATP1A1 |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/SOX11 |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/GATA2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/ABAT |
| https://identifiers.org/wikipathways/WP185_r126267 |
WP185 |
Integrin-mediated cell adhesion |
/CSK |
| https://identifiers.org/wikipathways/WP2805_r106523 |
WP2805 |
exRNA mechanism of action and biogenesis |
/DICER1 |
| https://identifiers.org/wikipathways/WP2870_r106411 |
WP2870 |
Extracellular vesicle-mediated signaling in recipient cells |
/DKK4 |
| https://identifiers.org/wikipathways/WP2805_r106523 |
WP2805 |
exRNA mechanism of action and biogenesis |
/DROSHA |
| https://identifiers.org/wikipathways/WP2870_r106411 |
WP2870 |
Extracellular vesicle-mediated signaling in recipient cells |
/MFGE8 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/RARB |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/KHSRP |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/PICK1 |
| https://identifiers.org/wikipathways/WP3580_r127752 |
WP3580 |
Methionine de novo and salvage pathway |
/SMS |
| https://identifiers.org/wikipathways/WP3580_r127752 |
WP3580 |
Methionine de novo and salvage pathway |
/ODC1 |
| https://identifiers.org/wikipathways/WP3580_r127752 |
WP3580 |
Methionine de novo and salvage pathway |
/SRM |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/CRABP2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/GRIP2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/GRIP1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/CRABP1 |
| https://identifiers.org/wikipathways/WP185_r126267 |
WP185 |
Integrin-mediated cell adhesion |
/RHO |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/CDKN1A |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/BAD |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/BID |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/GABRA1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/BAK1 |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/CDH1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/PIK3CB |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/PIK3CB |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/CAMK2B |
| https://identifiers.org/wikipathways/WP2513_r119820 |
WP2513 |
Nanoparticle triggered regulated necrosis |
/CASP8 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/CASP8 |
| https://identifiers.org/wikipathways/WP2513_r119820 |
WP2513 |
Nanoparticle triggered regulated necrosis |
/TNFRSF1A |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/CAMK2A |
| https://identifiers.org/wikipathways/WP3644_r118983 |
WP3644 |
NAD+ metabolism |
/SIRT6 |
| https://identifiers.org/wikipathways/WP3645_r123910 |
WP3645 |
NAD+ biosynthetic pathways |
/SIRT6 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/BAX |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/MAPK1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/SOS2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/MMP9 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/FMR1 |
| https://identifiers.org/wikipathways/WP2513_r119820 |
WP2513 |
Nanoparticle triggered regulated necrosis |
/TRADD |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/MAPK3 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/TSC2 |
| https://identifiers.org/wikipathways/WP3580_r127752 |
WP3580 |
Methionine de novo and salvage pathway |
/IL4I1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/AKT2 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/PIK3R2 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/RHEB |
| https://identifiers.org/wikipathways/WP3527_r126527 |
WP3527 |
Pre-implantation embryo |
/GATA3 |
| https://identifiers.org/wikipathways/WP2513_r119820 |
WP2513 |
Nanoparticle triggered regulated necrosis |
/MAPK8 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/RPS6KB1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/CCND1 |
| https://identifiers.org/wikipathways/WP3876_r123398 |
WP3876 |
BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation |
/SMAD5 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/SOS1 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/SOS1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/AKT3 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/PIK3R3 |
| https://identifiers.org/wikipathways/WP4549_r127643 |
WP4549 |
Fragile X syndrome |
/CREB1 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/FOXO3 |
| https://identifiers.org/wikipathways/WP3876_r123398 |
WP3876 |
BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation |
/SMAD9 |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/PIK3CA |
| https://identifiers.org/wikipathways/WP4255_r127755 |
WP4255 |
Non-small cell lung cancer |
/POLK |